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ABSTRACT 
 
Introduction: Executive dysfunction is a common non-motor symptom of Parkinson’s 
Disease (PD). However, in individuals with PD, executive function (EF) is also associated 
with motor functions, i.e. gait and balance (Xu et al., 2015) and impaired EF is a predictor of 
future recurrent falls (Mak et al., 2014). Previous research in PD has shown selected 
improvements in EF through varied exercise interventions, such as aerobic exercise, 
resistance training and combination exercise (David et al., 2015; Duchesne et al., 2015; 
Tanaka et al., 2009). Nevertheless, no research to date has investigated the influence of a 
balance or sensory-motor training (SMT) programme on EF in isolation. Therefore the 
current study investigated whether an eight-week sensory-motor training programme would 
alter EF in non-demented individuals with mild to moderate PD. 
 
Methods: A convenience sample of 42 individuals with idiopathic PD was divided into an 
experimental (EXP) and a placebo (PBO) group. This was a time-series design with an eight-
week baseline phase (pre- to mid-intervention), followed by an eight-week treatment phase 
(mid- to post-intervention) in both groups. The baseline phase was the control period in 
which the participants continued their normal activities with no intervention. The EXP (n = 
25; Age: 66 ± 8years; Hoehn & Yahr (HY) stage: 2.5, 2.0 – 3.0; Movement Disorder Society 
– Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) III rating: 31.9 ± 14.3) 
participated in an eight-week SMT, while the PBO (n = 17; Age: 71 ± 9years; HY: 2.0, 1.0 – 
3.0; MDS-UPDRS III: 22.5 ± 10.0) wore a placebo feedback-wristband over the eight-week 
treatment phase. The primary outcome measures assessed were Updating (Trail Making 
Test, TMT), Set shifting (Wisconsin Card Sorting Test; WCST), Inhibition (Adapted Stroop 
Task), Perceived stability of balance (Activities-Specific Balance Confidence Scale; ABC) 
and Mobility (Timed Up and Go; TUG). Secondary outcome measures evaluated were 
Global cognition (Montreal Cognitive Assessment; MoCA), Disease severity (MDS-UPDRS 
and HY), Quality of life (Parkinson’s Disease Questionnaire; PDQ-39) and Depression 
(Hamilton Rating Scale for Depression; HAM-D). Participants were assessed at pre-, mid- 
and post-intervention over 16 weeks.  
 
Results: Treatment effects were observed for MDS-UPDRS III (p<0.01) and MDS-UPDRS 
total score (p=0.02), TMT A (p<0.0001), Global WCST Score (p<0.0001), Choice reaction 
time (CRT) 1: accuracy (p=0.04), CRT 2: time (p=0.007), Interference: accuracy (p<0.0001) 
and TUG (p<0.001). The EXP and PBO differed significantly at post-intervention in PDQ-39 
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variable Bodily discomfort (p=0.04), TMT A (p=0.03), CRT 2: time (p=0.01), Incongruent 1: 
time (p=0.04) and TUG (p<0.001).; and the changes over time in EXP, for the treatment 
phase for UPDRS II (p=0.04), PDQ-39 variable Stigma (p=0.01), CRT 2: time (p=0.048), 
ABC (p=0.01) and TUG (p<0.001). 
 
Conclusion: The eight-week SMT was beneficial for selected aspects of EF, namely 
Inhibition, perceived stability of balance, mobility and disease severity. The EF of Updating 
and Set shifting as well as global cognition, depressive moods, and quality of life, remained 
unchanged. Thus, a SMT programme has the potential to improve Inhibition and mobility in 
individuals with mild to moderate PD, which could result in better balance and a reduction in 
falls.  
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ABSTRAK 
 
Inleiding: Uitvoerende disfunksie is `n algemene nie-motoriese simptoom van Parkinson se 
Siekte (PD). In individue met PD, word uitvoerende funksie (EF) egter ook geassosieer met 
motoriese funksies soos loopgang en balans (Xu et al., 2015) en ingekorte EF is `n 
voorteken van toekomstige herhalende val insidente (Mak et al., 2014). Vorige navorsing 
oor PD het getoon dat sekere verbeteringe in EF gevolg het deur middel van verskeie 
oefeningintervensies, soos aërobiese-, weerstands- en kombinasie oefeninge (David et al., 
2015; Duchesne et al., 2015; Tanaka et al., 2009). Nogtans het geen navorsing tot dusver 
die invloed van `n balans of sensoriese-motoriese oefenprogram (SMT) op EF in isolasie 
ondersoek nie. Daarom het die onderhawige studie ondersoek ingestel om te bepaal of `n 
agt-weke sensoriese-motoriese oefeningsprogram EF sal verbeter in nie-demensie 
individue met ligte tot matige PD. 
 
Metodes: Geriefshalwe is `n steekproef van 42 individue met idiopatiese PD opgedeel in `n 
eksperimentele (EXP) groep of `n placebo (PBO) groep. Hierdie was `n tyd-reeks ontwerp 
met `n agt-weke basislyn fase (pre- tot mid-intervensie) gevolg deur `n agt-weke 
behandelingsfase (mid- tot post-intervensie) in beide groepe. Die basislyn fase was die 
kontrole periode waartydens die deelnemers voortgegaan het met hul normale aktiwiteite 
sonder enige intervensie. Die EXP groep (n = 25; Ouderdom: 66 ± 8jaar; Hoehn & Yahr (HY) 
stadium: 2.5, 2.0 – 3.0; “Movement Disorder Society – Unified Parkinson’s Disease Rating 
Scale” (MDS-UPDRS) III rating: 31.9 ± 14.3) het deelgeneem aan `n agt-weke SMT, terwyl 
die PBO groep (n = 17; Oud: 71 ± 9jaar; HY: 2.0, 1.0 – 3.0; MDS-UPDRS III: 22.5 ± 10.0) `n 
placebo terugvoer-armband oor die agt-weke behandelingsfase gedra het. Die primêre 
eindresultate wat getoets is was Opdatering (Trail Making Test, TMT), Stel verskuiwing 
(Wisconsin Card Sorting Test; WCST), Inhibisie (Aangepaste Stroop Task), Waargenome 
stabiliteit van balans (Activities-Specific Balance Confidence Scale; ABC) en mobiliteit 
(Timed Up and Go; TUG).  Die sekondêre eindresultate wat geëvalueer is was Globale 
kognisie (Montreal Cognitive Assessment; MoCA), Siekte erns (MDS-UPDRS en HY), 
Lewenskwaliteit (Parkinson’s Disease Questionnaire; PDQ-39) en Depressie (Hamilton 
Rating Scale for Depression; HAM-D). Deelnemers is getoets by pre-, mid- en post-
intervensie oor 16 weke.  
Resultate: Behandelingseffekte is waargeneem vir MDS-UPDRS III (p<0.01) en MDS-
UPDRS totaal (p=0.02), TMT A (p<0.0001), Globale WCST Telling (p<0.0001), Keuse 
reaksietyd (CRT) 1: akkuraatheid (p=0.04), CRT 2: tyd (p=0.007), Interferensie: 
Stellenbosch University  https://scholar.sun.ac.za
v 
 
akkuraatheid (p<0.0001) en TUG (p<0.001). Die EXP en PBO het statisties betekenisvol 
verskil tydens post-intervensie in PDQ-39 veranderlike Liggaamlike ongemak (p=0.04), TMT 
A (p=0.03), CRT 2: tyd (p=0.01), Inkongruent 1: tyd (p=0.04) en TUG (p<0.001).; en die 
veranderinge met verloop van tyd in EXP, vir die behandelingsfase UPDRS II (p = 0.04), 
PDQ-39 veranderlike Stigma (p = 0,01), CRT 2: tyd (p = 0,048), ABC (p = 0,01) en TUG (p 
<0,001).  
 
Gevolgtrekking: Die agt-weke SMT was voordelig vir sekere aspekte van EF, naamlik 
Inhibisie, persepsie van balans stabiliteit, mobiliteit en die erns van die siekte. Die EF van 
Opdatering en Stel verskuiwing asook globale kognisie, depressiewe gemoedstoestande en 
lewenskwaliteit het onveranderd gebly. Dus, ` n SMT program het die potensiaal om Inhibisie 
en mobiliteit te verbeter in individue met lig tot matige PD, wat kan lei tot beter balans en 
afname in val insidente.  
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DEFINITIONS OF KEY TERMINOLOGY 
 
Categories Completed (CC): a Wisconsin Card Sorting Test (WCST) variable referring to 
the number of categories the individual has correctly sorted, i.e. ten consecutive 
correctly-sorted cards (maximum = 6) (Strauss et al., 2006). 
 
Cognitive Function (CF): includes both basic and higher-level functions. Basic cognitive 
functions comprise attention, working memory, long-term memory and perception, while 
higher-level cognitive functions comprise speech and language, decision making and 
executive functions (Glisky, 2007). 
 
Executive Function (EF): “higher-level” or “meta-cognitive” functioning that manages other 
more basic cognitive functions as well as the regulation of emotions and attention 
necessary for goal-directed behaviours (Etnier & Chang, 2009). 
 
Failure To Maintain Set (FTMS): a WCST variable that refers to a situation where an 
individual correctly sorts five or more consecutive cards, but then makes a mistake and 
fails to complete the category (Strauss et al., 2006). 
 
Independent-living: For the purpose of this study, individuals diagnosed with Parkinson’s 
Disease who are able to lead an independent life without the need for assistance in 
some ADL and can ambulate on their own or with an assistive device, i.e. a walking 
stick or crutch. Typically categorized by Hoehn & Yahr stages III and lower, thus 
excluding stages IV & V. 
 
Inhibition, or Inhibitory Control: involves an individual’s ability to intentionally inhibit a 
response which is dominant, automatic, or prepotent (priority response tendency) 
(Miyake et al., 2000). 
 
Mild to Moderate Parkinson’s Disease: refers to those classified as 1, 2 or 3 according to 
the Hoehn and Yahr Scale (Martínez-Martín et al., 2015). 
 
Neuroplasticity: structural or functional nervous system changes that occur as a result of 
experience (Nocera & Hackney, 2015). 
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Perseverative Responses (PR): a WCST variable referring to the number of times an 
individual continues to (or persists in) responding to an incorrect card characteristic 
(Strauss et al., 2006). 
 
Sensory-motor training: refers to an intervention that focuses on improving postural 
control, most often through the integration of sensory information and, particularly, 
through increasing proprioceptive function (Aman et al., 2014). 
 
Set shifting: also known as cognitive flexibility, it is the ability to shift back and forth between 
various tasks or mental sets (Miyake et al., 2000). 
 
Total Errors (TE): a WCST variable refers to the total number of errors that the participant 
makes during the WCST. 
 
Updating, or Working Memory: involves the monitoring of incoming task-relevant 
information and then appropriately updating the informational content by replacing no-
longer relevant information with newer and more appropriate information (Miyake et al., 
2000). 
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OVERVIEW 
 
This thesis begins with the first chapter, which provides a general introduction and brief 
overview of the research topic. This is followed by a more detailed review in Chapter 2 of 
the available literature on Parkinson’s Disease epidemiology and aetiology, cognitive and 
executive function, exercise and executive function both in the general population as well 
as the Parkinson’s Disease population, the mechanisms at play regarding the effect of 
exercise on executive function, and sensory-motor training in Parkinson’s Disease. Chapter 
Three outlines the main research question, the objectives and elaborates on variables, 
assumptions, limitations and delimitations as well as the rationale for the investigation. 
Thereafter, Chapter Four describes the methodology of the study, expounding on study 
design, the participants, the timeline and phases of the study, as well as elaborating on the 
tests and questionnaires which were used. Chapter Five details the results of the study and 
includes tables and graphs for straightforward reference. Chapter Six expands on and 
discusses the results of Chapter Five, in addition to providing insight into limitations and 
recommendations for future studies. The thesis adheres to the Harvard referencing style. 
Appendices are included at the end of the thesis to expand on or clarify sections which may 
not be evident in the text and include ethical approval, informed consent forms, tests, 
questionnaires, sensory-motor training programme lay out and other information pertinent 
to the study. 
 
Stellenbosch University  https://scholar.sun.ac.za
1 
 
CHAPTER ONE 
 
INTRODUCTION 
 
The main purpose of this study was to establish if an eight-week sensory-motor training 
(SMT) programme with added somatosensory cues could possibly alter executive 
functioning (EF) in non-demented individuals with mild to moderate Parkinson’s Disease 
(PD). This was to determine whether such an exercise intervention might have a meaningful 
impact on this important component of cognitive function. 
 
PD is a common, progressive neurodegenerative disease, second only to Alzheimer’s 
disease (Kalia & Lang, 2015; Nocera & Hackney, 2015). It is estimated that between 7 and 
10 million individuals worldwide are presently living with PD (Nocera & Hackney, 2015). In 
addition, PD prevalence rises with increasing age (Taba & Asser, 2004), which is considered 
the greatest risk factor for the development of PD (Kalia & Lang, 2015). Consequently 
Dorsey et al. (2007) predicted a 50% increase in PD worldwide by 2030. According to 
Okubadejo et al. (2006) Africa is undergoing a demographic transition with a growing 
number of individuals over the age of 65 years. This statement was supported by Velkoff 
and Kowal (2007) who predicted that by 2050 there would be an estimated 139 million 
people in Sub-Saharan African countries older than 60 years. Accordingly, diseases such 
as PD, which predominantly affect aging populations, are predicted to become more 
common (Okubaio et al., 2006) and developing countries need to investigate cost-effective 
interventions to reduce the disease burden. In 2006, Noyes et al. considered the progressive 
nature of PD and estimated that the cost of PD exceeded $100 000 (approximately ZAR 1 
382 240) per person. 
 
Individuals with PD are typically affected not only by motor symptoms such as bradykinesia, 
tremor, rigidity and postural instability but also by non-motor symptoms such as mood 
disorders, sleep disturbances as well as cognitive and executive dysfunction (Murray et al., 
2014; Dirnberger & Jahanshahi, 2013). A distinct association has been reported, especially 
in PD, between motor and cognitive functions (Nocera & Hackney, 2015), which may be 
attributed to the overlapping neural systems (cortical processing resources) (Domellöf et al., 
2011). As a result, cognitive impairment may interfere with the motor symptoms (Aarsland 
et al., 2003); for instance, in PD specifically slowness of movement (bradykinesia), mobility 
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and balance has been associated with executive dysfunction (Kelly et al., 2015; McKee & 
Hackney, 2014; Poletti et al., 2012). 
 
Most individuals with PD demonstrate executive dysfunction followed by memory problems 
(Nocera & Hackney, 2015). Executive Function relates to specific goal-directed behaviours 
which the brain’s frontal lobes process (Murray et al., 2014). The three main EF are 
considered to be Set shifting, Updating and Inhibition (Diamond, 2013; Miyake et al., 2000). 
According to Tanaka et al. (2009) these functions assist individuals with judging, planning 
and executing cognitive tasks, abstract thinking and problem-solving, forming sequential 
rational actions and approaching strategies, as well as mental or behavioural shifts, flexible 
attitudes, and monitoring of actions. All of these features are aspects that individuals with 
PD struggle with (Nocera & Hackney, 2015).  
 
Additionally, basal ganglia dysfunction disrupts automaticity (automated movements) in PD 
leading to poor motor planning, reduced sensory integration and regulating emotions as well 
as inadequate EF (Jankovic, 2008, Crossman & Neary 2000). Reduced automaticity 
contributes to PD mobility being more reliant on conscious processing (cognition) (Wu et al., 
2014). Consequently, a vicious cycle of impaired mobility and reduced cognition transpires. 
Furthermore, mild executive dysfunction may progress to mild cognitive impairment in PD, 
which is a predictor for dementia (Dirnberger & Jahanshahi, 2013). Aarsland et al. (2003) 
reported that only 20% of individuals with PD do not develop cognitive impairment as PD 
progresses. 
 
Interest in the relationship between motor-cognitive function and ineffectiveness of 
medication and surgical treatments in treating motor impairments, as well as side effects 
from pharmacological treatments has resulted in researchers investigating the possible use 
of exercise as a non-pharmacological treatment. A selection of exercise studies conducted 
in PD patients have revealed improvements in EF. Duchesne et al. (2015) and Rigdel et al. 
(2011) reported improvements following aerobic exercise, while David et al. (2015) observed 
improvements after a resistance training programme. Combination studies of aerobic and 
resistance training (Cruise et al., 2011; Tanaka et al., 2009) also reported improvements in 
EF, with the latter including balance and flexibility exercises as well. 
 
It is believed that individuals with PD have intact motor programs but it is suggested that 
they have difficulties with accessing these motor programs (Jankovic, 2008). Interestingly, 
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researchers have found that by adding sensory cues (visual, auditory and somatosensory) 
these motor programs may be accessed more readily (Abbruzzese et al., 2015; Abbruzzese 
et al., 2014; Browner & Giladi, 2010; Jankovic, 2008). The benefits of adding an external 
cue to activities may be explained by the cues bypassing the defective basal ganglia and 
stimulating the reticular formation in the brainstem of the amygdala in the limbic system 
(Crossman & Neary, 2000). Abbruzzese et al. (2014) and Rabin et al. (2013) specifically 
highlighted the benefits of somatosensory (proprioceptive and haptic) feedback to improve 
mobility and balance, and suggest a non-dopaminergic pathway. 
 
It is, thus, important to research EF and investigate which exercise interventions have the 
potential to improve or maintain EF or delay executive dysfunction. To the researcher’s 
knowledge, this is the first study to specifically investigate the effect of a sensory-motor 
training programme on the executive function of individuals with mild to moderate PD. 
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CHAPTER TWO 
 
LITERATURE REVIEW 
 
1. Overview of Parkinson’s Disease 
1.1  Introduction 
Parkinson’s Disease (PD) was first described by James Parkinson in 1817 where he referred 
to it as the “shaking palsy” or in Latin, Paralysis Agitans (Fahn, 2003). Later, Jean Martin 
Charcot recommended that the disorder be called Parkinson’s Disease (Maladie de 
Parkinson) (Lees et al., 2009). 
 
PD is considered to be the most commonly occurring movement disorder apart from 
essential tremor and, in terms of neurodegenerative diseases, it is the second most common 
after Alzheimer’s disease (Kalia & Lang, 2015; Nocera & Hackney, 2015, Wirdefeldt et al., 
2011; Alves et al., 2008; De Lau & Breteler, 2006). Currently, there is no cure for PD, which 
is progressive in nature and characterised by motor and non-motor features (Lees et al., 
2009).  
 
The main or cardinal signs of PD relate to motor problems, such as resting tremor, rigidity, 
bradykinesia (slowness of movement) and impaired postural reflexes (Wirdefeldt et al., 
2011; Jankovic, 2008; Gelb et al., 1999). Other secondary motor symptoms are also often 
observed in PD. These include hypomimia (reduction in facial expressiveness), dysarthria 
(difficulty in articulating speech), dysphagia (difficulty in swallowing), sialorrhoea (excessive 
secretion of saliva), micrographia (small handwriting), shuffling gait, festination (galloping 
forward locomotion), freezing of gait, dystonia (involuntary contractions of muscles) and 
glabellar reflexes (blinking induced by tapping over the glabella) (Loftus, 2014; Jankovic, 
2008; Cutson et al., 1995). Some non-motor characteristics include psychiatric symptoms, 
such as anxiety and depression, as well as a range of dysautonomic symptoms, from 
hypotension and constipation to seborrheic dermatitis along with sleep disorders and 
sensory abnormalities like anosmia, paresthesias and pain (Hoang, 2014; Wirdefeldt et al., 
2011; Jankovic, 2008). Of the varied non-motor symptoms, cognitive dysfunction, which is 
commonly associated with impaired EF, is particularly widespread in PD (Murray et al., 
2014; Hely et al., 2008; Higginson et al., 2003). Furthermore, according to Murray et al. 
(2014), these non-motor symptoms may be just as debilitating as motor symptoms for the 
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individual’s health and general quality of life (QOL). It is this broad spectrum of clinical 
manifestations of PD which makes this movement disorder heterogeneous.  
 
Parkinson therapies typically prevent neurochemical imbalances or treat symptoms related 
to the disease severity (Protas et al., 2009). Therapies include pharmacologic and non-
pharmacologic treatments such as surgical, physical and psychosocial interventions 
(Cutson et al., 1995). Unfortunately, these therapies are currently inadequate in treating 
motor impairments such as postural stability, speech and freezing of gait (Bloem et al., 
2015), and may even result in additional movement disabilities such as dyskinesia, dystonia 
or motor fluctuations (Protas et al., 2009). Curtze et al. (2015) also stated that prolonged 
use of medication in conjunction with disease progression may bring about 
unresponsiveness to medication. 
 
The onset of PD usually happens slowly, and since diagnosis generally follows from the 
onset of motor symptoms, early symptoms can often be mistaken for something else or go 
unnoticed. According to Lees et al. (2009) a delay of two to three years between initial 
symptoms and diagnosis of PD is not uncommon. In addition, Kalia & Lang (2015) explained 
that the official PD diagnosis may have been preceded by a premotor phase of about 20 
years or more. Symptoms may progress to include dyskinesia (abnormal involuntary 
movement), retropulsion (falling backwards), propulsion (falling forwards), reduced arm 
swing and decreased speed of walking (Loftus, 2014; Jones et al., 2008). QOL is impacted 
when decreased mobility and difficulties with balance, posture and walking, result in a loss 
of independence, lack of activity, social isolation, falls and an increased fear of falling 
(Loftus, 2014; Jones et al., 2008). 
 
The 2006 World Health Organization’s (WHO) incidence rate for PD, per 100 000 population 
per year, is given at 4.5 - 19. The main reasons given for the wide range in incidence include 
differences in study methodology and the sample population’s age distribution. Once age 
adjustments are applied, the incidence rate, per 100 000 population per year, becomes 9.7 
- 13.8 (World Health Organization, 2006). Lees et al. (2009) assert a steep increase with 
age and reported an incidence rate of 17.4 per 100 000 person years between the ages of 
50 and 59 years, which then rises sharply to 93.1 per 100 000 for the age group 70 to 79 
years. Sixty years of age is given as the median onset age and the mean duration is 15 
years from initial diagnosis to eventual mortality (Lees et al., 2009). South African 
epidemiological data for PD is not available (Van der Merwe et al., 2012) and there is 
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inadequate epidemiological data available regarding PD in Sub-Saharan Africa and Africa 
(Blanckenberg et al., 2013; Okubadejo et al., 2006). In addition, studies based on clinical 
data may underreport the incidence of PD as they do not include those who have not sought 
or do not have access to medical facilities (De Lau & Breteler, 2006; Okubadejo et al., 2006). 
However, according to Blanckenberg et al. (2013) PD prevalence in Sub-Saharan Africa 
may fluctuate between 7 and 20 per 100 000 people, compared to developed countries 
where the prevalence is estimated to range from 65.6 to 12,500 per 100 000 (Von 
Campenhausen et al., 2005). This is consistent with Kalia and Lang’s (2015) report that PD 
prevalence is higher in European, North and South American countries compared to African, 
Asian and Arabic countries. 
 
Few studies have investigated ethnicity or race in relation to PD and these studies differed 
in terms of their methodology. Although some data may seem to indicate that PD occurs 
less in Asian and black people, the study methodologies were not the same and the 
differences seen across ethnic groups may in fact be due to differences in case-
ascertainment, survival and response rates (De Lau & Breteler, 2006; McInerney-Leo et al., 
2004). A recent study by Geldenhuys et al. (2014) suggests the possibility of a founder effect 
for PD in the Afrikaner ethnic group, however, they recommend further genealogical analysis 
in regard to this (Carr, 2014; Geldenhuys et al., 2014). 
 
Despite the variation in methodologies used, most PD epidemiological studies consistently 
propose that the disease decreases life expectancy. The reduction in life expectancy of PD 
individuals appears to be mostly due to dementia, as there is only a moderate increase in 
mortality rate in those PD individuals who do not acquire dementia (De Lau & Breteler, 
2006). Identifying cognitive decline in individuals with PD is imperative as dementia 
increases the burden on health care as well as on patients and their caregivers (Dujardin et 
al., 2010). 
 
1.2 Pathophysiology 
An important pathological finding relating to the motor and non-motor dysfunction seen in 
PD patients is the dopaminergic neuron degeneration of the Substantia Nigra Pars 
Compacta. This results in dopamine loss of the striatum. Symptoms do not become evident 
until there is a loss of roughly 50 to 60% of these Nigral neurons and a depletion of 80 to 
85% of the striatum’s total dopamine. There may also be degeneration of the 
catecholaminergic and serotonergic neurons of the brainstem. The remaining neurons 
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exhibit the presence of Lewy-bodies (eosinophilic inclusion bodies which contain a wide 
variety of proteins) (Wirdefeldt et al., 2011). Hoang (2014) explains that the assumption is 
that this dopamine deficiency, as a result of the loss of dopaminergic neurons, is responsible 
for the motor and non-motor symptoms of PD. Although dopamine replacement therapy 
initially provides symptom relief, the disease continues to progress (Hoang, 2014), and 
individuals with PD may become unresponsive to medication as stated earlier in this chapter.  
 
Current basal ganglia models propose that, within the cerebral cortex, these structures have 
a minimum of five parallel loops. Two of these loops, frontal eye fields and supplementary 
motor area, are concerned with motor functioning, while the other three loops, Anterior 
Cingulate circuit, Dorsolateral Prefrontal circuit and the Lateral Orbitofrontal circuit, are 
involved in cognition and behaviour (McKinlay, 2013; Taylor & Saint-Cyr, 1995). It is thought 
that PD-associated deficits result from malfunctioning of these loops which occurs 
secondary to the dopaminergic neuron depletion in the Substantia Nigra. The resultant 
range of cognitive problems seen in PD individuals relates to this Fronto-striatal circuit 
degeneration (McKinlay, 2013). While the depletion of dopaminergic neurons is thought to 
be the stand-out characteristic of PD, it is not confined to the dopamine system only and 
should not be characterized as such. There is evidence of other subcortical structure 
abnormalities, which includes noradrenergic neuron loss from the nucleus Basalis of Meyner 
(McKinlay, 2013).  
 
There is also evidence to suggest that cognitive and behavioural functioning deficits stem 
from the mesocortical dopaminergic system. This system emerges from the ventral 
segmental area with projections directly to the frontal cortex. These projections have been 
found to be depleted in PD patients (McKinlay, 2013). Several genes which relate to PD 
have been identified giving an indication of molecular mechanisms potentially involved in its 
pathogenesis. It is thought that these could include dysfunction of mitochondria, 
inflammation, oxidative stress, excitotoxicity and a defect in protein handling (Wirdefeldt et 
al., 2011). These mechanisms are briefly highlighted in the following paragraphs. 
 
A significant discovery in PD is that of a complex 1 deficiency of the mitochondrial respiratory 
chain. Mitochondria are of utmost importance in the production of cellular energy. This 
deficiency is PD-specific and is not seen in any other neurodegenerative disorder. 
Dysfunction of the mitochondria may play a significant role in initiating apoptotic cell death 
(Zigmond & Smeyne, 2013; Macphee & Stewart, 2012). 
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Oxidative stress can also increase through mitochondrial dysfunction (Monteiro-Junior et al., 
2015; Macphee & Stewart, 2012). The cells of the Substantia Nigra are susceptible to 
oxidative stress due to the presence of iron and dopamine. The metabolism of dopamine 
results in the production of poisonous free radicals and the presence of ferrous iron 
accelerates this process (Macphee & Stewart, 2012).  
 
The presence of increased levels of inflammatory mediators, TNF-α and interleukins, have 
also been found in PD. Microglial cells are activated and nitric oxide is produced. This results 
in more oxidative stress and cellular damage (Zigmond & Smeyne, 2013; Macphee & 
Stewart, 2012). 
 
Cell damage (excitotoxicity) may occur due to enzyme system activation by excessive 
glutaminergic stimulation, while calcium ion influx mediates stimulation. A normal membrane 
potential prevents excessive influx. This is reliant on mitochondrial ATP production which, 
in PD, may be absent. Consequently, normal physiological glutamate levels in PD may in 
fact be toxic (Macphee & Stewart, 2012). 
 
Despite these advances, the exact molecular mechanisms involved are still mostly unknown 
(Murray et al., 2014; Macphee & Stewart, 2012; Wirdefeldt et al. 2011). Kalia and Lang 
(2015) discuss a number of risk factors at play in the development of PD. The primary risk 
factor for the development of PD is age. PD prevalence and incidence rises exponentially 
with increasing age and reaches its peak after 80 years. Gender is another factor: men are 
affected more than women at a ratio of 3:2. Ethnicity plays a role in PD risk, with certain 
races, such as Hispanics more at risk than others (Kalia and Lang, 2015). There are also 
several environmental factors that are considered risk factors and these include: exposure 
to pesticides, a previous head trauma, rural living, the use of beta-blocker medications, 
working in agriculture and consumption of well water. There is also a genetic contribution, 
with increased risk linked to a family history of PD (Kalia and Lang, 2015).  
 
2.  Executive Function 
2.1  Introduction 
Cognitive function (CF) includes both basic and higher-level functions. Basic functions 
comprise attention, working memory, long-term memory and perception, while higher-level 
function comprise speech and language, decision making and EF (Glisky, 2007).  
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The decline of CF is considered a normal part of the aging process. Van Uffelen et al. (2008) 
delineate mild cognitive impairment (MCI) as the intermediate stage in which an individual 
experiences cognitive deterioration that is more serious than the normal age-related decline 
but does not meet criteria specific for dementia. Although at an increased risk of progressing 
to dementia, an individual with MCI may remain in this state or return to a normal cognitive 
function. Conversely, dementia is associated with an irreversible, progressive decline in 
cognitive functioning as well as problems with physical and social functioning (Van Uffelen 
et al., 2008).  
 
In 2011 the Movement Disorder Society (MDS) set up a task force to draft the diagnostic 
criteria for MCI in PD. Table 2.1 summarizes the framework (Litvan et al., 2012). 
 
Table 2.1. Movement Disorder Society Diagnostic Criteria Framework for MCI in PD 
(From Litvan et al., 2012). 
1. MCI is defined within the context of existing etiology, namely PD; 
2. PD-MCI includes not just “memory” complaints, but also other cognitive changes; 
3. Cognitive decline can be noted from different sources; 
4. PD-MCI must have deficits on either formal neuropsychological testing or a test of 
global cognitive abilities; 
5. Specific level I and II categories are outlined, including the number of domains, tests 
per domain, and cut-off scores suggested; and  
6. Subtyping is recommended only for evaluations in which two neuropsychological 
tests for each of the five domains are assessed and is strongly suggested for 
research purposes. 
 
Cognitive dysfunction has a major impact on both the individual and on society as a whole. 
Firstly, it affects the individual and his or her significant others due to its negative effect on 
QOL and its potential for increased risk of disability and other limitations. Secondly, cognitive 
decline affects society by increasing pressure on health care, both financially and in terms 
of health care workers (Kandiah et al., 2009; Van Uffelen et al., 2008).  
 
As previously noted, cognitive dysfunction is particularly prevalent in PD and is considered 
one of its most debilitating aspects (Murray et al., 2014; Liu et al., 2012; Benito-León et al., 
2011; Hely et al., 2008). Both Liu et al. (2012) and Kandiah et al. (2009) reported that large 
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proportions of individuals with PD develop cognitive impairments in the early stages of the 
disease. As PD progresses, CF deteriorates and many PD patients may develop dementia. 
According to Dujardin et al. (2010) and De Lau and Breteler (2006) roughly 25 to 40% of 
individuals with PD will develop dementia, whereas Hely and colleague’s (2008) Sydney 
Multicentre Study reported the presence of dementia in 83% of individuals with PD after 20 
years. The latter study supported the earlier findings by Aarsland et al. (2003). The 2006 
review by De Lau and Breteler (2006) reported a 1.7 to 5.9 times higher risk of dementia in 
those with PD compared to healthy individuals. These cognitive dysfunctions are often 
associated with impaired EF, visuospatial function as well as memory loss (Dujardin et al., 
2010; Higginson et al., 2003).  
 
Halliday & McCann (2010) discussed three cognitive phenotypes in PD. The first phenotype 
consists of individuals with early-onset (50 to 60 years), longer duration PD (greater than 15 
years). This group developed dementia at a much later stage of the disease, often after 10 
to 15 years. The second phenotype involves individuals with dementia-dominant syndrome 
that is early and severe with akinetic-rigid PD and fulfils the requirements for dementia with 
Lewy bodies (DLB). The third phenotype includes those with an older age of onset (over 70 
years), shorter duration of PD (less than 15 years), increased disability and dementia 
(consistent with PD with Dementia – PDD). There remains much variation in age of onset, 
symptom onset as well as severity of cognitive impairment. 
 
Executive Function, also known as controlled cognition, resource-demanding cognition or 
executive control, is predominantly related to goal-directed behaviours which are processed 
by the brain’s prefrontal cortex (Murray et al., 2014; Diamond, 2013; Etnier & Chang, 2009; 
Lezak, 1995). According to Etnier and Chang (2009), EF is a “higher-level” or “meta-
cognitive” functioning that manages other more basic cognitive functions as well as the 
regulation of emotions and attention necessary for goal-directed behaviours (Etnier & 
Chang, 2009). Dirnberger and Jahanshahi (2013) support this by explaining that EF 
specifically relates to a group of cognitive processes responsible for goal-directed 
behaviours. These processes include formulating goals, forming intentions, successfully 
implementing these goals and outcome processing. Other researchers refer to this as 
planning, purposive action, effective performance and volition (Murray et al., 2014; Tanaka 
et al., 2009). This means that individuals with frontal lobe damage, specifically with EF 
problems, may exhibit decreased ability to plan and organize functional, goal-oriented 
behaviour. 
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There are three main or core EFs, namely Set shifting, Updating and Inhibition. Inhibition, 
or inhibitory control, involves an individual’s ability to intentionally inhibit a response which 
is dominant, automatic, or prepotent (priority response tendency) (Diamond, 2013; Miyake 
et al., 2000). Inhibition allows one to attend selectively, concentrating on what one chooses 
to, while suppressing other stimuli. It is also the ability to control one’s behaviour, thoughts, 
attentions, and / or emotions to supersede a strong inclination and rather do what is 
necessary or required in that situation (Diamond, 2013; Miyake et al., 2000).  
 
Updating, or Working Memory, involves the monitoring of incoming task-relevant information 
and then appropriately updating the informational content by replacing no longer relevant 
information with newer and more appropriate information (Diamond, 2013; Miyake et al., 
2000). Updating requires one to hold relevant information in one’s mind and work with it 
when it is no longer present perceptually. Updating is crucial in understanding things that 
take place over time, where one needs to keep in mind what has occurred previously and 
then relate it to something in the future. Updating and Inhibition are linked in that you must 
have in mind what is relevant to the situation and what to inhibit (Diamond, 2013).  
 
Set shifting, also known as Cognitive Flexibility is the ability to shift back and forth between 
various tasks or mental sets (Diamond, 2013; Miyake et al., 2000). An aspect of Updating is 
the ability to change perspectives spatially (i.e. viewing something from a different direction) 
or interpersonally (i.e. seeing another person’s point of view). In order to do this, one needs 
to inhibit one’s previous perspective and update to a different perspective. In this way, Set 
shifting is reliant on and contributes to Inhibition and Updating (Diamond, 2013). 
 
Executive functioning, in summary, concerns the things that people do, the way in which 
they do them and whether they do them in situations that are not routine. It can be described 
as intentional planning and adjustment that occurs in a situation where previously learned 
behaviours are inadequate or inaccessible. Executive functioning requires the inhibition of 
prepotent responses, cognitive flexibility, the ability to plan and monitor, and the ability to 
not only retrieve from memory but to maintain and manipulate information within memory. 
Individuals with PD battle with the performance of some or all of these tasks. In addition to 
this, individuals with PD often display bradyphrenia (decreased psychomotor speed), which 
may also impact on their executive functioning (Koerts et al., 2011).  
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Impaired cognitive function, more specifically EF in PD, interacts with the affected motor 
system. Originally, it was thought that distinct cortical regions directed movement and 
cognition. However, it is now believed that they are supplied by overlapping neural systems. 
An example of this can be observed in PD, where an increase in bradykinesia is associated 
with both mild cognitive impairment and impaired executive functioning (Nocera & Hackney, 
2015). Every day, individuals (both with and without PD) will encounter situations which 
require executive functioning. Navigating uneven terrain on a sidewalk, deciding whether 
there is enough time to cross at a pedestrian crossing before the light changes, 
remembering an address or the direction to a certain place while walking there are all 
examples of how executive functioning operates. These events are of particular importance 
to someone with PD as they are further impacted by their motor dysfunction. Resting tremor, 
rigidity, bradykinesia and impaired postural stability all play a role in how the individual with 
PD responds to these situations. Impaired executive functioning makes situations like these 
seem like large challenges that need to be overcome. 
 
Yogev-Seligmann et al. (2008) discussed how impairment in one or more of these elements 
of EF has the potential to influence a person’s ability to walk both efficiently and safely. 
Walking is a fundamental part of any independently ambulating individual’s life. Impaired 
gait and a loss of automaticity of walking are characteristics of PD and these are 
accompanied by EF and attention impairments. For instance, when an individual with PD is 
required to allocate attentional resources to more than one task, an increase in gait 
abnormalities manifests i.e. shortened stride length, stride variability increases, slower gait 
speed and double support time increases (Yogev-Seligmann et al., 2008). 
 
2.2 Exercise and Executive Function 
Emerging research increasingly shows that regular physical activity promotes cognitive 
functioning, especially for age-related neurocognitive decline (Daly et al., 2015; Gow, 2013; 
Ku et al., 2012) and for those with neurodegenerative diseases (Nocera & Hackney, 2015; 
Xu et al., 2010; Tanaka et al., 2009). The effect of exercise on cognitive and motor function 
in PD can be seen in Figure 2.1. 
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Figure 2.1 Theoretical Illustration demonstrating the relative impact of exercise on motor 
(black) and cognitive (red) function on disease progression in PD (Nocera & 
Hackney, 2015). 
 
Evidence suggests that healthy individuals who are physically active tend to demonstrate 
better executive functioning, as opposed to poor EF observed in individuals with low physical 
activity levels (Daly et al., 2015). The study of Daly et al. (2015) suggests a bidirectional 
relationship between exercise and EF. Subsequent decreases in physical activity 
participation rates were observed in older individuals with poor EF. In contrast, older 
individuals who regularly engaged in sports or other physically exerting activities were more 
likely, over time, to maintain EF at a high level. This adds credence to existing research 
showing that exercise or physical activity can serve to buffer the aging effects on EF decline. 
 
2.2.1 Possible mechanisms by which exercise may influence Executive Function 
The possible neural mechanisms for the benefits of exercise on cognitive function relate to 
neuroplasticity principles. Cotman and Berchtold’s (2002) opinion article on exercise and 
neuroplasticity refers to research that proposes that brain plasticity can be maintained or 
improved through exercise and behavioural stimulation (modifying behaviour and actions). 
Petzinger et al. (2013) define neuroplasticity as “a process by which the brain encodes 
experiences and learns new behaviours and is defined as the modification of existing neural 
networks by addition or modification of synapses in response to changes in behaviour or 
environment, which can encompass exercise”; or more simply defined as structural or 
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functional changes to the nervous system that occur as a result of experience (Nocera & 
Hackney, 2015). 
 
There are two main processes by which neuroplasticity takes place in the damaged or 
degenerating brain, namely recovery or compensation. Depending on whether the neural or 
behavioural level is referred to, recovery is loosely defined as the restoration of the original 
function and compensation as the regaining of function through processes other than the 
original (Kleim, 2011). The neural strategies of restoration, recruitment and retraining involve 
either recovery or compensation and take advantage of the brain’s functional redundancy. 
These three neural strategies are not independent of each other and may occur together 
during rehabilitation, which makes it difficult to distinguish them clearly in research. Hence 
motor recovery pertains to the ability to execute a previously impaired or lost motor task in 
precisely the same way as it was performed prior to the injury or degeneration. Whereas 
neural recovery refers to the reestablishment of motor function, in a region of the motor 
cortex that was lost (restoration). Motor compensation concerns the ability to carry out a 
task in a different way using new movements or sequences (recruitment and / or retraining) 
(Kleim, 2011). 
 
In 2008, based on an extensive review of existing human and animal studies, Kleim and 
Jones suggested 10 principles which clinical exercise therapists may potentially incorporate 
in their neurorehabilitation to induce experience-dependent (or exercise-related) 
neuroplasticity. These 10 principles are summarized in Table 2.2. 
 
Table 2.2 Principles of Experience-dependent Neuroplasticity (From Kleim & Jones, 
2008). 
Principle Description 
1. Use it or lose it Failure to drive specific brain functions can lead to 
functional degradation 
2. Use it or improve it Training that drives a specific brain function can lead 
to an enhancement of that function. 
3. Specificity The nature of the training experience dictates the 
nature of the plasticity.  
4. Repetition matters Induction of plasticity requires sufficient repetition. 
5. Intensity matters Induction of plasticity requires sufficient training 
intensity. 
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6. Time matters Different forms of plasticity occur at different times 
during training. 
7. Salience matters The training experience must be sufficiently salient to 
induce plasticity. * 
8. Age matters Training-induced plasticity occurs more readily in 
younger brains. 
9. Transference Plasticity in response to one training experience can 
enhance the acquisition of similar behaviours. 
10. Interference Plasticity in response to one experience can interfere 
with the acquisition of other behaviours. 
* Salient refers to something important. 
 
Recently Diamond (2015) reiterated the importance of cognitive involvement (attention), 
similar to Kleim and Jones’ (2008) point 7, to improve cognitive functions such as EF in 
individuals with PD.  
 
Possible mechanisms of neuroplasticity are now briefly discussed. 
 
Brain-derived neurotophic factor (BDNF) plays an important role in the growth and continuity 
of various neuronal subtypes. When the BDNF gene expression is raised through learning 
then the resultant BDNF could promote plasticity for learning and memory. The assumption 
is made that exercise may induce BDNF gene expression, which should then also improve 
learning (Monteiro-Junior et al., 2015; Coelho et al., 2013; Ahlskog, 2011; Cotman and 
Berchtold, 2002). Gene expression of BDNF is controlled in the hippocampus by 
neurotransmitter interactions and neuronal activity. Modulatory neurotransmitters, such as 
GABA (Gamma Amino Butyric Acid), ACh (Acetylcholine) and monamines, could affect the 
expression of BDNF (Xu et al., 2010; Cotman and Berchtold, 2002). In addition, peripheral 
mechanisms play an important role in the BDNF expression and include the effect of 
corticosteroids, oestrogen and insulin-like growth factor (IGF-I) (Cotman and Berchtold, 
2002).  
 
Gene expression, potentially regulated by exercise, also plays a role in neuroplasticity. 
Synaptic and neurite growth, vesicle recycling and membrane and neurotrophic factor 
trafficking are associated with these genes (Cotman and Berchtold, 2002). The impact of 
exercise on genes responsible for encoding neurotrophins and similar proteins reveals 
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potential for exercise to create a cascade of events resulting in neurogenesis (Cotman and 
Berchtold, 2002).  
 
Exercise, in animal studies, has been shown to increase blood flow in the brain (Rhyu et al., 
2010), and similarly, in human studies, regular exercise improves cerebral blood flow 
(Ainslie et al., 2008). In this way, neuroplasticity may be promoted by exercise, by modifying 
the central nervous system vasculature through angiogenesis and changes in the 
permeability of the blood-brain barrier (Paillard et al., 2015; Petzinger et al., 2013). 
 
Another mechanism is a reduction in beta-amyloid protein formation, which is associated 
with decreased beta-amyloid plaques as seen in Alzheimer’s disease (Erickson et al., 2014; 
Coelho et al., 2013; Adlard et al., 2005). 
 
Zigmond and Smeyne (2013) promote a model for exercise-induced neuroprotection. Their 
hypothesis is that dopamine signalling is increased by exercise, which increases the 
availability of neurotrophic factors. These neurotrophic factors are then able to promote 
energy production of mitochondria, synaptogenesis, angiogenesis, antioxidant defence, 
reduce inflammation and suppress apoptosis. Animal studies have also documented the 
protective effect of exercise in models of Parkinsonism by reducing the effects of 6-
hydroxydopamine (6-OHDA) and1-methyl,4-phenyl,1,2,3,6-tetrahydropyridine (MPTP) 
which are dopaminergic neurotoxins (Ahlskog, 2011). However, Ploughman (2008) has 
pointed out that research on the neuroprotective effects of exercise in humans are limited. 
These studies reported motor function improvements, dopamine neuron preservation and 
dopaminergic terminal restoration in the striatum (Petzinger et al., 2013). 
 
Furthermore, cognitive differences observed between individuals diagnosed with PD may 
potentially be clarified by the cognitive reserve theory (Koerts et al., 2013). The cognitive 
reserve theory proposes that the brain actively seeks to deal with brain damage through the 
utilization of already existing approaches of cognitive processing or by employing 
compensatory approaches. Thus, individuals possessing greater cognitive reserve would be 
able to cope better with comparable brain damage. In simple terms, cognitive reserve 
enables some to better cope with the ramifications of brain pathology and remain mentally 
intact for a longer duration (Poletti et al., 2011). A cognitive impairment buffer is provided by 
premorbid factors, such as high intellectual capacities or greater levels of education, in the 
presence of brain pathology (Koerts et al., 2013). In PD, individuals with greater cognitive 
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reserve and intact EF are more likely to enjoy a better QOL and have less difficulty with ADL 
(Hindle et al., 2014). Fratiglioni et al. (2004) suggest that neuroplasticity robustly supports 
the cognitive reserve theory as experience-dependent stimuli are required to elicit plasticity, 
regardless of the methods or the level at which they occur (cellular, molecular or structural). 
Becofsky (2014) in addition states that physical activity may protect elderly individuals from 
cognitive decline by improving their cognitive reserve theory. 
 
Thus, exercise plays an important role in the facilitation of neuroplasticity, via increased 
neurotrophic factors (BDNF), increased blood flow and angiogenesis, increased gene 
expression and its impact on neurogenesis and a decrease in beta-amyloid plaques, as well 
as having potential neuroprotection benefits and improving cognitive reserve. 
 
2.2.2 Aerobic Exercise and Executive Function  
Aerobic exercise is associated with modest improvements in executive function in 
individuals of varied ages and in both healthy and clinical populations (Smith et al., 2010). 
 
The study of Chang et al. (2014) observed the effects of acute aerobic exercise on cognitive 
performance in healthy, young individuals (n = 36; Age: 21.4 ± 1.6 years) with high, 
moderate or low fitness levels. They specifically looked at the EF component of Inhibition 
measured using the Stroop task. All three fitness categories (high, moderate and low) 
displayed an improvement in EF after a single session of acute aerobic exercise. The 
session consisted of 20 minutes of moderate intensity cycling with a five-minute warm-up 
and cool-down. A curvilinear relationship was observed between fitness level and 
performance on the incongruent condition of the Stroop task. The high fitness group 
exhibited significantly slower response times compared to the moderate and low fitness 
groups (p < 0.02), with the moderate fitness group producing the fastest response time (p = 
0.06), suggesting that a moderate fitness level may relate to better EF. 
 
The study of Baker et al. (2010) investigated the effects of aerobic exercise on cognition, 
more specifically executive function, and other Alzheimer’s disease biomarkers in a group 
of older adults (Age: 70.4 ± 8.3 years) diagnosed with MCI. Updating, Inhibition and Set 
shifting (referred to in this study as Task switching) as well as verbal fluency and processing 
speed were assessed. The participants (n = 33) were randomized to either an experimental 
group, which engaged in high-intensity aerobic exercise, or a control group, which 
participated in stretching exercises, over a six-month period. Participants of both groups 
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attended four 45-60 minute sessions per week, with the aerobic group exercising at 75-85% 
of heart rate reserve. Only 28 of the original 33 participants completed the six-month 
assessment. The experimental group showed improvement in all EF components compared 
to the control group (p = 0.04). However, when broken down by gender, the treatment effect 
(p = 0.04) differed for men (n = 9) and women (n = 10). Women demonstrated improvements 
in all of the assessed EF, while men only showed improvement in performance of the Trail 
Making Test (TMT) B (Updating) (p = 0.05). The authors proposed that these differences 
may be due to metabolic effects of exercise. In response to aerobic exercise, they observed 
improvements in glucoregulation and insulin sensitivity in women but not men. Furthermore, 
they found a reduction in cortisol levels for women whilst the levels increased for men. Risk 
of cognitive decline increases with increasing cortisol levels in women; however in men, 
cortisol fluctuations appear to have no impact on cognitive performance. 
 
Colcombe et al. (2004) looked at the impact of aerobic exercise on executive functioning in 
aging individuals through both a cross-sectional (n = 41; Age = 67.1 ± 8.0 years) and 
longitudinal study (n = 29; Age = 65.6 ± 5.7 years). In the cross-sectional study, participants 
completed either the Rockport 1-milewalk test or a treadmill-based VO2 max test to 
exhaustion. In a separate session, they underwent a functional MRI (fMRI) scan while 
completing a flanker task (assessing Inhibition). In the longitudinal study, participants were 
randomized to an aerobic group or a stretch and tone control group. Participants in both 
groups attended exercise sessions three times per week for six months. Participants in the 
aerobic group began with 10-minute walking sessions increasing by one minute until they 
were walking for 45 minutes and they increased their heart rate reserve up to 60-70% over 
the course of the study. Participants in the control group focused on stretching and toning 
exercises and followed the same duration of session progression as the aerobic group. 
Participants in the longitudinal study underwent the same functional MRI (fMRI) scan with 
flanker task. In the cross-sectional study, participants were rated by a median split as either 
high fit or low fit in terms of aerobic exercise capacity. Individuals rated as “high fit” 
performed significantly better on the Inhibition test than those rated as “low fit” (p = 0.02). In 
the longitudinal study, the aerobic group performed significantly better than the control group 
with regards to the Inhibition test (p < 0.04). Both the “high fit” group and aerobic group in 
these two studies also demonstrated significantly greater cortical activation in regions 
associated with attentional control compared to the “low fit” and control groups, respectively. 
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This is in contrast to other studies which investigated the influence of aerobic exercise 
programmes on EF. These studies compared aerobic exercise to a control group, in elderly 
individuals (> 60 years) and found no significant improvements in EF (Smiley-Oyen et al., 
2008; Fabre et al., 2002; Moul et al., 1995; Blumenthal et al,. 1989) while other meta-
analyses of randomized control trials reported minimal improvements (Smith et al., 2010; 
Angevaren et al., 2008). The investigations which reported possible benefits suggest that 
aerobic exercise training programmes of around six month’s duration improve inhibition and 
updating. There may possibly be gender differences involved as seen in the study of Baker 
et al. (2010). The researchers suggest that the following mechanisms may have contributed 
to the improvements: increased BDNF and other neural growth factors as well as increased 
blood flow to the brain. However, Diamond (2015) recommends that future studies explore 
the benefits of other exercise interventions besides aerobic activities which require little 
thought or attention. 
 
2.2.3 Resistance training and Executive Function  
Chang and Etnier (2009) examined the dose-response relationship between intensity of 
acute resistance training and cognitive performance, including EF (Inhibition), in young men 
and women (n = 68, Age: 26.0 ± 3.2). They looked at three differing resistance training 
intensities of 40%, 70% and 100% of a 10-repetition maximum together with a control group. 
Participants in each of the resistance training intensity groups performed two sets of 10 
repetitions for six exercises in a single 30-minute session. The control group watched a 
video on resistance training. The results of this study suggest that 30 minutes of resistance 
training has a task-related positive influence on Inhibition and information processing. The 
findings display a significant linear relationship between resistance training intensity and 
processing speed, and a significant quadratic relationship between resistance training 
intensity and Inhibition (p < 0.01). Thus, high intensity resistance training promotes speed 
of processing while moderate intensity resistance training is most profitable for EF. 
 
Liu-Ambrose et al. (2010) investigated the impact of resistance training on EF in older 
women, specifically whether there would be a difference between once-weekly (n = 54; Age 
= 69.5 ± 2.7 years) or twice-weekly (n = 52; Age = 69.4 ± 3.0 years) resistance training 
sessions compared to a twice-weekly combined balance and tone training control group (n 
= 49; Age = 70.0 ± 3.3 years). All sessions for all groups were 60 minutes long. Their primary 
outcome measure of EF was performance on the Stroop task (Inhibition) and their secondary 
outcome measures of EF were performance on the Trail Making Test, parts A and B (which 
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they used as a measure of Set shifting), and verbal digit span tests (working memory). At 
the end of the 12-month period, both resistance training groups (p ≤ 0.03) demonstrated 
significant improvements on the Stroop task compared to the balance and tone training 
group. There were no significant differences observed for the secondary outcome measures 
between any of the groups (p > 0.05). The authors did not elaborate on the results of their 
secondary outcome measures. 
 
The potential reported benefits from these studies suggest that resistance training may 
improve selected aspects of EF, most notably Inhibition. In contrast, additional studies which 
looked at resistance training as an active control condition together with another exercise 
modality (Moul et al., 1995) reported no improvement in EF as a result of resistance training.  
 
2.2.4 Combination exercise and Executive Function 
Liu-Ambrose et al. (2008) used the Otago Exercise Programme (OEP), which incorporated 
resistance and balance training in a home-based programme, to investigate its effect on 
older adults with regards to fall risk, functional mobility and EF. Seventy-four participants 
who had presented at a falls clinic were enrolled in the study, with 36 randomized to the 
OEP group (Age: 81.4 ± 6.2 years) and 38 to the control group (Age: 83.1 ± 6.3 years). The 
study was conducted over a six-month period, with those in the OEP encouraged to follow 
the programme three times per week for roughly 30 minutes, and also to walk a minimum of 
twice per week. Executive functioning was assessed using the Stroop task, Trail Making 
Test part B and the verbal digits backwards test. A significant improvement was noted in 
Inhibition (Stroop task) in the OEP group (p = 0.05) compared to the control group. No 
significant improvements were noted in Set shifting, working memory, physiological falls risk 
or functional mobility. Interestingly, after one year, the OEP group had reduced their fall 
incidence by 47% despite showing no significant reduction in falls risk or significant 
improvement in functional mobility. This is attributed to the significant improvement in 
Inhibition as a result of the OEP.  
 
These combination studies mainly reported improvements in the EF of Inhibition and 
Updating (working memory). The reported suggested mechanisms involved are: increased 
blood flow to the brain and increased neurotrophic or growth factors. In contrast to this, the 
combination study of Williamson et al. (2009) reported no significant differences between 
the combination training group and a control group after one year of training. 
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Langlois et al. (2013) looked at a combination exercise training programme on cognition 
(including EF) and QOL in a sample of frail older adults. The cognitive evaluation comprised 
six domains which included working memory and one they had termed EF, which referred 
collectively to the calculated difference score of the TMT and calculated interference score 
of the Stroop test. The participants were divided into an exercise-training group (n = 36; Age: 
71.6 ± 6.3 years) or a waiting listed control group (n = 36; Age: 73.2 ± 5.1 years). The 
exercise training programme comprised aerobic exercise (main component), resistance 
exercise, balance and stretching exercises performed three times per week for one hour. At 
the end of a 12-week period, the exercise training group exhibited significant improvements 
in cognitive performance, which included EF (p = 0.04), working memory (p = 0.04) and 
processing speed (p = 0.01) compared to the control group which did not improve. 
 
Pedroso et al. (2012) examined the effect of an exercise programme incorporating dual-
tasking on older adults with Alzheimer’s disease and its impact on falls, balance and EF. 
Twenty-one individuals with Alzheimer’s disease took part in the study with 10 in the training 
group (Age: 78.3 ± 7.4 years; MMSE (Mini-Mental State Examination): 20.1 ± 4.6) and 11 in 
the age-matched control group (Age: 77.5 ± 6.9 years; MMSE: 19.0 ± 3.2). Gender was not 
specified. The study ran over four months, those in the training group attended three 60 
minute sessions per week on non-consecutive days. The dual task exercise programme 
involved performing exercises pertaining to coordination, agility, balance, flexibility, aerobic 
and resistance exercise while simultaneously performing a cognitive task. The Frontal 
Assessment Battery (FAB) and Clock Drawing Test (CDT) were used to assess EF. 
Significant improvements in EF, as seen in the FAB (p < 0.01) and CDT (p = 0.03) were 
observed in the training group compared to the control group. This improvement appeared 
to also be related to improved balance performance and a decreased fall risk. 
 
2.2.5 Balance training and Executive Function 
The pilot study of Shubert et al. (2010) looked at the influence of an exercise-based balance 
programme on physical and cognitive function, specifically EF (Updating and Set shifting) 
performance. Of the 76 participants who participated in the 12-week programme, only 52 
(Age: 79.6 ± 6.8 years) completed the post-testing. Gender was not specified. Participants 
attended sessions twice per week for the duration of the study and sessions were roughly 
60 minutes long. The programme incorporated balance specific exercises, dual task 
activities, balance challenges as well as some walking, strength training and flexibility. There 
was no control group used in this pilot study. Executive function was assessed using the 
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TMT parts A and B and the Symbol Digit Modality Test (SDMT). At the end of the 12 weeks, 
participants showed significant improvement in the SDMT (p < 0.02), which assesses Set 
shifting and processing speed, and a tendency towards a significant improvement in TMT 
part A (p = 0.03), which is a measure of visual search. There was no significant improvement 
in TMT part B. 
 
As can be seen, balance training studies and their impact on EF are sorely lacking. Even in 
this study by Shubert et al. (2010), the balance training programme included small 
components of resistance and endurance exercise, thus it is questionable whether the 
observed improvements may be purely attributed to the balance training. This highlights a 
need and a significant gap in the current literature for an investigation of the impact of a 
specifically balance-focused exercise intervention on EF, and more specifically in the PD 
population. 
 
2.3  Exercise and Executive Function in the Parkinson’s Disease population 
The available literature on exercise and the influence on EF in individuals with PD is sadly 
limited. Nevertheless, the preliminary investigations as well as available animal studies have 
shown positive influences of exercise on EF in PD (Murray et al., 2014).  
 
Only six exercise studies have specifically investigated EF in PD (Tanaka et al., 2009; Rigdel 
et al., 2011; Cruise et al., 2011; McKee & Hackney, 2013; David et al., 2015). All six studies 
included participants with disease severity rated mild to moderate (Hoehn and Yahr Scale 
(HY) 1 - 3).  
 
The 2009 study of Tanaka et al. looked at 20 older PD participants: there was an equal age-
matched split of 10 in the experimental (EXP) group (Age: 64.8 ± 8.5 years; HY: 1.4 ± 0.5; 
UPDRS Total: 31.0 ± 13.1) and 10 in the control (CON) group (Age: 64.6 ± 6.3 years; HY: 
1.8 ± 0.8; UPDRS Total: 39.9 ± 19.7). It is not known whether the participants were tested 
on or off their medication. The study was conducted over a six-month period with participants 
attending three 60 minute sessions per week. They used the Wisconsin Card Sorting Test 
(WCST; Set shifting) and saw significant improvements in the results for “Categories 
completed” (p = 0.046) and “Perseverative errors” (p = 0.043) in the EXP. The exercise 
programme used was a combination of aerobics, flexibility, muscular resistance, motor 
coordination and balance.  
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Rigdel et al. (2011) observed changes in EF following sessions of acute passive cycling in 
participants with PD. The study had a total of 19 PD participants (Age: 63.2 ± 8.5 years; HY: 
1.9 ± 0.8; UPDRS: not utilized) and used a within-subject design (each participant was also 
his or her own control). Participants were assessed off their medication (minimum of 10 
hours since previous dosage), except for the first session which was a baseline testing 
session for fitness and measurements. Participants had three sessions, after the initial 
baseline session, which involved passive for 30 minutes on a motorized bicycle cycling (thus 
participants did not actively cycle). Each session was one week apart and always on the 
same day of the week. They made use of the TMT A and B to assess EF (Updating) and 
they noted significant improvements in the total time to complete TMT B (p = 0.01) as well 
as TMT B-A, the difference score between TMT B and TMT A, (p = 0.01). 
 
The study of Cruise et al. (2011) investigated the influence of a progressive aerobic and 
anabolic exercise programme on cognition and QOL in PD. The study included 28 PD 
participants divided into age-matched experimental (EXP) (Age: 59.5 ± 11.5 years; HY: 1 - 
3; UPDRS: not utilized) and control (CON) (Age: 60.6 ± 7.3 years; HY: 1 - 3; UPDRS: not 
utilized) groups. Participants were tested on medication, 1 to 2 hours after taking it. 
Participants in the EXP took part in a 12-week progressive programme of strengthening and 
cardiovascular exercise while those in the CON were asked to maintain their usual activities 
for the duration. At the end of the study those in the CON were given the opportunity to 
participate in the 12-week programme that the EXP followed. Those in the EXP had twice 
weekly 60-minute exercise sessions over the 12-week study period. The authors of the study 
chose to calculate inferences regarding the true value of the change scores. Their results 
showed “likely benefit” (>75% confidence interval) for selected frontal lobe-based EF 
specifically, verbal fluency and spatial working memory. They assessed this using the 
Cambridge Neuropsychological Test Automated Battery. There was no significant change 
in QOL or mood (p > 0.05). 
 
McKee and Hackney (2013) studied the effects of tango dance classes on the spatial 
cognition and disease severity of those with PD. A total of 31 PD participants completed the 
study, 23 in the experimental (EXP) group (Age: 68.4 ± 7.5 years; HY: 2.3 {2.0, 2.6} median 
{first, third quartiles}; UPDRS III: 28.1 ± 6.9) and eight in the age-matched control (CON) 
group (Age: 74.4 ± 6.5 years; HY: 2.0 {2.0,2.0} median {first, third quartiles}; UPDRS III: 27.2 
± 7.0). All participants were tested on their medication. The study took place over 12 weeks 
with each participant attending twenty 90-minute sessions, with tango lessons for the EXP 
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and educational lessons for the CON. They reported significant improvements in the EXP, 
compared to the CON, with spatial cognition (p = 0.021), measured using the Brooks Spatial 
Task, and global cognition measured with the MoCA (p = 0.01). They also found significant 
improvements in disease severity (p = 0.01) and balance (p = 0.04) in the EXP.  
 
David et al. (2015) investigated the impact of two different types of exercise programmes on 
EF in PD. A total of 51 PD participants took part in the study, with 46 and 38 completing the 
12- and 24-month follow-ups, respectively. Participants were randomized to a Progressive 
Resistance Exercise Training (PRET) or modified Fitness Counts (mFC) group. The PRET 
(Age: 59.0 ± 4.6 years; HY: 2 (range: 2 – 2.5); UPDRS III: 34.5 ± 11.9) followed a progressive 
resistance training weight-lifting programme while the mFC (Age: 58.6 ± 5.6 years; HY: 2 
(range: 2 – 2.5); UPDRS III: 34.7 ± 11.5) followed non-progressive strengthening, balance 
exercises, stretches and breathing. All results reported were collected off medication. The 
study was conducted over 24 months, with participants attending twice-weekly sessions of 
unknown duration. At the 12-month follow-up, they observed improvements in the Digit Span 
(Updating) in both the PRET (p < 0.01) and mFC group (p = 0.04) and improvement in the 
Stroop (Inhibition) in the mFC only (p = 0.04). At the 24-month follow-up, improvements were 
noted in the Digit Span (p < 0.01), Stroop (p = 0.048) and Brief Test of Attention (p = 0.048) 
for the PRET and in the Digit Span (p < 0.01) and Stroop (p = 0.03) for the mFC. 
 
The most recent study by Duchesne et al. (2015) looked at the effect of aerobic exercise on 
both motor and cognitive functioning (specifically EF) in PD. For this discussion, we will only 
focus on the EF component of the study. Nineteen PD participants (Age: 64 ± 8.2 years; HY: 
2 ± 0; UPDRS III: 21.8 ± 6.2) and 20 healthy controls (Age: 59 ± 7.1 years) took part in the 
study. Participants engaged in high intensity aerobic exercise cycling on a recumbent 
bicycle, three times per week for 12 consecutive weeks. They started at 20 minutes, 
progressing by 5 minutes per week until they attained 40 minutes. Participants were 
assessed pre- and post-intervention with the Stroop task and TMT A and B tests. Following 
12 weeks of aerobic exercise training, there was a significant improvement in Inhibition (p = 
0.01) but not in other EF measures (p > 0.05). 
 
In contrast to the above mentioned studies, Pierobon et al. (2014) decided to investigate 
whether EF or depression impact on the outcome of a rehabilitation programme. Forty PD 
participants (Age: 70.1 ± 8.0 years; HY: 3; UPDRS Total: 41.2 ± 10.4; UPDRS III: 21.4 ± 
5.3) were enrolled in the study. The participants were subdivided into two groups for two 
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criteria. Criterion one was impaired or not impaired (EF) and criterion two was depressed or 
not depressed. Participants were assessed on their medication. The rehabilitation 
programme was an intensive one for the four-week duration. Participants took part in three 
daily sessions, for a collective three hours of rehabilitation, five days per week. The authors 
concluded that neither impaired EF nor moderate-to-severe symptoms of depression 
impeded the outcome of the rehabilitation programme. PD participants remained on their 
meds for the duration of the study.  
 
There are other studies which did not specifically investigate EF, but did look at related 
aspects of cognition in individuals with PD after balance-related interventions (Sehm et al., 
2014; Dos Santos Mendes et al., 2012; Pompeu et al., 2012). 
 
Both Pompou et al. (2012) and Dos Santos Mendes et al. (2012) used the popular Nintendo 
WiiTM game console in their studies with PD participants. Pompeu et al. (2012) studied the 
effect of motor and cognitive training on the Nintendo WiiTM in PD participants and its impact 
on their ADL compared to balance exercise therapy. Thirty-two PD participants (HY: 1.7 ± 
0.5) were included in the study and split into a WiiTM group (Age: 68.6 ± 8.0 years; UPDRS 
II: 10.1 ± 3.8) and a Balance group (Age: 66.2 ± 8.3 years; UPDRS II: 8.9 ± 2.9). Participants 
were assessed on their medication. The participants of both groups participated in 14 twice-
weekly individual training sessions over seven weeks. Each session lasted one hour and 
was composed of two 30 minute components. Both groups performed the same global 
exercises for 30 minutes which incorporated stretches, resistance and diagonal pattern 
exercises. The WiiTM group received 30 minutes of motor and cognitive training while the 
Balance group received 30 minutes of balance exercise therapy. Both groups improved 
significantly in UPDRS II (p < 0.01) and MoCA (p < 0.01) scores. The authors concluded 
that because the improvement seen in cognition, as measured by the MoCA (which also has 
an EF component), also occurred in the Balance group it could be ascribed to the 
advantageous effects of physical activity. 
 
Dos Santos Mendes et al. (2012) examined the effect of WiiTM training on learning, retention 
and transfer of improvements in performance in PD and healthy elderly participants. Sixteen 
PD participants were included in the experimental (EXP) group (Age: 68.6 ± 8.0 years; HY: 
1.9 ± 0.3; UPDRS: not utilized) and 11 age-matched healthy elderly in the control (CON) 
group (Age: 68.7 ± 4.1 years). Both groups took part in twice-weekly sessions conducted 
over seven weeks. Each session began with 30 minutes of global exercises (same as 
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Pompeu et al., 2012) followed by the WiiTM Fit training. This study suggests that the ability 
of individuals with PD to learn, retain and transfer this learning, following WiiTM Fit training, 
depends to a large extant on the cognitive demands of the individual games. 
 
The study of Sehm et al. (2014) investigated morphometric changes in the brains of 
individuals with PD following balance training. Twenty PD participants (Age: 62.9 ± 7.1 
years; HY: 2.1 ± 0.4; UPDRS III: 21.9 ± 9.5) and 16 age- and sex-matched healthy 
volunteers participated in the study. Both groups participated in a whole-body dynamic 
balancing task (DBT) programme which was run over six consecutive weeks. Each session 
was 45 minutes long and there was one session per week. Magnetic resonance imaging 
(MRI) and balance testing were assessed at baseline as well as after 2, 4 and 6 weeks of 
training. Both groups displayed improvements in performance. The healthy controls 
exhibited learning-dependant changes in grey matter in the left hippocampus, while the PD 
participants demonstrated changes in grey matter in the right anterior precuneus, left ventral 
premotor cortex, left inferior parietal cortex, left middle temporal gyrus and bilateral anterior 
cingulate cortex. There was also a treatment effect for time-dependant changes in grey 
matter in the right cerebellum. The authors elucidate the ability of the brain to undergo 
structural plasticity, related to learning, in a degenerative condition such as PD. 
 
The study of Dos Santos Mendes et al. (2012) was not able to show that the improvements 
seen were linked specifically to the balance component of the WiiTM Fit training or whether 
it was due to the combined balance and cognitive component of this training. The study of 
Sehm et al. (2014), however, revealed the neuroplasticity of the brain that took place in 
response to balance training.  
 
Comparisons between investigations are challenging for a number of reasons, which are not 
limited to the studies mentioned. For instance, executive functioning is not defined uniformly, 
and each of these studies assessed executive functioning with different assessment tools. 
Similarly, the exercise protocols vary greatly from study to study. This is the variable with 
the widest range as it can be influenced by type of exercise, duration of session (minutes or 
hours), exercise sessions per week (or total exercise sessions), duration of exercise period 
(weeks or months) or intensity of exercise. 
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2.4 The relationship between Executive Function and Balance, Mobility and Fall 
Risk 
Executive dysfunction is common amongst individuals with PD, with impairments reported 
in Inhibition, Updating and Set shifting (Xu et al., 2014; Camicioli & Majumdar, 2010). 
Impaired EF in older adults has also been shown to have an association with reduced 
balance performance and gait as well as an increased risk of falling (Xu et al., 2014). 
Camicioli and Majumdar (2010) report that individuals with PD are at a greater risk of falling 
than age- and sex-matched controls. A study by Xu et al. (2014) revealed impairments in 
EF, cognition, gait and balance in a PD sample. More specifically, they showed that EF, and 
not general cognition, was linked to poorer gait and balance in individuals with PD. The 2014 
study of Gothe et al. proposed that the EF components of Inhibition and Set shifting could 
be potential early indicators of mobility limitations in the future, which could result in difficulty 
conducting ADL or disability in older adults. 
 
3. Parkinson’s Disease and Sensory-motor Training 
3.1 Benefits of Exercise for Parkinson’s Disease  
Recent research shows that the early intervention of physical activity or exercise is valuable 
in improving or maintaining the physical performance of those with mild to moderate PD. 
This is of particular importance in retaining independence and lessening the load of 
caregivers (Crizzle & Newhouse, 2006). Physical activity, such as aerobic exercise, 
resistance training and flexibility exercises, can elicit improvements in general fitness and 
aerobic capacity as well as improve both motor and non-motor aspects of PD (Van der Kolk 
& King, 2013; Goodwin et al., 2008; Cutson et al., 1995). The following section summarizes 
briefly the benefits of exercise previously reported in the literature. 
 
The types of physical activity or exercise programmes range widely, including but not limited 
to: aerobic exercise, resistance training, balance and sensory-motor training programmes 
as well as combination programmes. A variety of benefits of exercise in PD have been 
reported but more specifically the balance-related improvements include improved balance 
(King et al., 2015; Loftus, 2014; Lauhoff et al., 2013; McKee and Hackney, 2013; Smania et 
al., 2010; Hackney and Earhart, 2008; Hirsch et al., 2003), increased balance confidence 
(King et al., 2015; Smania et al., 2010), a reduction in falls (Loftus, 2014; Smania et al., 
2010), improved equilibrium (Toole et al., 2000) and increased axial mobility and functional 
reach (Schenkman et al., 1998). These balance-related improvements have been reported 
in varied exercise interventions and not specifically balance interventions. 
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Increased ambulation or walking speed (Uc et al., 2014; Hass et al., 2012; Dibble et al., 
2009; Miyai et al., 2002; Scandalis et al., 2001), stride length (Scandalis et al., 2001) and 
number of steps (Miyai et al., 2002) are reported improvements related to gait and also 
include positive changes in gait variability (King et al., 2015), walking economy (Schenkman 
et al., 2012) and initiation of gait (Hass et al., 2012).  
 
Various studies have also documented increased muscular strength (Schilling et al., 2010; 
Hirsch et al., 2003; Scandalis et al., 2001) as well as enhanced control and coordination of 
grasping (Rigdel et al., 2009). In addition to this, aerobic capacity has been shown to 
improve (Duchesne et al., 2015; Uc et al., 2014; Bergen et al., 2002), fatigue to decrease 
(Uc et al., 2014) and exercise tolerance to increase (Baatile et al., 2000). Another advantage 
of exercise in PD is an improved functional ability (Lauhoff et al., 2013; Dibble et al., 2009; 
Hackney and Earhart, 2008) or physical performance (King et al., 2015; Schenkman et al., 
2012). 
 
Reductions in disease severity of PD have been noted in a decrease in the UPDRS (Unified 
PD Rating Scale) total score (Lauhoff et al., 2013; Baatile et al., 2000) as well as in UPDRS 
I, the mood subscale, (Uc et al., 2014), UPDRS II, the ADL (Activities of Daily Living) 
subscale, (King et al., 2015; Schenkman et al., 2012) and UPDRS III, the motor subscale, 
(Carvalho et al., 2015; Uc et al., 2014; Rigdel et al., 2009; Hackney and Earhart, 2008), as 
well as reductions seen in bradykinesia and tremors (Rigdel et al., 2012; Dibble et al., 2009). 
 
Decreased depression (King et al., 2015; Uc et al., 2014; Smania et al., 2010) and increased 
QOL scores (King et al., 2015; Uc et al., 2014; Dibble et al., 2009; Baatile et al., 2000), as 
well as improvements in apathy, self-efficacy (King et al., 2015) and subjective well-being 
(Reuter et al., 1999) have been reported as well. 
 
Crizzle and Newhouse (2006) emphasized the importance of designing exercise 
programmes in a manner that recognize the link between the neurological impairments that 
pertain specifically to PD (tremor, rigidity, motor planning) and the ensuing musculoskeletal 
impairments (bent over posture, reduced flexibility of spine and extremities).  
 
In the study of Xu et al. (2010) future risk of PD was lowered in those with increased levels 
of moderate to vigorous exercise between the ages of 35-39 or within the previous 10 years, 
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again highlighting the importance of exercise with regards to PD. They noted this association 
in both genders. Thus, it would appear that being moderately to vigorously active, in these 
age groups, is associated with a decreased PD risk. 
 
There is sufficient evidence to confirm the benefits of exercise for those with PD. These 
range from physical and motor improvements to those pertaining to mood and QOL. 
Exercise has the potential to play a significant, and yet relatively inexpensive, role in the 
nonpharmacological management of PD. 
 
3.2 Sensory-motor Training 
Somatosensory-, sensory-motor-, neuromuscular- and proprioceptive- training are often 
used interchangeably since these training modalities refer to interventions that focus on 
improving postural control, most often through the integration of sensory information and, 
particularly, through increasing proprioceptive function.  
 
Aman et al. (2014) describe proprioception as “the conscious awareness of one’s body and 
limbs and has several distinct properties: passive motion sense, active motion sense, limb 
position sense, and the sense of heaviness.” When information from other sensory sources, 
such as the visual or vestibular systems, is absent, it uses somatosensory signals in the 
form of proprioception or haptic feedback. The main focus according to Aman et al. (2014) 
is on improving or completely restoring sensory and / or sensory-motor function. Similarly, 
Riemann and Lephart (2002) referred to the sensory-motor system as encompassing the 
sensory, motor and central integration as well as processing features involved with joint 
homeostasis maintenance during movements; in other words, functional joint stability 
through neuromuscular control. 
 
Aman et al. (2014) outlined pertinent features of sensory-motor training in general: sensory-
motor training has the potential to improve proprioception and interventions run over a longer 
period (≥ 6 weeks) appear to show greater improvements; sensory-motor training is relevant 
and beneficial for a variety of clinical populations, such as those with impaired proprioception 
(like PD), regardless of whether it is due to a musculoskeletal or neurological problem. 
 
Adults rely predominantly on somatosensory (proprioceptive) information for postural 
control. As a result, balance activities are often used by clinical exercise therapists as a 
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means to train proprioception and vice versa. Proprioceptive or neuromuscular activities are 
often incorporated to improve body control as well as joint control and stability. 
 
Balance (postural control) relies on an ability to maintain centre of mass within the base of 
support limits, during sitting or standing, and to control it, during walking or running, while 
changing to a new base of support. Considerable everyday activities are balance-related: 
walking or getting up off a chair, for example, requires centre of mass control while changing 
base of support. Most PD individuals will eventually see reductions in their balance, which 
will further deteriorate as their disease progresses. Poor mobility, falls, disability and a 
decline in quality of life are associated with reduced balance in individuals with PD. Thus, 
there is a crucial need to investigate interventions, such as those using sensory-motor 
training programmes, that could potentially improve balance in this clinical population (Allen 
et al., 2011). 
 
3.3 Parkinson’s Disease and Sensory-motor Training  
Although there have been some sensory-motor training or balance training studies 
conducted with individuals with PD, most of them tended to look at balance training together 
with other forms of training (King et al. 2015; Schenkman et al., 2012; Tanaka et al., 2009; 
Toole et al., 2000). Research suggests that external cues (peripheral sensory feedback) can 
be used to counteract the defective internal signal generation in PD. The provision of 
external cues can assist with initiating and maintaining continuous motor activities, such as 
walking (Abbruzzese et al., 2015; Abbruzzese et al., 2014). 
 
 
3.3.1 Balance as Part of a Combination Training Programme  
The research of Hirsch et al. (2003) compared a combination group (balance and resistance 
training) (n = 6; Age: 70.8 ± 2.8 years; HY: 1.8 ± 0.3; UPDRS: not utilized) with a balance 
only group (n = 9; Age: 75.7 ± 1.8 years; HY: 1.9 ± 0.6; UPDRS: not utilized) in a sample of 
idiopathic PD participants. The study ran over a 10-week period and participants were 
assessed pre-, post- and four weeks post-intervention. Both groups received the same 
balance training three times per week for 30 minutes, while the combination group also 
participated in 15-minute resistance training sessions three times per week. Both groups 
significantly improved their balance (p = 0.06) with the combination group marginally better 
than the balance group. Both groups improved their balance time before falling (p = 0.03), 
and this improvement was maintained after four weeks. Strength increased significantly in 
Stellenbosch University  https://scholar.sun.ac.za
31 
 
both groups (p < 0.01) and was maintained at the 4-week follow-up, although this increase 
was small in the balance group compared to a considerable improvement in the combination 
group. 
 
Balance and functional training, within a combination programme which included spinal and 
extremity flexibility, was investigated by Schenkman et al. (2012). The balance and flexibility 
group (n = 39; Age: 64.5 ± 10.0 years; HY: 2.3 ± 0.4; UPDRS III: 24.3 ± 10.5; UPDRS Total: 
35.5 ± 13.9) was compared to an aerobic exercise group (n = 41; Age: 63.4 ± 11.2 years; 
HY: 2.2 ± 0.5; UPDRS III: 24.4 ± 9.1; UPDRS Total: 34.6 ± 13.0) and a home-based exercise 
group (control) (n = 41; Age: 66.3 ± 10.1 years; HY: 2.3 ± 0.4; UPDRS III: 25.9 ± 8.9; UPDRS 
Total: 37.5 ± 13.7). The study was conducted over 16 months and all groups exercised 5 to 
7 times per week for 45 to 50 mins. The control group exercised at home on their own with 
one supervised session per month, while the balance and flexibility group and aerobic 
exercise group had three supervised sessions per week for the first 4 months. Thereafter, 
the frequency of supervised sessions in the latter two groups tapered down, with the 
responsibility on themselves to keep up with the frequency of sessions. Overall function (a 
performance-based physical function measure), measured using the Continuous Scale – 
Physical Functional Performance Test, was significantly improved in the balance and 
flexibility group after four months compared to the aerobic exercise group (p = 0.048) and 
control (p < 0.01). This was not sustained at the 10- and 16-month follow-ups, possibly due 
to the fact that supervision tapered down from three times per week to once a month. 
Interestingly, the balance and flexibility group did not significantly improve their balance over 
the intervention but neither did it deteriorate. The authors did not elaborate on possible 
reasons for this result. 
 
King et al. (2015) observed the effect of a sensory-motor programme on individuals with PD 
in three different settings, namely, one-on-one individual sessions (n = 21; Age: 64.2 ± 6.7 
years; HY: 2.4 ± 0.5; UPDRS III: 39.4 ± 11.1), group sessions (n = 20; Age: 63.9 ± 8.5 years; 
HY: 2.4 ± 0.5; UPDRS III: 35.4 ± 14.1) or a home programme (n = 17; Age: 64.6 ± 6.8 years; 
HY: 2.5 ± 0.5; UPDRS III: 35.2 ± 13.7). The programme included various activities, such as 
Pilates and Tai Chi, to target kinesthesia, stability limits, biomechanical constraints, 
anticipated adjustments of posture, gait coordination and bradykinesia, and the programme 
was progressed systematically. The programme took place over a four-week period with 
individuals attending three one hour sessions per week. The individual group demonstrated 
the greatest improvements in measures of function, which included the Physical 
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Performance Test (p < 0.01), balance (p < 0.01), UPDRS II (p = 0.01), depression (p = 0.01), 
self-efficacy (p = 0.02) and apathy (p = 0.048), while the group sessions group demonstrated 
the greatest improvements in measures of gait, which included arm swing (p < 0.01), stride 
velocity (p < 0.01), gait variability (p = 0.049), gait while dual tasking (p = 0.01), trunk 
movement (p < 0.01) and freezing of gait (p < 0.01). The home programme group showed 
the least improvement – they only showed improvements in PDQ (p = 0.02) and mini-
BESTest (p = 0.01). They concluded that individual exercise sessions might be most 
beneficial for improving balance and function while gait might be best improved through 
group sessions.  
 
The study of Wong-Yu and Mak (2015) examined the effects of an inside and outside multi-
dimensional balance training programme in individuals with PD. The programme ran for 
eight weeks with participants in the exercise group (n = 41; Age: 59.4 ± 9.0 years; HY: 2.5 
± 0.3; UPDRS III: 26.9 ± 10.4) attending a single two-hour session per week. The first four 
weeks took place indoors and the second four weeks outside. The programme consisted of 
varied exercises focusing on strengthening, flexibility and balance, among others. A control 
group (n = 43; Age: 62.6 ± 8.9 years; HY: 2.4 ± 0.3; UPDRS III: 31.3 ± 11.1) performed 
upper body exercises at the same session frequency. The experimental group showed 
significant improvements for dual-task TUG (p < 0.01) and balance (p < 0.01) at post-
intervention and these were sustained at six- (balance: p < 0.01; dual-task TUG: p < 0.01) 
and twelve-month (balance: p < 0.01) follow-up. 
 
3.3.2 Balance Training Programme in Isolation 
Smania et al. (2010) investigated the impact of balance training on postural instability, 
compared to general physical activity, in individuals with PD. Participants were randomized 
to the balance training group (n = 28; Age: 67.6 ± 7.4 years; HY: 3.0 ± 0.1; UPDRS Total: 
46.1 ± 11.5), which performed balance training exercises aimed at improving feedback and 
feedforward postural reactions, maintaining balance on uneven surfaces and coordinating 
limbs during movement, or the physical activity group (n = 27; Age: 67.3 ± 7.2 years; HY: 
3.1 ± 0.3; UPDRS Total: 43.0 ± 16.9), which performed muscle stretching, coordination and 
joint mobilization exercises. Each group participated in sessions three times a week for 
seven weeks. Balance (p < 0.01), balance confidence (p < 0.01), postural transfers (p < 
0.01) and centre of foot pressure self-destabilization (p < 0.01) (the latter two both measures 
of postural instability) had improved statistically significantly after the intervention, and this 
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was maintained at one-month follow-up. No significant improvement was noted in the control 
group. 
 
The pilot study of Mirelman et al. (2011) looked at the use of an audio-biofeedback system 
(ABF) in conjunction with a balance training programme in a small group of PD participants 
(Age: 71.3 ± 8.3 years; HY: 2.5 ± 0.5; UPDRS III: 25.3 ± 11.7). The study was conducted 
over six weeks and each participant completed 18 45-minute sessions. The ABF provided 
feedback as a result of the participants’ movements and body orientation changes. Balance 
improved significantly (p = 0.03) over the six weeks and there was a trend towards 
improvement in functional mobility (p = 0.07). These changes were maintained at a one-
month follow-up. Participants also improved their depressive (p = 0.05) and quality of life 
scores (no reported p value), however, these were not maintained at follow-up. 
 
The study of van den Heuvel et al. (2014) investigated the use of augmented visual feedback 
on balance training compared to conventional balance training (control). Participants took 
part in twice-weekly sessions over the five-week duration of the study. The visual feedback 
group (Age: 66.3 ± 6.4 years; HY: 2.5 (2.0, 3.0); UPDRS III: 28 (19.0, 40.5); UPDRS Total: 
46.0 (32.3, 63.8)) was exposed to interactive balance games making use of augmented 
visual feedback, while the control group (Age: 68.8 ± 9.7 years; HY: 2.5 ( 2.0, 2.5); UPDRS 
III: 28 (17.8, 35.6); UPDRS Total: 46.0 (32.3, 62.0)) participated in balance training, which 
included one-leg balancing (eyes open and closed) and dual-task exercises among others. 
The study found no significant differences between the visual feedback and control groups 
with regards to functional reach, balance and gait, and health status, level of activity and 
participation (p > 0.05). HY and UPDRS III and Total were reported as median (first quartile 
– third quartile). 
 
Thus balance studies in PD participants tend to improve balance, physical performance or 
function, functional mobility and aspects of gait. 
 
4.  Conclusion 
Exercise seems to play an assistive role in the protection of neurons from injury or 
degeneration. Although the degree to which, and specifically how exercise impacts EF in 
PD is not clear. To date, the problem with EF research in the PD population is the 
heterogeneous subject populations, the diverse exercise interventions (in terms of the 
intensity, mode and duration of the programme) as well as differences in outcome measures. 
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However, regardless of this, the exercise-based EF interventions conducted in the PD 
population, have still demonstrated improvement in a range of EF measures. Furthermore, 
because EF has been linked to poor gait performance and balance in PD, sensory-motor 
exercise interventions have the potential to improve components of EF as well as aspects 
of balance and mobility in the PD population. 
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CHAPTER THREE 
 
PROBLEM STATEMENT 
 
1.  Study Purpose 
Motor dysfunction, impaired balance and fear of falling are a part of the daily life of an 
individual with PD. Current therapies, both pharmacologic and non-pharmacologic, remain 
largely inadequate in successfully treating these daily problems (Cutson et al., 1995). 
Executive Function is important in everyday life and involves setting goals, planning and 
achieving these goals, even for seemingly simple activities such as walking down stairs 
(Murray et al., 2014). Impairment of EF has been associated with poorer gait and balance 
in PD (Xu et al., 2014) and cognitive impairment has been shown to contribute to QOL 
scores in this same population (Schrag et al., 2000). Impaired EF has an impact on gait 
efficiency and safety and affects the person with PD’s balance in their daily activities (Yogev-
Seligmann et al., 2008). By investigating the influence of a sensory-motor training program 
on EF, the findings could be used to enhance clinical practice and neuro-rehabilitation 
exercise programmes used for treating EF deficits in PD. This is of particular importance in 
a developing country such as South Africa, where therapists are constantly searching for 
evidence-based practices that are cost effective to implement. 
 
To date, research which has investigated the influence of various types of exercise on EF in 
individuals with PD, included sample sizes between 19 and 51 (with an average of 17.0 per 
group and 28.3 per study) and participants with reported average ages ranging between 
58.6 and 74.4 years (average age of 63.2 ± 7.3 years). Participants were at a PD level of 
mild to moderate based either on the HY scale, with reported average scores ranging from 
1.4 to 2.0 (average HY: 1.8 ± 0.5) and/or UPDRS score, with reported average scores 
ranging from 27.2 to 34.7 for UPDRS III (average UPDRS III: 31.1 ± 9.3) and 21.8 to 39.9 
for UPDRS Total (average UPDRS Total: 31.0 ± 13.0). Of the six studies specifically 
focusing on EF and exercise in PD, four studies included age-matched PD control groups 
(David et al., 2015; McKee & Hackney, 2013; Cruise et al., 2011; Tanaka et al., 2009), one 
study included an age-matched healthy control group (Duchesne et al., 2015) and another 
only used an experimental group (Rigdel et al., 2011). In all the studies examined, 
participants continued taking their regularly prescribed medication. Two studies reported 
testing of participants OFF their medication (David et al., 2015; Rigdel et al., 2011) and three 
studies reported testing of participants ON their medication (Duchesne et al., 2015; McKee 
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& Hackney, 2013; Cruise et al., 2011). One study was unclear as to whether testing took 
place while participants were on or off medication (Tanaka et al., 2009). These studies 
assessed global cognitive function, Set shifting (cognitive flexibility), Inhibition, working 
memory (updating) as well as both spatial working memory and spatial recognition memory, 
attention, visual search, processing speed and verbal fluency as indictors of EF. 
 
It is still not clearly known how PD drugs affect executive function. Dirnberger and 
Jahanshahi (2013) discussed the dopamine overdose hypothesis. This hypothesis attempts 
to explain the varying effects of dopaminergic medication on motor versus certain cognitive 
functions. Whilst dopaminergic medication raises low levels of dopamine in the putamen 
and dorsal striatum, the ventral striatum becomes over- stimulated or “overdosed” as it is 
not seriously depleted of dopamine. This impact on the ventral striatum can affect the limbic 
and orbitofrontal circuits and influence certain executive function tasks. 
 
It is not ethical to test PD participants off their medication. Some studies have assessed 
their participants in the morning following an overnight withdrawal or wash-out period. It was 
beyond the scope of the man-power and resources of this study to do this. With one person 
assessing the participants, it would have meant testing one person per day which would not 
have been possible. In this study, participants were tested at the same time (plus or minus 
an hour) on all three testing occasions – thus consistency was maintained within the study. 
 
To the researcher’s knowledge, no studies to date have investigated the influence of 
sensory-motor or balance training on EF in individuals with mild to moderate PD.  
 
2. Research Question 
The main research question was to establish if an eight-week SMT programme could alter 
EF in individuals with mild to moderate PD. 
 
2.1 Research Objectives 
To investigate whether an eight-week SMT programme influenced: 
I. Executive Function, namely Updating (working memory), Set shifting and Inhibition 
with TMT A and B, WCST and adapted Stroop task (including selective attention 
and processing speed), respectively; 
II. Global cognitive function, namely Montreal Cognitive Assessment (MoCA), and the 
cognition component of PDQ-39; 
Stellenbosch University  https://scholar.sun.ac.za
37 
 
III. Disease severity with HY as well as MDS-UPDRS i.e. subsections II, III and Total. 
IV. QOL with the 39-Item PD Questionnaire (PDQ-39); 
V. Perception of depressive mood (referred to hereafter as depression: hence it does 
not refer to the clinical diagnosis of depression) with Hamilton Rating Scale for 
Depression (HAM-D); 
VI. Perceived balance confidence via Activities-specific Balance Confidence (ABC) 
Scale;  
VII. Functional balance and mobility with the Timed Up and Go (TUG) test. 
 
2.2 Variables 
2.2.1 Independent Variable 
The independent variable was the eight-week sensory-motor training programme. 
 
2.2.2 Dependent Variables 
The dependent variables were Set shifting, Updating (Working Memory), Inhibition, 
processing speed (primary outcome variables). In addition, balance and mobility, as well as 
QOL and depression, were also assessed (secondary outcome variables). 
 
2.2.3 Categorical Variables 
 Participant age: 50-85 years of age 
 Gender: men and women 
 Level of PD: stages 1 - 3 according to the Hoehn and Yahr (HY) Scale and a 
functional status level of PD less than 59 on subscale III of MDS-UPDRS 
(Movement Disorder Society – Unified PD Rating Scale). 
 
2.2.4 Confounding variables 
Mood, medication and education (also relating to socioeconomic status) were considered 
as variables that may influence executive functioning. 
 
However, individuals with moderate to severe depressive moods (including apathy) on 
medication which could influence cognition and balance, as well as individuals with 
moderate to severe/demented global cognition, were excluded. In addition, global cognition 
was corrected for individuals with < 12 years’ education, and the convenience sampling took 
participants from two areas with a similar socio-economic distribution (Development 
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Information and GIS Department, 2014; Western Cape Government Provincial Treasury, 
2014a, 2014b). 
 
2.2.5 Assumptions 
Certain assumptions concerning the research participants were made at the start of the 
study. It was assumed that each participant would answer all questions asked and complete 
all their forms honestly, and that they would not withhold any information relevant to the 
study. It was assumed they would attend the exercise sessions and that they would 
specifically adhere to a 70% attendance rate. It was assumed the participants would perform 
each test to the best of their ability.  
 
In addition to this, certain assumptions were made regarding the study itself. It was assumed 
that the sensory-motor training programme would have an effect on executive function and 
balance. 
 
2.2.6 Limitations 
A number of limitations were recognized at the beginning of the study. These comprised: 
the possibility of participants dropping out of the study due to illness or injury, a variety of 
personal reasons or a lack of interest in continuing with the study; the possibility that 
participants could be dishonest or not completely truthful when completing forms or 
answering questions; the possibility that individuals would continue with other activities 
(although they were asked not to add any additional activities); the possibility of transport 
issues affecting attendance (especially if the person was reliant on public transport or on 
another person); and lastly, the possibility that the sample size may be too small and inhibit 
ability of the research team to conduct a randomized controlled trial. 
 
2.2.7 Delimitations 
Certain delimitations were set at the beginning of the study. The study was delimited to 
individuals who presented with a clinical diagnosis of idiopathic PD between stages I and III 
(mild to moderate), as classified according to the HY scale and a neurologist. Participants 
with a classification above III were not considered as they would have been unable to 
participate fully in the sensory-motor training programme. Participants needed to reside 
within a 70km radius of Stellenbosch in the Western Cape. The research team did not have 
the resources (manpower or financial) to implement this study further afield at the time.  
 
Stellenbosch University  https://scholar.sun.ac.za
39 
 
Participants needed to be between the ages of 50 and 85 years. They were set a minimum 
attendance requirement of 70% for the sensory-motor training programme sessions and 
could not miss two consecutive training sessions. Participants unable to meet this 
requirement were allowed to continue their sessions but their data was excluded from the 
study. It was accepted that participants who were colour-blind would not be able to complete 
the WCST or the Stroop Task but would be able to complete all the other tests. 
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CHAPTER FOUR 
 
METHODOLOGY 
 
1.  Study Design 
This study was conducted as an interrupted time series (ITS) experimental design with two 
groups and pre-, mid- and post-data collection. The ITS is considered to be one of the 
strongest quasi experimental research designs. The two groups (allocation ratio of 18:31, 
respectively) were a placebo group (PBO) which wore a wristband during the treatment 
phase and an experimental group (EXP) which participated in the eight-week sensory-motor 
training programme). Data collection was divided into a ‘baseline phase’ (pre- to mid-testing) 
and a ‘treatment phase’ (mid- to post-testing) for both the EXP and PBO (Figure 4.1). 
 
*SMT: sensory-motor training 
Figure 4.1 Illustration of the study design for both placebo and experimental groups. 
The baseline phase refers to the eight weeks in which dependent variables were observed 
and assessed before introduction of the independent variable for eight weeks. The baseline 
time provided a frame of reference against which the treatment was compared. The 
treatment phase is when the intervention (independent variable) was introduced and the 
dependent variables were observed and recorded. In other words, each participant was 
observed three times and their performance during the intervention (treatment phase) was 
compared to their own performance prior to this during the baseline phase, hereby making 
the participant their own control. In addition, to add increased quality to the research design, 
a placebo group was added. To make the study feasible a sample of convenience was used. 
This specific placebo-controlled study design was selected as typical exercise-based PD 
research includes only a few available participants. 
 
1.1 Place of Study 
The study was conducted in the Cape metropolitan region (Western Cape) of South Africa, 
specifically in the Southern Suburbs of Cape Town (including Simonstown, Fish Hoek, 
Pre Baseline Phase:continue typical routine Mid
Treatment Phase:
either 'wristband' or 
SMT 
Intervention 
Post
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Muizenberg; Kirstenhof, Tokai, Claremont, Athlone, Ottery, Sea Point and Hout Bay) as well 
as the Winelands region (incorporating Stellenbosch, Paarl, Strand and Somerset West) 
from July 2014 to March 2015.  
 
Participants in the EXP took part in the eight-week sensory-motor training programme at 
one of two similar venues in the Southern Suburbs of Cape Town. A church hall was used 
in the Fish Hoek area and a Scout hall in the Bergvliet area. Both halls had comparable 
wooden flooring. Eleven participants attended the venue in Fish Hoek and the remaining 17 
in Bergvliet.  
Testing sessions for the EXP took place in their homes. Testing for the PBO took place 
either in the participant’s home or at the Stellenbosch University’s Department of Sport 
Science. Participants were tested at the same location, at the same or similar time of day 
for all the testing sessions. One participant was an exception as he moved mid-way through 
the study and thus his subsequent two testing sessions were at different venues. 
 
2.  Participants 
2.1 Recruitment  
Ninety-six participants with PD were recruited by way of an invitation to support groups and 
care facilities in the Western Cape, as well as through newspaper articles which appeared 
in four local newspapers (Appendix C). However, only those areas which voluntarily 
responded to the research invitation were contacted for further possible recruitment. These 
areas were Kenilworth, Noordhoek, Blouberg, Panorama, Stellenbosch, Paarl, Hermanus 
and Helderberg Basin. The local newspapers were the Plainsman, False Bay Echo, 
Constantiaberg Bulletin and the Eikestad Nuus. The articles gave a brief introduction to the 
study as well as the contact details of the researchers for those interested in participating. 
Participants who showed interest during visits to the support groups were given additional 
information regarding the study and their contact details were taken.  
 
Of the ninety-six people that responded to the various advertisements, 49 met the criteria 
for inclusion in the study and completed the informed consent forms (Appendix B). Thirty-
one took part in the EXP and 18 in the PBO who wore the wristband. This ratio difference 
between the two groups was because the EXP and PBO were geographically located in 
different areas but with a similar socio-economic status (Development Information and GIS 
Department, 2014; Western Cape Government Provincial Treasury, 2014a, 2014b). 
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2.2  Inclusion criteria 
In order to be eligible for inclusion in this study, participants needed to: 
 Present with a clinical diagnosis of idiopathic PD. Diagnosis was confirmed by the 
participants’ neurologist or primary care physician. 
 Be rated between stages I and III (mild to moderate) as classified according to the 
Hoehn and Yahr Scale (Hoehn & Yahr, 1967; HY) (Appendix D) and have a functional 
status level of PD less than 59 on the motor subscale (part III; Martínez-Martín et al., 
2015) of the Movement Disorder Society-Unified PD Rating Scale (MDS-UPDRS).  
 Be men and women aged between 50 and 85 years. 
 Reside within a 70km radius of the Cape Metropole in the Western Cape and be 
responsible for their own transport to the sensory-motor training programme.  
 Be able to stand tandem and perform dynamic balance activities without support for 
30 seconds; customary walking aids were permitted such as crutches and walkers.  
 Be on a stable medication programme (medication should not have been changed 
within four weeks of commencing the study). Participants remained on their medication 
during all testing and during the sensory-motor training programme.  
 Have a Montreal Cognitive Assessment (MoCA) score of 18 and above. According to 
Hoops et al. (2009) a score of 27 to 30 is considered normal and 18 to 26 as mild 
cognitive impairment (MCI) (Hoops et al., 2009). 
 
2.3  Exclusion criteria 
Participants were excluded from this study for the following reasons: 
 If they had a PD classification of stage 4 or 5 as classified according to the Hoehn and 
Yahr Scale (Hoehn & Yahr, 1967).  
 If they had any neurological condition (e.g. stroke, diabetes with neuropathy) other than 
PD or vestibular problems. 
 Moderate to severe mental health conditions, with a Montreal Cognitive Assessment 
(MoCA) score of 17 or less (Hoops et al., 2009).  
 If they demonstrated moderate to severe depression throughout the study, which is 
indicated as less than 18 on the Hamilton Rating Scale for Depression questionnaire 
(Cusin et al., 2009). 
 If they had any visual problems which could not be corrected through glasses or 
contact lenses. Participants who were colour blind would not be included for both the 
Wisconsin Card Sorting Test and the Adapted Stroop Task, since these two tests 
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require the participant to recognize colour. They were allowed to participate in the other 
tests. 
 If they had sustained any orthopaedic or moderate to severe musculoskeletal injuries 
(needing the care of a medical practitioner) in the six months prior to the start of the 
study. 
 If they were on any medication with adverse effects such as instability, dizziness and 
brain fogginess. In addition, individuals specifically on Rasagiline and Selegiline which 
may affect balance (Pescatello et al., 2014) as well as Rivastigmine and Amantadine 
that affect cognitive function were excluded (Pescatello et al., 2014). For the specific 
list of PD-related medications see Appendix E.   
 In the PBO group, participants who did not wear their wristband for 24 hours a day 
were excluded.  
 In the EXP group, participants who did not maintain a minimum attendance of 70% for 
the sensory-motor training programme sessions and/or missed more than two 
consecutive training sessions were excluded from the data analysis but were allowed 
to continue with the programme. A minimum attendance rate of 70% is in line with other 
studies on PD and EF (Tanaka et al., 2009). 
 
2.4  Sampling method 
Due to the nature of the intervention, the study population consisted of a convenience 
sample of idiopathic PD patients. However, sampling areas used had the same or similar 
socioeconomic status (Development Information and GIS Department, 2014; Western Cape 
Government Provincial Treasury, 2014a, 2014b). 
 
2.5  Sample size 
The Centre for Statistical Consultation (Stellenbosch University, South Africa) was consulted 
prior to the start of the research for a priori power analysis set at 0.80. The statistician 
performed a power analysis from pilot study data and determined that at least 14 participants 
per group would be required. However, the researcher was advised to recruit as many 
participants as possible because the study design was not randomized and the power 
analysis was calculated only on one outcome variable. 
 
3.  Ethical Approval 
Ethical approval (proposal number HS1040/2014) was granted by the Departmental Ethical 
Screening Committee of the Sport Science Department (Stellenbosch University) as well as 
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the Research Ethical Committee: Human Research (Humanities) of Stellenbosch University 
(Appendix A). The Declaration of Helsinki was followed as an ethical conduct guide and the 
researcher and participants were familiarised with this prior to the start of the study. 
 
4.  Visits 
4.1 Pre-intervention Testing: Telephonic Session 
During the recruitment phase of the study, participants who indicated their interest were sent 
an informed consent form, a personal information form (Appendix F) and a session 
information sheet (Appendix G) via email or post. The personal information form asked for 
information pertaining to level of PD (if known), when they were diagnosed, medication, daily 
activities as well as specialist or doctor information. The session information sheet required 
them to indicate which three days of the week they would be able to attend, which time of 
the morning would be most suitable as well as the area most convenient for them. They 
were asked to complete these forms and return them via post or email. The participants 
using the postal service were sent a self-addressed, stamped envelope in which to return 
their completed forms.  
The researcher telephoned participants who returned their forms and informed them 
whether they met the study criteria and were able to participate in the study.  
During this discussion the researcher introduced herself to participants. The informed 
consent form was verbally read and explained and participants were given the opportunity 
to ask questions. Meeting the inclusion criteria and giving their informed consent verbally 
resulted in their inclusion in the study. During the first face-to-face visit the participants were 
asked if they had any further questions and to sign the written consent form. Participants 
were allowed to withdraw at any time and they were informed of this during every testing 
session. Only after informed consent was given did the researcher complete a brief health 
questionnaire, the general information and health form (Appendix H) with the participant. 
The participant was also asked questions about his or her physical activity status according 
to the General Practice Physical Activity Questionnaire (GPPAQ) and these answers were 
submitted on an online GPPAQ site and the generated activity status was recorded (Patient, 
2011). The testing procedures and nature of the intervention were then explained to the 
participants in detail. 
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4.2 Pre-Intervention Testing: First and Second Testing Sessions 
To avoid participant fatigue each testing session was split into two separate visits due to the 
number of questionnaires and cognitive tests that needed completion. During the first testing 
session, the informed consent form was checked to see that it had been completed correctly 
and that all signatures were in place. The participant was then given an additional 
opportunity to ask questions. After this, testing began with the recording of the participant’s 
height and body mass. The following questionnaires were then completed with the 
participant: the 39-Item PD Questionnaire (PDQ-39) (Appendix I), the Activities-specific 
Balance Confidence Scale (ABC Scale) (Appendix J) and the Movement Disorder Society – 
Unified PD Rating Scale (MDS – UPDRS) which included the HY scale. The Timed Up and 
Go test completed the testing for this session. This session took approximately one hour to 
complete.  
 
During the second testing visit, the Hamilton Rating Scale for Depression (Ham-D) 
(Appendix K) was completed. Following this, the researcher conducted the cognitive tests, 
namely the Montreal Cognitive Assessment (MoCA) (Appendix L) and the Trail Making Tests 
part A and part B (Appendix M) which are paper-based tests. The computer-based 
Wisconsin Card Sorting Test (WCST) and Adapted Stroop Task completed the testing 
battery. This session took approximately one hour to complete. 
Participants were asked to remain on their medication for the duration of the study for ethical 
reasons. The logistics of testing everyone at the same time after an overnight withdrawal of 
medication was also beyond the scope of this study. Time of testing was recorded and re-
testing was always performed at the same time or at least within an hour of the initial testing 
time to ensure consistency. If participants were fatigued or experienced a distressing event 
(such as a funeral or family-related stress) the testing was rescheduled as this may have 
influenced the results. 
After the second visit participants were assigned to their intervention groups by the main 
researcher. 
 
4.3  Mid-intervention Testing: Third and Fourth Testing Sessions 
During this testing session with the participant, all of the questionnaires, cognitive tests and 
anthropometric tests which were conducted during the pre-intervention testing session were 
repeated. The tests were again split into two separate visits. The order of the tests remained 
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the same, and the same researcher collected the same data pre-, mid- and post-
intervention. 
 
4.4 Post-intervention Testing: Fifth and Sixth Testing Sessions 
Again during this testing session with the participant, all of the questionnaires, cognitive tests 
and anthropometric tests which were conducted during the pre- and mid-intervention testing 
sessions were repeated. The tests were again split into two separate visits, the order of the 
tests and researcher collecting the data remained the same as previously noted.  
 
5.  Phases and Interventions 
5.1 Baseline Phase 
During the baseline phase, participants (in both the placebo and experimental groups) 
continued with their usual daily activities without any interference from the researcher for 
eight weeks. Participants were allowed to continue their normal activities, but were asked to 
refrain from adding additional structured physical activities (in other words, exercises).  
 
5.2 Treatment Phase  
The eight-week treatment phase included the sensory-motor training programme and 
placebo wristband interventions. 
 
5.2.1 Eight-week Sensory-motor Training Programme  
The sensory-motor training programme took place over eight consecutive weeks. 
Participants were required to attend morning sessions three times per week for the duration 
of the study. The duration of the sessions was 60 minutes and included a 10-minute warm-
up and 10-minute cool-down period before and after the main sensory-motor training 
component, respectively. The same warm up and cool down activities were incorporated for 
all the sessions as a method to familiarise the participants. The focus of the exercise 
intervention was on neuromotor exercises (postural control and not strength, endurance 
and/or flexibility).  
 
The sensory-motor training programme was generated using the principles and 
progressions developed by Janda (Page, 2006). The main sensory-motor focus of the 
intervention was through somatosensory simulation. Aman et al. (2014) explained that 
somatosensory training included proprioception and haptic feedback while receiving no or 
limited information from the visual and vestibular system (Aman et al., 2015). Aman et al. 
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(2015) also stated that these interventions should mainly focus on the improvement of 
proprioception and sensory-motor function. Each week of the sensory-motor training 
programme had a different aim and each session focused on a different objective, from 
posture, alignment and body awareness, to static, dynamic and functional balance activities 
(Appendix N). The programme became increasingly more challenging as the weeks 
progressed. Participants were instructed with verbal cues and allowed to use light touch 
during the sessions. Each session was led by at least one qualified biokineticist and at least 
one research assistant. Even though a predetermined programme was followed and 
completed by all participants, the biokineticist monitored each participant during the 
sessions and either allowed them to progress to the next activity or repeat if the activities 
were too difficult. The self-paced activities focused on the quality rather than the quantity for 
improved motor control. Participants were given a hand-out with safety guidelines (Appendix 
O) before the start of the sensory-motor training programme. 
 
5.2.2 Eight-week Placebo 
The placebo group wore an activity monitor (Pivotal LivingTM, Pivotal Corporation, U.S.A.) 
as illustrated in Figure 4.2., referred to as a feedback-wristband (placebo). The placebo was 
introduced to determine whether the results of the study were due to the exercise 
intervention itself. It was important to ensure that the results obtained were as a result of the 
treatment (in this case the sensory-motor training programme) rather than an expectation 
from the participants that the programme would work. The placebo group was blinded to the 
fact that the wristband was a placebo. They were informed that they were participating in a 
sensory-motor intervention, wearing a feedback-wristband and that when they saw the 
activity monitor they should sit and/or stand up straight, since the purpose of the band was 
to change their balance behaviour. The wristbands were actual activity monitors which were 
not activated so they looked authentic. The wristband had to be worn throughout the eight-
week duration, including when sleeping or bathing/showering. Participants in the placebo 
group received a follow-up phone call from the researcher every fortnight and had to keep 
a weekly diary in which they reported on their mobility and balance. Motivation has been 
shown to have an influence on cognitive variables such as EF, thus the wristband served to 
keep them motivated in the same way as the sensory-motor training programme.  
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Figure 4.2 Placebo wristband worn by placebo group participants (photo by K Welman©) 
 
During the treatment phase, participants continued with their usual daily activities regardless 
of whether they were in the placebo or experimental group. After the intervention the 
researcher disclosed to the PBO participants that the wristband was a placebo. 
 
6.  Procedures 
In addition to collecting medical and personal information the following tests were also 
assessed at pre, mid and post-intervention, unless otherwise specified. 
 
6.1  Anthropometry 
6.1.1 Height 
Stature was measured using the stretch stature method and a measuring tape (Siber-
Hegner GPM, Switzerland) attached to the wall. Participants were barefoot and stood erect 
with their arms at their sides. They were instructed to look straight ahead and inhale deeply. 
The measurement was recorded as the maximum distance from the ground to the vertex of 
the head. The vertex of the head is the highest point on the skull when the head is placed 
in the Frankfort Plane. This position is attained when the imaginary line which joins the 
orbitale to the tragion is perpendicular to the body’s long axis (De Ridder, 2005). Baseline 
height was measured in metres and recorded to the nearest 0.01 m.  
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6.1.2 Body mass 
Body mass was measured using a portable electronic scale (Safeway® Scale, South Africa). 
Participants were weighed barefoot and with minimal clothing. They were instructed to stand 
in the centre of the scale with weight evenly distributed on both feet, and to look straight 
ahead as their weight was recorded. Before each measurement, the scale was zeroed and 
baseline body mass was recorded to the nearest 0.1 kg (De Ridder, 2005). Body mass index 
(BMI) for each participant was determined from their height and body mass measurements. 
 
6.2 Secondary Outcome Variables 
6.2.1 Global Cognition: Montreal Cognitive Assessment (MoCA) 
The Montreal Cognitive Assessment (MoCA) assesses global cognition (Nasreddine et al., 
2005) and was created to be a more sensitive screening instrument for those presenting 
with mild cognitive complaints, in particular for those participants who score within the 
normal range for the Mini Mental State Examination (MMSE) (Nazem et al., 2009; Zadikoff 
et al., 2008; Nasreddine et al., 2005). Hoops et al. (2009) consider it to be a superior 
screening tool to the MMSE. In particular, the MoCA is considered to be more sensitive in 
identifying cognitive changes in the early stages of PD, specifically those with impairment of 
executive function (Chou et al., 2014). Dalrymple-Alford et al. (2010) concluded that the 
MoCA is able to successfully differentiate both dementia and MCI in PD (Dalrymple-Alford 
et al., 2010).  
 
The MoCA is a 30 point test conducted on a single page. A result ≥ 26 is considered normal 
global cognitive ability (Nasreddine et al., 2005). Test-retest reliability is high (Pearson 
correlation coefficient = 0.92). The internal consistency is good (Cronbach α = 0.83 on 
standardized items). The test was conducted during the study with pen and paper. Each 
participant was asked to state whether they had completed 12 years of schooling and 
whether they had any additional training after school, as the MoCA assigns an additional 
point to those who have completed 12 or less years of education. This is to negate the effect 
of fewer years of education as a confounding variable. Participants could choose to perform 
the test in either English or Afrikaans. 
 
6.2.2 Parkinson’s Disease Severity 
Hoehn and Yahr  
The Hoehn and Yahr Staging Scale (HY) is the most frequently used global assessment for 
PD. The basis for this scale is the disability which results from impaired motor and balance 
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functions; however, it does not provide information on motor features or non-motor 
symptoms (Martínez- Martín et al., 2015). It was initially designed to be a simple descriptive 
staging scale that furnished an estimate of PD clinical function, bringing together both 
deficits in function (disability) and objective signs (impairment). Although it was formulated 
as a five-point scale (1-5) in 1967 (Hoehn & Yahr, 1967), some studies have added 0.5 
increments to a modified scale (Goetz et al., 2004). The HY scale is simple in application, 
quickly completed, practical in both research and patient care, and it may be used by both 
specialist as well as those without expertise in movement disorders (Goetz et al., 2004). 
Inter-rater reliability is documented as moderate to significant ranging from 0.44 to 0.71. 
Test-retest reliability has not been established (Goetz et al., 2004).  
 
The current study made use of the original HY scale and not the modified version. 
Consequently, parkinsonian motor impairment was rated as unilateral (Stage 1) to bilateral 
disease (Stage 2) without balance difficulties, to the presence of postural instability (Stage 
3), loss of physical independence (Stage 4), and being wheelchair- or bed-bound (Stage 5) 
(Goetz et al., 2004). A HY score < 3.0 is considered to be in the early stages of PD (Martínez- 
Martín et al., 2015; Siderowf et al., 2002). 
 
Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS – UPDRS) 
The original Unified PD Rating Scale (UPDRS) was created in the 1980s and has since 
become the most extensively used and tested PD clinical rating scale (Martínez- Martín et 
al., 2015; Goetz et al., 2008; Ramaker et al., 2002). In 2008, the revised Movement Disorder 
Society – Unified PD Rating Scale (MDS-UPDRS) was presented. This scale is considered 
to be more comprehensive than the previous version and devotes several new items to non-
motor elements of PD (Goetz et al., 2008). The MDS-UPDRS is made up of four parts: Part 
I relates to the “non-motor experiences of daily living” (nM-EDL) while Part II concerns the 
“motor experiences of daily living” (M-EDL), Part III is the “motor examination” (ME) and Part 
IV involves “motor complications” (MC) and specifically assesses complications of therapy 
for participants treated with dopaminergic medications (Horváth et al., 2015). The MDS-
UPDRS demonstrated high internal consistency across parts I-IV ranging from 0.79 to 0.93 
as well as strong concurrent validity with the original UPDRS with a total score of r = 0.96 
and scores ranging from 0.76 to 0.96 across parts I-IV (Goetz et al., 2008).  
 
The participants in the study were asked to complete part II on their own or with the help of 
a caregiver, and for part I and IV they were asked to think back over the past 7 days and 
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then to answer the specific question. Part III was assessed by a qualified assessor. Harrison 
et al., (2009) suggest that the ADL (ADL) sub score on the UPDRS may be a better indication 
of disease progression than what is assessed in other sections of the UPDRS. 
 
6.2.3 Quality of Life: 39-Item Parkinson’s Disease Questionnaire (PDQ-39) 
QOL was assessed through the use of the 39-Item PD Questionnaire (PDQ-39), which 
measures functioning and well-being in those with PD (Hagell et al., 2003; Peto et al., 1998). 
With regards to disease-specific questionnaires, the PDQ-39 is considered to be the most 
widely used rating scale in PD (Hagell & Nygren, 2007; Hagell et al., 2003). The PDQ-39 
contains 39 items covering eight discrete scales, namely: mobility, emotional well-being, 
ADL, stigma, social support, cognitions, communication and bodily discomfort. For each item 
on the scale, there are five possible options: never, occasionally, sometimes, often, always 
(or cannot do at all).  
 
Participants in the study were asked to think back over the past month and answer each 
item according to the five possible answers. The higher the score, the lower the QOL. 
Hagnell and Nygren (2007) reported adequate score reliabilities (Cronbach’s α = 0.72-0.95 
and test-retest: 0.76-0.93) (Hagell & Nygren, 2007; Peto et al., 1998). This questionnaire 
was included to control for participants’ perceived QOL, which may have an impact 
(confounding variable) on the executive function results.  
 
6.2.4 Depression: Hamilton Rating Scale for Depression (HAM-D) 
Depression was assessed using the Hamilton Rating Scale for Depression (HAM-D). 
Leentjens et al. (2000) found the Hamilton Rating Scale for Depression to be a good 
diagnostic instrument to measure depressive symptoms in PD patients. In the current 
investigation the HAM-D was not used for diagnosing depression but rather determining the 
feeling or mood of being depressed or disheartened. The HAM-D contains 17 items which 
consider depressive symptoms that the patient may have experienced over the past week. 
It was decided beforehand that if the researcher noticed excessive depressive moods and 
the participant acknowledged that he or she was experiencing some of these excessive 
depressive symptoms for most of the day, every day for more than two weeks, and/or rated 
on the HAM-D as severe depression, which is a score of 24 and above (Cusin et al., 2009), 
the researcher would refer the participant to a clinical psychologist. Signs of excessive 
depressive moods are listed in (Appendix P). Although, the HAM-D was originally meant to 
be completed after an unstructured interview, it is now usually administered following a semi-
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structured interview guide and this is how it was conducted in the current study. Most 
clinicians accept the following cut-off scores regarding the HAM-D: 0 – 6 as no depression 
present; 7 to 17 as mild depression; 18 to 24 as moderate depression and any score above 
24 as severe depression (Cusin et al., 2009). The 2011 meta-analysis of Trajković et al. 
(2011) reported internal consistency at 0.789, inter-rater reliability at 0.937 and test-retest 
reliability ranging from 0.65 to 0.98. The HAM-D is considered to be both a good screening 
and diagnostic instrument for depression (Leentjens et al., 2000). It was thus included in the 
study to control for participants’ depressive mood which may have an impact (confounding 
variable) on EF as well as working memory (Harvey et al., 2004). 
 
6.3 Primary Outcome Variables 
6.3.1 Executive Function 
Updating: Trail Making Test part A and part B 
Updating was assessed using the Trail Making Test part B (TMT-B). The TMT comprises 
two different parts: TMT-A (part A) involves connecting consecutive numbers (1 to 25) by 
drawing a line. TMT-B (part B) involves connecting numbers and letters in a progressive 
alternating sequence (1-A-2-B) (Etnier & Chang, 2009). Participants performed one trial of 
each part, with a shorter sample trial for each part preceding it. Sanchez-Cubillo et al. (2009) 
while investigating the construct validity of the TMT, showed that while TMT-A requires 
predominantly visuo-perceptual abilities such as visual scanning and visuomotor speed, 
TMT-B reflects mainly working memory (also known as Updating) and secondly, task-
switching ability. However, some researchers see Set shifting as the primary component to 
this test (Higginson et al., 2013; Liu-Ambrose et al., 2010; Periáñez et al., 2007; Arbuthnott 
& Frank, 2000). 
 
In the study this test was conducted with pen and paper. Time taken to complete part A and 
B of the test was recorded separately and to the nearest 0.1 second. Although, errors 
committed were recorded, they were not reported on in this study. Most studies do not report 
on errors, as it is felt that the additional time taken to correct these errors is reflected in the 
overall score. Variables investigated were time to complete TMT A, time to complete TMT 
B, B-A (the difference score between TMT B and TMT A) and B/A (the ratio score). The 
difference score (B-A) is believed to minimize both visuo-perceptual abilities and working 
memory demands resulting in a truer reflection of executive control abilities (Sanchez-
Cubillo et al., 2009). Test-retest reliability is 0.79 for TMT A and 0.89 for TMT B (Dikmen et 
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al., 1999). Interrater reliability was reported as 0.94 for TMT A and 0.90 for TMT B: both 
correlation coefficients are considered to be high (Fals-Stewart, 1992). 
 
Set shifting: Wisconsin Card Sorting Test (WCST) 
Set shifting was assessed using the Wisconsin Card Sorting Test (WCST) (Albinet et al., 
2012; Miyake et al., 2000). This test was conducted only once on a laptop with a separate 
mouse (not a laptop mousepad). This test requires the participant to arrange cards based 
on one of three card characteristics, namely colour, number and form. The participant is 
reliant on examiner feedback regarding the correct sorting characteristic which is changed 
every 10 cards. The participant is required to identify the card characteristic and maintain 
this task set until instructed to change (Etnier & Chang, 2009). The variables investigated 
were: “categories completed” (CC), “perseverative responses” (PR), “failure to maintain set” 
(FTMS) and “total errors” (TE). The first two variables are the most commonly used 
measures of executive control in the WCST (Strauss et al., 2006). Categories completed 
(CC) refers to the number of categories the individual has correctly sorted, namely ten 
consecutive correctly sorted cards (Strauss et al., 2006). Perseverative responses (PR) 
refers to the number of times an individual continues (or persists) in responding to an 
incorrect card characteristic (Strauss et al., 2006). Failure To Maintain Set (FTMS) refers to 
a situation where an individual correctly sorts five or more consecutive cards, but then makes 
a mistake and fails to complete the category (Strauss et al., 2006). The FTMS assesses 
distractibility or the inability to maintain attention (Figueroa & Youmans, 2013; Barceló & 
Knight, 2002). Total Errors (TE) refers to the total number of errors that the participant makes 
during the WCST. A global score for the WCST was calculated using a formula proposed 
by Laiacona et al. (2000). This score is representative of overall WCST performance and is 
calculated as:  
Global Score = [number of trials – (number of categories achieved X 10)] 
It gives an estimation of the number of cards the participant actually used beyond the 
necessary minimum to complete the six categories. The score ranges from a theoretical 
perfect score of 0 to a worse-possible score of 128 (a better performance is indicated by a 
lower Global Score). 
 
Paolo et al. (1995) showed construct validity for the WCST and recommended that it 
continue to be used as part of a complete neuropsychological evaluation for individuals with 
PD. This study showed a coefficient of congruence of 0.96 for the first factor, which included 
the variables number of categories completed, total number of errors, perseverative 
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responses and errors, and conceptual level response (the latter two were not assessed in 
the current study) and for the second factor, a coefficient of congruence of 0.71. The second 
factor comprised the variables number of trials to complete the first category, failure to 
maintain set and non-perseverative errors (only failure to maintain set was assessed in the 
current study) (Paolo et al., 1995). 
 
Inhibition: Adapted Stroop Task 
Inhibition (also known as cognitive inhibition or inhibitory control) was assessed using an 
adapted Stroop Task as used by Lucas et al. (2012). The version of the test used in this 
study had four conditions instead of the traditional three conditions. The first two conditions 
related to Choice Reaction Time (CRT), whereas the second two conditions related to 
interference (Incongruent 1 and Incongruent 2). Finally, an interference score was calculated 
using the ‘new’ formula proposed by Chafetz and Matthews (2004), which has been used in 
PD related studies (Damholdt et al., 2012), instead of the original ‘Golden’ formula proposed 
by Golden (1978). Chafetz and Matthews (2004) found the new formula to be more sensitive 
for clinical inferences: the predicted Colour-Word/ Interference Score (items 3 & 4 on 
adapted Stroop task) in 45 seconds can be calculated with  
((216−𝑊)×𝐶)
(216−𝑊)+𝐶)
 ; where’ W 
‘represent the word or first congruent task (Reading) and ‘C’ the Colour or second congruent 
task (Naming) in the current study’s methodology. The predicted interference score is then 
subtracted from the actual score achieved on the average incongruent trails. 
 
During the test the participant had to complete 4 test conditions and received one practice 
trial. Participants could choose to perform the test in either English or Afrikaans. In the first 
condition, CRT 1 (Reading), the participant has to select the word which is the same as the 
stimulus word, thus reading. In the second condition, CRT 2 (Naming), the participant has 
to select the colour of a stimulus block, thus naming. In the third condition, Incongruent 1, 
the participant has to select the colour in which the stimulus word is written (the text is also 
a colour). Finally, in the fourth condition, Incongruent 2, the participant is again required to 
select the colour in which the stimulus word is written, but this time all words are in different 
colours. Cognitive performance was assessed for both speed and accuracy.  
 
Many different versions of the Stroop task have been developed which vary with regard to 
colour, number of test items, number of subtests as well as administration method; however, 
the basis of the Stroop task has remained the same. Basic task performance (such as 
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reading names of colours) is compared to performance of a corresponding task in which a 
habitual response needs to be inhibited in aid of a different or unusual one (such as naming 
the text colour of a word rather than the meaning of this “colour” word). The Stroop 
Interference Effect refers to the increased time taken to do this when compared to the basic 
task (Van der Elst et al., 2006). In this test, the participant is required to inhibit a habitual 
response (Etnier & Chang, 2009). Interference scores for time and accuracy were calculated 
according to Chafetz and Matthews (2004). 
 
 
Figure 4.3 Adapted computer-based Stroop task from Lucas et al. (2012). 
 
The Stroop task has been used in several studies on executive function (Albinet et al., 2012; 
Hsieh et al., 2008). In the current study this test was conducted on a laptop, using left and 
right arrow keys on the keyboard. Each participant was allowed two trials of the test and the 
best score was used from each condition. Mean response time and percentage correct 
responses were recorded. The Stroop Colour-Word Task assessed by Dikmen et al. (1999) 
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reported test-retest reliability as 0.84 for both Stroop I and II (interference) variables (Dikmen 
et al., 1999). 
 
6.3.2 Functional Balance 
Perceived Stability of Balance: Activities-specific Balance Confidence Scale (ABC Scale)  
Perceived stability or balance was assessed using the Activities-specific Balance 
Confidence Scale (ABC questionnaire). The ABC Scale is used to assess balance 
confidence, which is particularly relevant in PD with fear of falling. This scale required 
participants to rate 16 ADLs according to the confidence they had in completing the activity 
without falling. Designed to detect loss of confidence in balance for individuals of varying 
functional levels, the scale includes activities that challenge postural control such as walking 
and reaching activities, as well as indoor and outdoor activities. The scale ranges from 0% 
(no confidence) to 100% (complete confidence) (Adkin et al., 2003). Internal consistency of 
the ABC has been reported as ranging between 0.80 and 0.98 and test-retest reliability 
values ranging from 0.70 to 0.92 (Lohnes & Earhart, 2010; Steffen & Seney, 2008). When 
comparing fallers and non-fallers, Lajoie and Gallagher (2004) showed that the overall ABC 
score of fallers was significantly lower. 
 
Mobility: Timed Up and Go Test (TUG) 
Mobility was assessed using the Timed Up and Go Test (TUG). The TUG test is used to 
assess lower extremity function and mobility in older adults, specifically balance, walking 
ability and fall risk (Donoghue et al., 2012; Herman et al., 2011). In addition, Donoghue et 
al. (2012) reported that a slower TUG time is associated with poorer memory, EF and 
processing speed. Other researchers have also shown a relationship between TUG and 
cognitive performance in PD (Stegemöller et al., 2014). 
 
The TUG test requires a participant to stand up from a seated position on a standard chair, 
walk 3 metres at a comfortable pace, turn around and return to a seated position in the chair. 
Time taken is measured in seconds and recorded to the 0.01 s (Donoghue et al., 2012, 
Herman et al., 2011, Morris et al., 2001). Interrater reliability for the TUG is high with 
intraclass correlation coefficients (ICC) ≥ to 0.80 (Huang et al., 2011; Morris et al., 2001). 
Pearson correlation coefficients for retest reliability range from 0.73 to 0.99 (Huang et al., 
2011; Morris et al., 2001). 
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7.  Statistical Analysis 
Descriptive statistics are reported as percentages, frequencies, mean (?̅?) and standard 
deviation (SD), unless otherwise specified. For all primary and secondary outcome 
variables, if normality was demonstrated with a Shipiro-Wilks test, a multi-factorial ANOVA 
(3 x 2) was conducted to compare the group, time and treatment effect. Non-normally 
distributed data was log transformed, and again assessed for normality, before a multi-
factorial ANOVA was also performed. For a post-hoc analysis the Fisher Exact LSD test was 
used at individual time points. Ordinal data which did not satisfy parametric assumptions 
was assessed with the Mann–Whitney U-test (between groups) and Wilcoxon signed rank 
test (over time in a group). For categorical data the Fisher Exact test was used. The alpha 
level was set as 5%.  
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CHAPTER FIVE 
 
RESULTS 
 
1.  Participants 
In total ninety-six people responded to the newspaper articles, support group talks and 
information left at medical practices. These prospects were sent additional information 
regarding the study including a personal information form. Sixty-seven participants 
completed and returned this form.  
 
In the EXP group, 46 participants were allocated to take part in the sensory-motor training 
programme. Three did not meet the inclusion criteria for the study, seven had problems with 
transportation (lived too far away or were reliant on others for transport, for example), three 
were going away on holiday or for business during the testing and / or treatment phase and 
two did not proceed due to personal reasons. Of the remaining 31, only 25 (16 men, 9 
women) were included in the final data analysis. Three participants fell below the required 
70% attendance, one participant had a bad fall prior to beginning the intervention (which 
was unrelated to the research), another participant stopped coming and was uncontactable 
and the sixth participant could not keep up with his session attendance due to clashes with 
his work.  
 
Twenty-one participants were allocated to the PBO group, three of whom did not meet the 
inclusion criteria: one presented with moderate cognitive impairment (MoCA score of 14) 
and could not complete the cognitive component of testing (this participant also scored 4 on 
the Hoehn and Yahr scale) and the other two both scored 4 on the Hoehn and Yahr scale. 
Out of the remaining 18, only 17 (8 men, 9 women) were included in the final data analysis 
as one participant felt unmotivated to complete the last 3 weeks of the study and withdrew. 
This participant also indicated severe depression on the Hamilton Rating Scale for 
Depression (HAM-D) and was referred to a clinical psychologist as well as her neurologist 
for assessment and treatment. Two of the included participants were colour blind, and could 
not complete the Stroop and Wisconsin Card Sorting (WCST) tests. They were able to 
complete the other cognitive tests, however, and were included for statistical analysis. 
Eighty-four percent (n = 21) of participants in the EXP (14 men, 7 women) and 88% (n = 15) 
of participants in the PBO (7 men, 8 women) had more than 12 years of education. 
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The results of the General Practice Physical Activity Questionnaire (GPPAQ; Figure 5.1) 
revealed that half of the participants in the EXP group indicated that they were inactive, 21% 
indicated that they were moderately active, 17% said that they were moderately inactive and 
just 13% of the EXP indicated that they were active, with one participant not completing the 
section on activity status. In the PBO group, none of the participants indicated that they were 
active. Sixty-five percent rated themselves as inactive, 24% as moderately active and 12% 
as moderately inactive. There was no significant difference between the two groups in terms 
of physical activity status (p = 0.53). 
 
 
Figure 5.1 Self-reported activity status (frequencies; f). 
 
Tables 5.1 – 5.3 summarize the descriptive and baseline characteristics of all the 
participants at pre-intervention. 
At pre-assessment the baseline descriptive characteristics (Table 5.1) for HY, MDS-UPDRS 
I, III & IV and HAM-D, differed significantly between the two groups (p  0.05).  
The two groups showed no statistically significant difference for the 39-Item Parkinson’s 
Disease Questionnaire at the pre-intervention assessment for QOL (Table 5.2). 
Table 3 summarises the EF variables between the two groups at pre-intervention, with the 
EXP showing significantly worse WCST PR scores as well as faster reaction time during 
Incongruent 2 trials and in the Interference score (p < 0.05).
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Table 5.1  Pre-intervention descriptive characteristics for the EXP and PBO groups as mean (?̅?) ± standard deviation (SD) and range. 
Characteristics EXP (n=25) Range PBO (n=17) Range p value 
Age (y) 66 ± 8 50 – 79 71 ± 9 49 – 83 p = 0.057 
Height (m) 1.67 ± 0.1 1.50 – 1.89 1.67 ± 0.1 1.48 – 1.79 p = 0.97 
Body mass (kg) 80.8 ± 17.2 52.0 – 126.7 79.0 ± 17.6 47.0 – 106.3 p = 0.75 
BMI (kg.m-2) 28.8 ± 6.0 21.1 – 43.6 28.1 ± 5.8 19.7 – 40.0 p = 1.00 
MoCA 24 ± 3 19 – 30 24 ± 3 17 – 30 p = 0.89 
HY 2.3 ± 0.6 (Med = 
2.5 ) 
2.0 – 3.0 1.9 ± 0.7 (Med = 
2) 
1.0 – 3.0 p = 0.01* 
MDS-UPDRS I 3.4 ± 2.3 0 – 9 11.4 ± 5.0 3 – 19 p ˂ 0.001* 
MDS-UPDRS II 13.0 ± 6.0 2 – 28 10.2 ± 5.6 2 – 23 p = 0.22 
MDS-UPDRS III 31.9 ± 14.3 6 – 53 22.5 ± 10.0 7 – 45 p = 0.02* 
MDS-UPDRS IV 4.5 ± 3.9 0 – 17 1.9 ± 2.1 0 – 7 p = 0.003* 
MDS-UPDRS Total 52.1 ± 22.1 17 – 88 45.9 ± 18.6 16 – 85 p = 0.41 
HAM-D 5 ± 3 0 – 13 8 ± 4 2 – 14 p ˂ 0.001* 
ABC 74.1 ± 19.9 41.5 – 100 65.6 ± 23.9 20.6 – 93.1 p = 0.07 
TUG (s) 11.3 ± 3.4 5.8 – 18.3 11.7 ± 4.9 8.0 – 26.9 p = 0.71 
BMI: Body Mass Index; MoCA: Montreal Cognitive Assessment; HY: Hoehn and Yahr Scale; Med: Median; MDS-UPDRS: Movement Disorder Society – Unified 
Parkinson’s Disease Rating Scale; HAM-D: Hamilton Rating Scale for Depression; ABC: Activities-specific Balance Confidence Scale; TUG: Timed Up and Go; y: 
years; m: metres; kg: kilogrammes; s: seconds; * p  0.05 
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Table 5.2 Pre-intervention QOL assessment for the EXP and PBO groups as mean (?̅?) ± standard deviation (SD) and range. 
Domains EXP (n=25) Range PBO (n=17) Range p value 
PDQ MOB (%) 21.3 ± 21.8 0 – 75 27.8 ± 27.0 3 – 93 p = 0.23 
PDQ ADL (%) 25.0 ± 21.1 0 – 79 20.8 ± 18.9 0 – 67 p = 0.74 
PDQ EMO (%) 25.3 ± 16.6 4 – 63 23.5 ± 22.5 0 – 67 p = 0.59 
PDQ STI (%) 14.3 ± 13.7 0 – 44 12.1 ± 20.8 0 – 75 p = 0.39 
PDQ SOC (%) 10.8 ± 14.0 0 – 50 9.8 ± 18.0 0 – 58 p = 0.49 
PDQ COG (%) 22.7 ± 17.2 0 – 63 21.3 ± 18.1 0 – 63 p = 0.71 
PDQ COM (%) 28.8 ± 21.4 0 – 83 19.1 ± 16.1 0 – 67 p = 0.22 
PDQ BOD (%) 34.7 ± 22.5 0 – 92 35.8 ± 26.6 8 – 83 p = 0.69 
PDQ: 39-Item Parkinson’s Disease Questionnaire; MOB: Mobility; ADL: Activities of Daily Living; EMO: Emotional being; STI: Stigma; SOC: Social support; COG: 
Cognitions; COM: Communication; BOD: Bodily discomfort; * p < 0.05 
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Table 5.3 Pre-intervention EF characteristics for the EXP and PBO groups as mean (?̅?) ± standard deviation (SD) and range. 
Variables EXP (n=25) Range PBO (n=17) Range p value 
TMT A (s) 55.6 ± 21.2 26.3 – 97.7 52.7 ± 32.5 24.2 – 143.3 p = 0.83 
TMT B (s) 145.5 ± 77.1 64.3 – 345.5 169.0 ± 151.5 51.6 – 677.0 p = 0.93 
TMT B / TMT A 2.6 ± 1.0 1.6 – 5.7 3.3 ± 2.4 1.6 – 9.7 p = 0.30 
TMT B – TMT A 89.8 ± 63.3 24.0 – 285.2 116.2 ± 138.6 23.7 – 601.2 p = 0.82 
WCST Global Score 106 ± 16 68 - 128 98 ± 78 10 - 118 p = 0.11 
WCST CC 2.2 ± 1.6 0 – 6 3.0 ± 1.0 1 – 5 p = 0.18 
WCST PR 9.4 ± 8.3 0 – 31 17.5 ± 6.5 6 – 25 p = 0.004* 
WCST FTMS 1.4 ± 1.6 0 – 5 0.5 ± 0.7 0 – 2 p = 0.38 
WCST TE 60.0 ± 16.2 13 – 87 66.3 ± 9.4 43 – 76 p = 0.22 
CRT 1: Reading Time (s) 1.5 ± 0.3 1.1 – 2.1 2.2 ± 2.2 0.9 – 10.2 p = 0.16 
CRT 1: Reading Accuracy (%) 99.5 ± 1.8 91.7 – 100 99.3 ± 2.2 91.7 – 100 p = 0.82 
CRT 2: Naming Time (s) 1.5 ± 0.3 1.2 – 2.1 2.1 ± 2.3 0.9 – 10.3 p = 0.26 
CRT 2: Naming Accuracy (%) 99.2 ± 2.1 91.7 – 100 98.1 ± 4.1 87.5 – 100 p = 0.29 
Incongruent 1: Time (s) 2.7 ± 0.9 1.7 – 4.8 3.6 ± 3.1 1.6 – 14.1 p = 0.31 
Incongruent 1: Accuracy (%) 93.8 ± 7.0 79.2 – 100 92.5 ± 11.4 58.3 – 100 p = 0.48 
Incongruent 2: Time (s) 2.8 ± 0.9 1.9 – 5.1 4.5 ± 3.4 2.1 – 15.3 p = 0.005* 
Incongruent 2: Accuracy (%) 90.8 ± 11.5 54.2 – 100 86.4 ± 14.9 58.3 – 100 p = 0.13 
Interference Score: Time (s) 1.3 ± 0.7 0.5 – 2.9 1.9 ± 1.1 1.0 – 4.8 p = 0.003* 
Interference Score: Accuracy (%) 38.7 ± 8.5 13.0 – 47.5 36.2 ± 11.0 11.1 – 46.3 p = 0.26 
TMT: Trail Making Test; WCST: Wisconsin Card Sorting Test; CC: Categories Completed; PR: Perseverative Responses; FTMS: Failure To Maintain Set; TE: Total 
Errors; CRT: Choice Reaction Time; s: seconds; * p < 0.05
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2. Secondary Outcome Variables 
2.1 Global Cognition: Montreal Cognitive Assessment (MoCA) 
There was no significant treatment effect (Assessment x Group) (p = 0.10), nor difference 
between EXP and PBO over the time points – pre- (p = 0.89) and mid-intervention (p = 0.49) 
for the MoCA. However, there was a weak tendency for EXP and PBO to differ at post-
intervention (p = 0.09). There was a significant difference from pre- to mid-intervention (p = 
0.001) and pre- to post-intervention (p ˂ 0.001) in EXP, which can be seen in Figure 5.2. 
There was no significant difference from pre- to mid-intervention (p = 0.12) and mid-to post-
intervention in PBO (p = 0.82). Both EXP and PBO did not change significantly from mid- to 
post-intervention (p > 0.05). 
 
Figure 5.2 Overall global cognition (MoCA) between EXP and PBO over 16 weeks (?̅? ± 
SEM). * p  0.05 
2.2  Parkinson’s Disease Severity 
2.2.1 Hoehn and Yahr (HY) 
No treatment effect (Assessment x Group) was observed for HY for the EXP (p = 0.65) nor 
PBO (p = 0.43). In addition, there was a significant difference between EXP and PBO at pre- 
(p = 0.01) and mid-intervention (p = 0.002). There was no significant difference observed at 
post-intervention between EXP and PBO (p = 0.18). There was no significant change over 
time in EXP (pre- to mid-, mid- to post- or pre- to post-intervention, p > 0.05) or in PBO (pre- 
to mid-, mid- to post- or pre- to post-intervention, p > 0.05). Although not significant, PBO 
severity deteriorated by 15% from mid- to post-intervention (p < 0.01) and overall by 15% 
from pre- to post-intervention (p < 0.01) as shown in Figure 5.3. 
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Figure 5.3 Overall Hoehn and Yahr (HY) classification between EXP and PBO over 16 
weeks (?̅? ± SEM). * p  0.05 
2.2.2 Movement Disorder Society – Unified Parkinson’s Disease Rating Scale (MDS – 
UPDRS) 
There was no significant treatment effect (Assessment x Group) for MDS-UPDRS I (p = 
0.31), MDS-UPDRS II (p = 0.22) or MDS-UPDRS IV (p = 0.94). There was, however, a 
significant treatment effect (Assessment x Group) for MDS-UPDRS III (p < 0.01) as well as 
for the total MDS-UPDRS score (p = 0.02). Table 5.4 summarizes the MDS-UPDRS data 
for MDS-UPDRS I to IV and Total. Figure 5.4 illustrates the change over time for MDS-
UPDRS II. There was no significant difference between EXP and PBO at pre-, mid- or post-
intervention (p > 0.05). There was, however, a significant change in EXP from mid- to post-
intervention (p = 0.04), indicating an improvement in motor experiences of daily living (M-
EDLs) for the EXP. There was no significant change in EXP, from pre- to mid- or pre- to 
post- intervention (p > 0.05), or in PBO, from pre- to mid-, mid- to post- and pre- to post-
intervention (p > 0.05). 
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Figure 5.4 MDS-UPDRS subscale II (M- EDL) between EXP and PBO over 16 weeks (?̅? ± 
SEM). * p = 0.04 
There was a significant difference between EXP and PBO at pre-intervention (p = 0.02), but 
no significant difference between EXP and PBO at mid- (p = 0.09) or post-intervention (p = 
0.50) for MDS-UPDRS III motor subscale. There was no significant change over time in EXP 
(pre- to mid-, mid- to post- and pre- to post-intervention EXP, p > 0.05). 
 
Figure 5.5 MDS-UPDRS III (ME) between EXP and PBO over 16 weeks (?̅? ± SEM). *p < 
0.05 
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There was no change in the PBO group from pre to mid-intervention (p = 0.29), however, 
Figure 5.5 reveals a significant deterioration from pre- to post-intervention in PBO (p = 
0.007), as well as a tendency from mid- to post-intervention (p = 0.09) in the direction of 
increased PD severity for motor functioning.  
 
Figure 5.6 Total MDS-UPDRS between EXP and PBO over 16 weeks (?̅? ± SEM).  
For the Total MDS-UPDRS score there was no significant difference between EXP and PBO 
over any of the time points – pre- (p = 0.41), mid- (p = 0.42) or post-intervention (p = 0.71). 
There was no significant change over time in EXP (pre- to mid-, mid- to post- and pre- to 
post-intervention EXP, p > 0.05). Although PBO did not change from pre- to mid-intervention 
(p = 0.97), there was a non-significant 8% and 9% deterioration from mid- to post- (p = 0.07) 
and pre- to post-intervention (p = 0.07), respectively. This change in PBO is depicted in 
Figure 5.6. Additional post-hoc analysis revealed a 4% difference only at post-intervention 
between the groups (p = 0.71). 
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Table 5.4  Summary of MDS-UPDRS data over 16 weeks reported as mean (?̅?) ± standard deviation (SD), with (range). 
Variable EXP (n = 25)a PBO (n = 17)b p value 
Assessments  Pre1 Mid2 Post3 Pre1 Mid2 Post3  
MDS-UPDRS I 3.4 ± 2.3 
(0 – 9) 
3.5 ± 2.4 
(0 – 9) 
3.8 ± 1.7 
(1 – 7) 
11.4 ± 5.0 
(3 – 19) 
10.5 ± 4.6 
(4 – 19) 
11.4 ± 5.1 
(4 – 22) 
p ˂ 0.001a1 vs b1 
p ˂ 0.001a2 vs b2 
p ˂ 0.001a3 vs b3 
MDS-UPDRS II 13.0 ± 6.0 
(2 – 28) 
12.7 ± 5.5 
(3 – 22) 
11.2 ± 5.1 
(2 – 20) 
10.2 ± 5.6 
(2 – 23) 
10.3 ± 5.3 
(2 – 19) 
10.5 ± 6.2 
(2 – 24) 
p = 0.04a2 vs a3 
MDS-UPDRS III 31.9 ± 14.3 
(6 – 53) 
31.5 ± 12.7 
(10 – 56) 
29.6 ± 12.5 
(6 – 54) 
22.5 ± 10.0 
(7 – 45) 
24.1 ± 11.0 
(6 – 50) 
26.6 ± 11.3 
(10 – 56) 
p = 0.007b1 vs b3 
MDS-UPDRS IV 4.5 ± 3.9 
(0 – 17) 
3.6 ± 3.5 
(0 – 17) 
3.3 ± 1.7 
(1 – 7) 
1.9 ± 2.1 
(0 – 7) 
1.1 ± 1.7 
(0 – 7) 
1.4 ± 1.4 
(0 – 5) 
p = 0.003a1 vs b1 
p = 0.003a3 vs b3 
MDS-UPDRS Total 52.1 ± 22.1 
(17 – 88) 
51.4 ± 18.7 
(19 – 80) 
47.8 ± 16.2 
(18 – 71) 
45.9 ± 18.6 
(16 – 85) 
46.0 ± 17.9 
(18 – 84) 
49.9 ± 18.9 
(16 – 97) 
p > 0.05 
MDS-UPDRS: Movement Disorder Society – Unified Parkinson’s Disease Rating Scale; a EXP (Experimental group); b PBO (Placebo group); 1 Pre-testing; 2 Mid-
testing; 3 Post-testing 
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2.3 Quality of Life: 39-Item Parkinson’s Disease Questionnaire (PDQ-39) 
There was no significant treatment effect (Assessment x Group) for any of the PDQ-39 
domains (p > 0.05), although there was a tendency for a treatment effect (p = 0.07) with 
Mobility (MOB). Table 5.5 summarizes the variables for the PDQ-39. Mobility (MOB) 
changed by 13% from pre- to mid-intervention PBO and demonstrated a tendency for 
significance (p = 0.053). Emotional Being (EMO) showed a significant 21% decrease from 
pre- to post-intervention EXP (p = 0.04) and a 31% decrease from pre- to mid-intervention 
PBO (p = 0.03). Stigma (STI) was significant from mid- to post-intervention EXP (p = 0.01) 
demonstrating a 35% reduction between the two time points. Communication (COM) was 
significant between EXP and PBO at mid-intervention (p = 0.047) where the two groups 
differed by 50%. Bodily Discomfort (BOD) was significant between EXP and PBO at post-
intervention (p = 0.04) with a 49% difference between the two groups. 
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Table 5.5 Summary of PDQ-39 (%) domains over 16 weeks reported as mean (?̅?) ± standard deviation, with (range). 
Variable EXP (n = 25)a PBO (n = 17)b p value 
Assessments Pre1 Mid2 Post3 Pre1 Mid2 Post3  
MOB 21.3 ± 21.8 
(0 – 75) 
21.4 ± 24.4 
(0 – 75) 
18.5 ± 22.5 
(0 – 75) 
27.8 ± 27.0 
(3 – 93) 
24.1 ± 24.7 
(0 – 93) 
23.1 ± 20.3 
(0 – 60) 
p = 0.053b1 vs b2 
ADL 25.0 ± 21.1 
(0 – 79) 
20.0 ± 18.2 
(0 – 58) 
16.8 ± 13.7 
(0 – 46) 
20.8 ± 18.9 
(0 – 67) 
17.9 ± 25.3 
(0 – 100) 
21.9 ± 15.7 
(4 – 54) 
p > 0.05 
EMO 25.3 ± 16.6 
(4 – 63) 
25.3 ± 20.0 
(0 – 83) 
20.0 ± 18.3 
(0 – 63) 
23.5 ± 22.5 
(0 – 67) 
16.2 ± 16.2 
(0 – 58) 
17.7 ± 19.4 
(0 – 63) 
p = 0.04a1 vs a3 
p = 0.03b1 vs b2 
STI 14.3 ± 13.7 
(0 – 44) 
17.2 ± 5.6 
(0 – 69) 
11.2 ± 13.7 
(0 – 50) 
12.1 ± 20.8 
(0 – 75) 
14.7 ± 22.4 
(0 – 63) 
11.3 ± 17.6 
(0 – 69) 
p = 0.01a2 vs a3 
SOC 10.8 ± 14.0 
(0 – 50) 
10.4 ± 15.4 
(0 – 50) 
8.3 ± 13.7 
(0 – 50) 
9.8 ± 18.0 
(0 – 58) 
9.3 ± 17.4 
(0 – 67) 
7.3 ± 12.9 
(0 – 42) 
p > 0.05 
COG 22.7 ± 17.2 
(0 – 63) 
23.2 ± 16.5 
(0 – 69) 
23.7 ± 14.0 
(0 – 44) 
21.3 ± 18.1 
(0 – 63) 
19.5 ± 17.2 
(0 – 63) 
20.7 ± 14.6 
(6 – 50) 
p > 0.05 
COM 28.8 ± 21.4 
(0 – 83) 
26.0 ± 17.1 
(0 – 58) 
21.5 ± 14.3 
(0 – 50) 
19.1 ± 16.1 
(0 – 67) 
15.7 ± 17.6 
(0 – 58) 
17.7 ± 18.0 
(0 – 58) 
p = 0.047a2 vs b2 
BOD 34.7 ± 22.5 
(0 – 92) 
26.4 ± 20.4 
(0 – 67) 
25.0 ± 18.6 
(0 – 83) 
35.8 ± 26.6 
(8 – 83) 
35.3 ± 24.4 
(0 – 83) 
41.1 ± 25.2 
(8 – 92) 
p = 0.04a3v s b3 
ADL: Activities of Daily Living; BOD: Bodily Discomfort; EMO: Emotional being; STI: Stigma; SOC: Social support; COG: Cognitions; COM: Communication; BOD: 
Bodily discomfort. a EXP (Experimental group); b PBO (Placebo group); 1 Pre-testing; 2 Mid-testing; 3 Post-testing 
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2.4 Depression: Hamilton Rating Scale for Depression (HAM-D) 
There was no significant treatment effect (Assessment x Group) for HAM-D (p = 0.42). The 
two groups, EXP and PBO, were significantly different at each of the three time points: pre- 
(p ˂ 0.001), mid- (p ˂ 0.001) and post-intervention (p ˂ 0.001) as is illustrated in Figure 5.7 
Additional analysis revealed the two groups differed from each other at each time point by 
52% at pre-, 69% at mid- and 77% at post-intervention. Over the 16 weeks the EXP group 
reported an average rating of 5 ± 3 and the PBO of 9 ± 4 for depressive mood (p < 0.01). 
There was no significant change in time over EXP (pre- to mid-, mid- to post- and pre- to 
post-intervention EXP, p > 0.05) or PBO (pre- to mid-, mid- to post- and pre- to post-
intervention PBO, p > 0.05). 
 
 
Figure 5.7 Hamilton Rating Scale of Depression (HAM-D) between EXP and PBO over 
16 weeks (?̅? ± SEM). * p ˂ 0.001. 
 
3.  Primary Outcome Variables 
3.1 Executive Function 
3.1.1 Updating: Trail Making Test (TMT) part A (TMT A) and part B (TMT B) 
A significant treatment effect (Assessment x Group) was observed for TMT A (p < 0.0001) 
but not for TMT B, TMT B / TMT A or TMT B – TMT A (p > 0.05). At post intervention PBO 
and EXP differed significantly (p = 0.03) as can be seen in Figure 5.8. The PBO showed a 
significant increase in time to complete TMT A from pre- to post-intervention (p = 0.02), while 
EXP remained constant in their times.  
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Figure 5.8 TMT A between EXP and PBO over 16 weeks (?̅? ± SEM). * p ˂ 0.05. 
Figure 5.9 depicts the ratio (TMT B / TMT A; treatment effect = 0.97) and difference (TMT B 
– TMT A; treatment effect = 0.54) between TMT B and TMT A and Table 5.6 summarizes 
the absolute values for the TMT variables. Although there was no significant difference 
between the two groups for TMT B / TMT A, over the three time points, pre- (p = 0.30), mid- 
(p = 0.24) and post-intervention (p = 0.38), additional analysis revealed that the two groups 
differed from each other at each time point by 23% at pre-, 21% at mid- and 23% at post-
intervention. Similarly, TMT B – TMT A showed no significant difference between the two 
groups at pre- (p = 0.82), mid- (p = 0.32) and post-intervention (p = 0.31) although the two 
groups differed at these time points by 26%, 53% and 55%, respectively. 
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a)                          b) 
 
Figure 5.9 Ratio (a) and difference (b) between TMT B and TMT A between EXP and PBO over 16 weeks (?̅? ± SEM).  
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Table 5.6 Summary of Trail Making Test (TMT) variables over the 16 weeks reported as mean (?̅?) ± standard deviation (SD), with 
(range). 
TMT Variable EXP (n = 25)a PBO (n = 17)b p value 
Assessments  Pre1 Mid2 Post3 Pre1 Mid2 Post3  
TMT A (s) 55.6 ± 21.2 
(26.3 – 97.7) 
58.3 ± 22.4 
(24.0 – 
114.0) 
55.2 ± 20.0 
(28.5 – 
108.5) 
52.7 ± 32.5 
(24.2 – 
143.3) 
68.7 ± 51.0 
(22.5 – 
171.8) 
84.2 ± 105.4 
(17.6 – 
437.6) 
p = 0.02b1 vs b3 
p = 0.03a3 vs b3 
TMT B Time (s) 145.5 ± 77.1 
(64.3 – 
345.5) 
145.6 ± 87.8 
(57.7 – 
401.3) 
132.3 ± 75.0 
(62.8 – 
393.2) 
169.0 ± 
151.5 
(51.6 – 
677.0) 
219.8 ± 
226.5 
(53.1 – 
916.8) 
219.7 ± 
232.1 
(46.6 – 
657.4) 
p > 0.05 
TMT B / TMT A 2.6 ± 1.0 
(1.6 – 5.7) 
2.5 ± 1.0 
(1.4 – 5.5) 
2.4 ± 0.9 
(1.3 – 4.8) 
3.3 ± 2.4 
(1.6 – 9.7) 
3.0 ± 1.4 
(1.4 – 5.4) 
3.1 ± 2.9 
(1.2 – 14.0) 
p > 0.05 
TMT B – TMT 
A (s) 
 89.8 ± 63.3 
(24.0 – 
285.2) 
87.3 ± 74.8 
(16.1 – 
327.5) 
77.1 ± 63.2 
(20.6 – 
310.9) 
116.2 ± 
138.6 
(23.7 – 
601.2) 
151.1 ± 
189.9 
(17.7 – 
745.0) 
135.5 ± 
171.5 
(22.9 – 
610.4) 
p > 0.05 
TMT: Trail Making Test; s: seconds; a EXP (Experimental group); b PBO (Placebo group); 1 Pre-testing; 2 Mid-testing; 3 Post-testing 
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3.1.2  Set shifting: Wisconsin Card Sorting Test: (WCST) 
Table 5.7 summarizes all of the variables for the WCST. There was no significant treatment 
effect (Assessment x Group) for any of the WCST variables i.e. Perseverative responses 
(PR), Categories completed (CC), Failure to maintain set (FTMS) and Total Errors (TE) (p 
> 0.05). The PR was significantly different between EXP and PBO at pre-, mid- and post-
intervention (p < 0.01), as well as from pre- to mid-intervention EXP (p = 0.04). There were 
no changes from mid- to post-intervention for either PBO or EXP (p > 0.05). Failure to 
maintain set (FTMS) showed no significant differences between EXP and PBO, however 
there was a tendency for the two groups to differ by 56% at mid-intervention (p = 0.07). Total 
errors (TE) was statistically significant from pre- to mid-intervention EXP (p = 0.050). 
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Table 5.7 Summary of WCST variables over the 16 weeks reported as mean (?̅?) ± standard deviation (SD), with (range). 
WCST Variable EXP (n = 25)a PBO (n = 15)b p value 
Assessments  Pre1 Mid2 Post3 Pre1 Mid2 Post3  
CC  2.2 ± 1.6 
(0 – 6) 
1.7 ± 1.8 
(0 – 6) 
2.0 ± 2.1 
(0 – 6) 
3.0 ± 1.0 
(1 – 5) 
2.6 ± 1.1 
(1 – 4) 
2.7 ± 0.6 
(1 – 3) 
p > 0.05 
PR  9.4 ± 8.3 
(0 – 31) 
6.2 ± 7.7 
(0 – 25) 
6.4 ± 8.4 
(0 – 34) 
17.5 ± 6.5 
(6 – 25) 
10.5 ± 3.0 
(6 – 18) 
15.1 ± 6.3 
(7 – 31) 
p = 0.004a1 vs b1 
p = 0.004a2 vs b2 
p = 0.003a3 vs b3 
p = 0.04a1 vs a2 
FTMS  1.4 ± 1.6 
(0 – 5) 
2.2 ± 2.1 
(0 – 8) 
1.8 ± 1.3 
(0 – 4) 
0.5 ± 0.7 
(0 – 2) 
1.3 ± 0.8 
(0 – 2) 
1.6 ± 1.8 
(0 – 7) 
p > 0.05 
TE  60.0 ± 16.2 
(13 – 87) 
55.2 ± 18.9 
(15 – 88) 
56.9 ± 17.8 
(20 – 93) 
66.3 ± 9.4 
(43 – 76) 
61.1 ± 7.9 
(41 – 69) 
62.5 ± 10.8 
(35 – 77) 
p = 0.050a1 vs a2 
WCST: Wisconsin Card Sorting Test; CC: Categories Completed; PR: Perseverative Responses; FTMS: Failure To Maintain Set; TE: Total Errors; a EXP (Experimental 
group); b PBO (Placebo group); 1 Pre-testing; 2 Mid-testing; 3 Post-testing 
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Two participants in PBO were colour blind and could not perform the WCST therefore the 
results are reported as n = 15 in PBO group.  
Additional analysis was performed concerning the Global Wisconsin Card Sorting Test 
(WCST) Score, which indicates the participant’s overall efficiency in the WCST (Figure 
5.10). A score closer to zero is better. A statistically significant treatment effect (Assessment 
x Group) (p < 0.0001) was found. No significant differences were found specifically between 
groups and over time (p > 0.05), however on average the PBO group scored better (group 
effect; p < 0.0001).  
 
Figure 5.10 Global WCST Score between TMT B and TMT A between EXP and PBO over 
16 weeks (?̅? ± SEM).  
3.1.3  Inhibition: Adapted Stroop Task 
Table 5.8 summarizes all of the variables for the Adapted Stroop task. There was a weak 
tendency for a treatment effect (Assessment x Group) for time, for Choice Reaction Time 
for Reading (CRT 1) (p = 0.08) and a significant treatment effect for time, for Choice Reaction 
Time for Naming (CRT 2) (p = 0.007). However only CRT 1 showed a significant treatment 
effect for accuracy (p = 0.04). The Stroop variables for Incongruent exhibited no significant 
treatment effect for time or accuracy (p > 0.05).  
 
The congruent trials include the CRT 1 and 2 trials. In CRT 1: time there was a significant 
difference between EXP and PBO at mid- (p = 0.03) and post-intervention (p = 0.01). No 
significant change over time was found in EXP from pre- to mid-intervention (p = 0.13). 
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Nonetheless, there was a significant change in EXP from pre- to post-intervention (p < 0.01), 
as well as a tendency to differ from mid- to post-intervention (p = 0.06). The PBO showed 
no change over the 16 weeks (p > 0.05) in CRT 1: time. The CRT 1: accuracy for PBO and 
EXP groups differed at mid-intervention (p = 0.02). For CRT 2: time the two groups differed 
by 42% (p = 0.01) at post-intervention. While PBO’s reaction time was maintained over the 
16 weeks, EXP’s did not change from pre- to mid-intervention (p = 0.18), but improved by 
7% from mid- to post-intervention (p = 0.048). In addition, EXP also improved over the 16 
weeks by 10% (p = 0.01).  
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Table 5.8 Summary of Adapted Stroop task variables over the 16 weeks reported as mean (?̅?) ± standard deviation (SD), with 
(range). 
Variable  EXP (n = 24)a PBO (n = 15)b p value 
Assessments  Pre1 Mid2 Post3 Pre1 Mid2 Post3  
CRT 1: Reading        
 Time (s) 1.5 ± 0.3 
(1.1 – 2.1)  
1.5 ± 0.5 
(1.0 – 2.7) 
1.4 ± 0.5 
(1.0 – 2.8) 
2.2 ± 2.2 
(0.9 – 10.2) 
2.2 ± 2.2 
(1.0 – 10.2) 
2.2 ± 2.0 
(1.0 – 9.3) 
p = 0.03a2 vs b2 
p = 0.01a3 vs b3 
p ˂ 0.001a1 vs a3 
 Accuracy 
(%) 
99.5 ± 1.8 
(91.7 – 100) 
99.8 ± 0.8 
(95.8 – 100) 
99.5 ± 1.4 
(95.8 – 100) 
99.3 ± 2.2 
(91.7 – 100) 
97.5 ± 4.9 
(83.3 – 100) 
98.6 ± 3.5 
(88.0 – 100) 
p = 0.002a2 vs b2 
CRT 2: Naming        
 Time (s) 1.5 ± 0.3 
(1.2 – 2.1) 
1.5 ± 0.3 
(1.1 – 2.2) 
1.4 ± 0.3 
(0.9 – 2.0) 
2.1 ± 2.3 
(0.9 – 10.3) 
2.0 ± 2.0 
(1.0 – 8.8) 
2.1 ± 1.6 
(1.0 – 7.1) 
p = 0.01a3 vs b3 
p = 0.048a2 vs a3 
p = 0.001a1 vs a3 
 Accuracy 
(%) 
99.2 ± 2.1 
(91.7 – 100) 
99.7 ± 1.2 
(95.8 – 100) 
99.0 ± 2.2 
(91.7 – 100) 
98.1 ± 4.1 
(87.5 – 100) 
98.6 ± 3.0 
(91.7 – 100) 
98.3 ± 5.4 
(79.2 – 100) 
p > 0.05 
Incongruent 1        
 Time (s) 2.7 ± 0.9 
(1.7 – 4.8) 
2.5 ± 0.9 
(1.6 – 5.0) 
2.3 ± 1.0 
(1.3 – 5.1) 
3.6 ± 3.1 
(1.6 – 14.1) 
3.7 ± 3.9 
(1.4 – 17.2) 
3.4 ± 2.9 
(1.3 – 11.7) 
p = 0.04a3 vs b3 
p = 0.02a1 vs a2 
p = 0.053a2 vs a3 
p ˂ 0.001a1 vs a3 
 Accuracy 
(%) 
93.8 ± 7.0 
(79.2 – 100) 
96.4 ± 4.3 
(83.3 – 100) 
97.2 ± 3.6 
(87.5 – 100) 
92.5 ± 11.4 
(58.3 – 100) 
92.8 ± 11.1 
(62.5 – 100) 
94.2 ± 9.1 
(67.0 – 100) 
p = 0.05a1 vs a3 
Incongruent 2        
 Time (s) 2.8 ± 0.9 
(1.9 – 5.1) 
2.6 ± 0.9 
(1.6 – 4.7) 
2.6 ± 1.1 
(1.5 – 5.3) 
4.5 ± 3.4 
(2.1 – 15.3) 
4.2 ± 3.0 
(1.6 – 14.2) 
4.2 ± 3.5 
(1.5 – 15.3) 
p = 0.005a1 vs b1 
p = 0.005a2 vs b2 
p = 0.008a3 vs b3 
 Accuracy 
(%) 
90.8 ± 11.5 
(54.2 – 100) 
93.9 ± 7.2 
(75.0 – 100) 
95.3 ± 6.4 
(79.2 – 100) 
86.4 ± 14.9 
(58.3 – 100) 
89.2 ± 11.4 
(62.5 – 100) 
89.2 ± 14.5 
(54.0 – 100) 
p = 0.053a3 vs b3 
Interference Score        
 Time (s) 1.3 ± 0.7 
(0.5 – 2.9) 
1.1 ± 0.7 
(0.3 – 2.9) 
1.1 ± 0.8 
(0.4 – 3.6) 
1.9 ± 1.1 
(1.0 – 4.8) 
1.9 ± 1.7 
(0.4 – 7.2) 
1.7 ± 1.6 
(0.3 – 6.6) 
p = 0.003a1 vs b1 
p ˂ 0.001a2 vs b2 
 Accuracy 
(%) 
38.7 ± 8.5 
(13.0 – 47.5) 
41.5 ± 5.3 
(27.6 – 47.5) 
42.7 ± 4.0 
(32.9 – 46.3) 
36.2 ± 11.0 
(11.1 – 46.3) 
37.2 ± 10.4 
(11.1 – 46.3) 
38.2 ± 11.0 
(5.6 – 46.3) 
p = 0.05a2 vs b2 
p = 0.04a3 vs b3 
CRT: Choice Reaction Time; s: seconds; a EXP (Experimental group); b PBO (Placebo group); 1 Pre-testing; 2 Mid-testing; 3 Post-testing 
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For Incongruent trials, the reaction time for Incongruent 1 differed by 41% at post-
intervention (p = 0.04), EXP improved from pre to mid-intervention (p = 0.02), as well as 
from mid to post-intervention (p = 0.053) and over the 16 weeks in total (p < 0.01), whereas 
PBO demonstrated no change over time (p > 0.05). The accuracy during this trial only 
improved from pre- to post-intervention in EXP (p = 0.048). For the second, more distractive 
trial (Incongruent 2) EXP and PBO differed significantly at pre-, mid- and post-intervention 
(p < 0.01) by 45%, 44% and 45% respectively. Both EXP and PBO’s reaction times tended 
to slow over the 16 weeks (p = 0.06), but no differences were noted from pre- to mid-
intervention or from mid- to post-intervention (p > 0.05). Only EXP tended to improve their 
accuracy (less errors) over the 16 weeks (p = 0.06) while EXP and PBO tended to differ by 
7% at post-intervention (p = 0.053).  
 
A treatment effect was observed for Interference: score accuracy (p < 0.0001) but not for 
Interference: score time (p > 0.05). The EXP and PBO differed significantly at all three time 
points: pre- (p = 0.003); mid- (p < 0.0001) and post-intervention (p = 0.006) for Interference: 
time and at mid- (p = 0.050) and post-intervention (p = 0.04) for Interference: accuracy. A 
tendency for significant change was observed from pre- to post-intervention (p = 0.07) in 
EXP. 
 
Two participants in PBO were colour blind and could not perform the Stroop test. The results 
are reported as n = 15 in PBO. One participant in EXP was unable to read words in the 
colour yellow for the conditions of Incongruent 1 and 2 and his results were excluded for 
these two conditions. The results for these two conditions are reported as n = 24 in EXP. 
 
3.2 Functional Balance 
3.2.1 Perceived Stability of Balance: Activities-specific Balance Confidence Scale (ABC 
Scale) 
There was no significant treatment effect for ABC (p = 0.54). Post-hoc analysis found a 14% 
difference between EXP and PBO at post-intervention (p = 0.051), however the two groups 
did tend to differ at pre-intervention (p = 0.07) by 12%. Closer investigation showed that 
there was a significant difference from mid- to post-intervention (p = 0.02) and pre- to post-
intervention for the EXP (p = 0.01), but not from pre- to mid-intervention for the EXP (p = 
0.87). The PBO showed no change from pre- to mid-intervention or from mid- to post-
intervention (p > 0.05), but tended to improve over the 16 weeks (p = 0.06) in general as 
can be seen in Figure 5.11. 
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Figure 5.11 Perceived Stability of Balance (ABC) between EXP and PBO over 16 weeks 
(?̅? ± SEM). * p < 0.05 
 
3.2.2 Mobility: Timed Up and Go Test (TUG) 
There was a significant treatment effect for TUG (p ˂ 0.01; Figure 5.12). In addition, EXP 
and PBO differed by 28% at post-intervention (p < 0.01). There was a significant difference 
from pre- to mid- (p = 0.001), mid- to post- (p < 0.01) and pre- to post-intervention (p ˂ 0.01) 
in EXP. Additional analysis revealed a 14% improvement by EXP compared to a 3% change 
by PBO from mid- to post-intervention).  
 
 
Figure 5.12 Timed Up and Go (TUG) between EXP and PBO over 16 weeks (?̅? ± SEM). * 
p < 0.05  
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4. Summary 
In summary, there were significant treatment effects observed for MDS-UPDRS III and 
MDS-UPDRS total score, TMT A, Global WCST Score, CRT 1: accuracy, CRT 2: time, 
Interference Score: accuracy and the TUG.  
 
Between-groups differences were observed for EXP and PBO at pre-intervention in HY, 
MDS-UPDRS III, HAM-D, WCST: PR, Incongruent 2: time and Interference: accuracy; at 
mid-intervention in HY, PDQ-39 variable COM, HAM-D, WCST: PR, CRT 1: time, CRT 1: 
accuracy, Incongruent 2: time, Interference: time and Interference: accuracy; and at post-
intervention in PDQ-39 variable BOD, HAM-D, TMT A, WCST: PR, CRT 1: time, CRT 2: 
time, Incongruent 1: time, Incongruent 2: time, Incongruent 2: accuracy, Interference: time, 
Interference: accuracy, ABC and TUG.  
 
Within-group changes over time in EXP were seen from pre- to mid-intervention in MoCA, 
WCST PR, WCST TE, Incongruent 1: time and TUG; from mid- to post-intervention in MDS-
UPDRS II, PDQ-39 variable STI, CRT 2: time, Incongruent 1: time, ABC and TUG; and from 
pre- to post-intervention in MoCA, PDQ-39 variable EMO, CRT 1: time, CRT 2: time, 
Incongruent 1: time, Incongruent 1: accuracy, ABC and TUG. Within-group changes over 
time in PBO were seen from pre- to mid-intervention in PDQ-39 variables MOB and EMO; 
and from pre- to post-intervention in MDS-UPDRS III and TMT A. The following chapter will 
discuss these findings. 
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CHAPTER SIX 
 
DISCUSSION 
 
1. Introduction 
The current study set out to determine if an eight-week SMT programme could influence 
executive functioning, namely Inhibition, Set shifting and Updating in non-demented 
individuals with mild to moderate PD. The main findings of the study suggest that 
participants with PD who engaged in this exercise intervention in comparison to those who 
received a placebo, showed a slowing in disease progression, a reduction in perceived body 
discomfort, improvement in dynamic balance, mobility and confidence, as well as 
maintaining visuomotor abilities, and possibly an improvement in inhibitory control. Even 
though there is some evidence suggesting that sensory-integration and processing may 
have improved with the SMT, this programme had no significant benefit on Updating and 
Set shifting. These findings will be discussed in more detail in the following section. The 
chapter starts with a basic discussion about the participants’ descriptive characteristics, as 
well as secondary outcomes, and identifies possible confounding factors; this is followed by 
a discussion about the primary outcome variables. 
 
2. Participants 
The participants differed significantly, before the start of the baseline phase, regarding 
disease severity (HY and MDS-UPDRS I, III & IV), depressive moods (HAM-D) and some 
EF, namely Set shifting and Inhibition (WCST PR and Incongruent 2: time and Interference 
Score: accuracy). In addition, even though age differences were not statistically significant 
(the PBO was older), there was a tendency for the two groups to differ. These factors may 
have contributed to the specific reaction of each group to their intervention. Both EXP and 
PBO had similar activity status profiles, with most participants indicating that they were 
inactive. 
 
The descriptive variables of Depression (HAM-D) and Disease Severity (MDS-UPDRS I, III, 
IV and HY) differed significantly between the two groups at baseline. At mid-intervention 
(before the start of the treatment phase), only depressive mood and HY differed. 
Consequently, an ANCOVA was run and the analysis showed that only depression had an 
influence on the PDQ variables of perceived emotional well-being, cognitions and bodily 
discomfort. HY had no statistically significant difference and neither did gender or education. 
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Thus, depression may have influenced participants' perceived wellbeing, cognitive abilities 
and bodily discomfort. Additional statistical analysis (ANOVA) was done, dividing the groups 
into men and women to see if gender, as an independent variable, had an influence: there 
were no statistically significant differences regarding any of the dependent variables. 
 
Participants in EXP were on average five years younger than those in PBO. The study of 
Allain et al. (2005) revealed that apparently healthy older adults (80.3 ± 5.9 years) typically 
demonstrate impairments in planning, which relate to executive functions. In other words, 
elderly individuals have greater difficulty in deciding upon a complex course of action which 
will result in a specific goal, than they do in actually performing and successfully completing 
this course of action. This suggests that normal aging has an effect on the ability to formulate 
complex plans more than it impacts on the ability to execute the task (Allain et al., 2005). 
The 5-year difference between groups in the current study, therefore, may have had an 
influence on the lower Set shifting (WCST: PR) and Inhibition (Incongruent 2 & Interference 
Scores) results, even though no group differences were noted in global cognition (MoCA) or 
in mobility (TUG). Previous research has also shown that a large inter-individual variability 
exists in age-related changes in cognition (Gilsoul et al., 2015) which has also been reported 
in individuals with PD (Hindle et al., 2014; Koerts et al., 2013). However, as discussed later 
in this chapter, these differences may be attributed more to the cognitive reserve differences 
found between individuals with PD (Hindle et al., 2014; Koerts et al., 201).  
 
Furthermore, a reduction in postural control in the elderly, is accompanied by an increase in 
the prevalence of falls and poor mobility (Kanekar & Aruin, 2014). Likewise, there is a 
tendency for TUG performance times to decrease with increasing age in both men and 
women (Steffen et al., 2002). For individuals aged 65 years and older, falls are the chief 
cause of injury-related fatalities and falling is also the third highest cause of reduced or poor 
health (Scheffer et al., 2008). Roughly 30% of this age category will fall once per year and 
at least half of these will fall again (Scheffer et al., 2008; Stel et al., 2004; Moreland et al., 
2003). Once individuals reach 80 years and above, 50% will fall once per year (Hartholt et 
al., 2011). Correspondingly, both groups on average, fell in an age bracket associated with 
a higher risk for falls. However, even though the two groups seem to differ in age, there was 
little indication that this age difference directly influenced the mobility performance between 
the two groups, as seen in the TUG, particularly as there was no significant difference at 
baseline between EXP and PBO for the TUG. On the other hand, as noted before, the age 
bracket in which the two groups fell would have influenced their mobility and balance.  
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PD severity was worse in EXP compared to PBO as determined by the MDS-UPDRS and 
Hoehn and Yahr scales. The only exception was the MDS-UPDRS I scale, in which the PBO 
scored worse. Nevertheless, the total MDS-UPDRS and MDS-UPDRS II scores did not differ 
significantly when compared to the PBO. Part I of the MDS-UPDRS gives an indication of 
the non-motor experiences of daily living such as cognitive impairment, hallucinations, 
depressive and anxious mood, apathy and dopamine dysregulation. This part was assessed 
by the researcher, except for the final 7 questions, which were completed by the participant 
or caregiver and included questions on sleep, staying awake, pain, abnormal sensory 
sensations, urinary functions, constipation, light-headedness when standing and fatigue. 
The possible differences between the two groups in part I could, therefore, be attributed to 
non-motor experiences seven days prior to the testing day. This is partially supported by the 
HAM-D, as the two groups differed significantly from the start. A score between 0 and 6 
indicates no depression, between 7 and 17 indicates mild depression, between 18 and 24 
indicates moderate depression and any score above 24 indicates severe depression (Cusin 
et al., 2009). Hence the PBO were classified as having mild depressive moods and the EXP 
classified as having no depressive moods. Consequently, depression (with HAM-D) was 
considered a confounding variable in this study. One possible explanation for these 
significant differences observed (MDS-UPDRS I and HAM-D) during the pre-testing is that 
the start of the study for the two groups was staggered (due to practical constraints). The 
EXP group started first with their intervention, followed by the PBO. The time during which 
the PBO was assessed for their pre-intervention (and for some mid-intervention) data 
coincided with the largest religious and family holiday of the year. Even though this is merely 
speculative, the time of the year may have contributed to the PBO group possibly 
experiencing depressive emotions. Carr et al. (2014) found that older bereaved individuals 
experience psychological distress at times of special significance like Christmas or times 
usually spent with loved ones. Similar results have recently been reported in individuals who 
have suffered an injury or disability (Deegan et al., 2015). Therefore, individuals who are 
disabled (chronic or acute injury) may experience feelings of loneliness, isolation, absence 
from loved ones, and depression (Deegan et al., 2015).  
 
Part IV of the MDS-UPDRS discloses motor complications typically associated with 
medication such as dyskinesia and motor fluctuations (Goetz et al., 2007) whereas most PD 
studies use the UPDRS II and/or III in their investigations (Harrison et al., 2009) for reasons 
which will be highlighted later in this chapter. Hence part II and III, which report the 
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participants’ motor experiences of daily living (self-reported) and the motor examination by 
the researcher, respectively, may be considered the most relevant subscales of the current 
study.  
 
The two groups differed at pre-intervention for part III: in particular, the EXP performed 
worse than PBO, which was supported by the HY staging in which the PBO’s disease 
severity was better compared to EXP. An increase in HY staging has been associated with 
dopaminergic loss, increased motor impairment, disability and reduced quality of life (Goetz 
et al., 2004). Typically, the HY only takes into consideration postural instability (balance and 
gait problems) and bilateral involvement, and no other motor or non-complications, which 
may explain why the results on the HY of this study relates to the motor subscale (part III) 
of the MDS-UPDRS. 
 
In this study, the EXP (Med: 2.5) predominantly consisted of participants between stage 2 
(bilateral involvement without balance difficulties) and stage 3 (bilateral disease with balance 
difficulties), whereas the PBO (Med: 2.0) was predominantly composed of stage 2 
participants (bilateral involvement without balance difficulties). Stages 1 and 2 are 
considered as mild or early PD, whereas stage 3 is seen as moderate PD (Goetz et al., 
2004). Consequently, both groups could be considered to include mild to moderate PD. 
Goetz et al. (2004) further explains how participants in stage 2 may demonstrate a stable 
disease severity rating (as reported by MDS-UPDRS) even with an increase in medication, 
whereas stage 3 disease severity fluctuates with changes in medications and places the 
participant at a higher risk for dementia, balance problems and a decreased survival rate. 
Hence the EXP participants may not have differed clinically from the PBO but were 
progressing towards stage 3, suggesting that they may have had slightly poorer disease 
severity than the PBO. 
 
The MoCA is considered to be a more sensitive test for the detection of mild cognitive 
impairment (MCI) than the Mini-Mental State Exam (MMSE) and is an indication of global 
cognition (Nazem et al., 2009; Zadikoff et al., 2008; Nasreddine et al., 2005). A score below 
26 is considered the optimal cut-off for cognitive impairment (Nasreddine et al., 2005). Thus, 
both groups were classified as having mild cognitive impairment (MCI) and did not seem to 
differ in global cognition. Harkness et al. (2011) found that elderly individuals (> 65 years) 
who scored lower than 26 on the MoCA (suggesting MCI), had significant deficits in the 
delayed recall, language and visuospatial/executive function compared with individuals who 
Stellenbosch University  https://scholar.sun.ac.za
86 
 
scored more than 26. Nevertheless, Harkness et al. (2011) did not assess individuals with 
PD. However executive functioning is a subdomain of the MoCA, in addition to attention, 
concentration, memory, language, visuospatial skills, abstraction, calculation and 
orientation, which may suggest that both groups in the current study had some executive 
dysfunction, which is reflected in the MoCA score of less than 26. This is supported by 
Dalrymple- Alford et al. (2010) who reported cut-off scores of 20/21 for PD with dementia, 
and 25/26 for PD with MCI. 
 
Baseline differences between EXP and PBO were also evident for some aspects of EF, 
namely Set shifting as seen in PR and Inhibition as seen in Incongruent 2: Time and 
Interference: time. The PBO group seems to have had more problems with ‘thinking outside 
the box’, adjusting to shifting priorities and reacting to impulsive, unexpected opportunities 
or problems (Diamond, 2015). They also struggled more at the start of the study with 
inhibiting automatic responses (habits) or resisting temptations and distractions (Diamond, 
2015). One possible contributing factor that may have influenced the PBO group negatively 
is depressive mood (referring to MDS-UPDRS I and HAM-D). Uekermann et al. (2003) 
suggest that even mild depressive symptoms are likely to worsen cognitive impairment in 
early PD. However, Uekermann et al. (2003) used different tests of EF as well as a different 
rating scale of depression compared to the current study. It is possible that the mild 
depressive moods seen in the PBO had an impact on these two EF variables, although one 
would expect to also see this for all or at least more of the variables (CC, FTMS, TE, CRT 
1: time and accuracy; CRT 2: time and accuracy; Incongruent 1: time and accuracy and 
Incongruent 2: accuracy). Both of the tests used for these two variables, namely the WCST 
and the adapted Stroop task, made use of a laptop computer. It is possible that the older 
age profile of the PBO relative to the EXP had an impact in terms of computer use. It was 
informally noted that some older participants in both groups were less comfortable using a 
computer and mouse than some of the younger participants. 
 
Hu et al. (2006) stated that Body Mass Index (BMI) ≥ 23 kg/m2 is associated with an 
increased risk of PD among middle-aged men and women, yet individuals with PD have 
typically been reported to have a lower BMI than healthy age-match controls (van der Marck 
et al., 2012). Consequently, one may think that BMI should be considered when making 
inferences. Both groups in the current study were classified as overweight (defined as a BMI 
between 25.0 kg/m2 and 29.9 kg/m2). Interestingly, Gunstad et al. (2007) previously found 
that regardless of age, elevated body mass index (BMI) is associated with executive 
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dysfunction in healthy individuals. Conversely, it is undetermined whether this same 
relationship is also true for PD specific populations, although lower BMI has been found to 
be associated with cognitive decline in PD (Kim et al., 2012).  
 
The two groups were conveniently recruited from two different areas in the Cape 
metropolitan and Winelands district of the Western Cape. More specifically the EXP group 
was from the Cape metropole (southern suburb areas), whereas the PBO was from the 
Cape metropole (Strand and Somerset West) and Winelands districts (Stellenbosch and 
Paarl). The socioeconomic status of the two areas was similar. Socioeconomic status may 
have indirectly influenced global cognition and, as a result, also EF. However, based on the 
MoCA, both groups had similar education levels with only 4 (EXP group) and 2 participants 
(PBO group) having less than 12 years of education. Both groups also achieved an average 
global cognition score of 24 which is indicative of mild cognitive impairment (Nasreddine et 
al., 2005). Hackman et al. (2015) suggested that the association between socioeconomic 
status and EF has its roots in early childhood, a factor that the study could not have 
controlled. 
 
When looking at the various baseline differences between the two groups (disease severity, 
depressive mood and some EF) one may expect the mobility test (TUG) to also differ 
between groups, as previous researchers have shown that these descriptive specific 
variables have an influence on balance. For instance, Donoghue et al. (2012) showed that 
poorer performance on TUG for mobility is independently associated with reduced global 
cognition, EF, memory and processing speed. As pointed out earlier, balance impairment is 
the critical criteria between stages of disease severity on HY specifically (Goetz et al., 2004). 
Whereas Cubo et al. (2000) found that lower global cognition, axial bradykinesia, as well as 
gait and balance impairment were significant predictors of depression. Consequently, one 
may ask why the two groups would have similar TUG scores at baseline assessments. A 
possible reason is the heterogeneity found between the two groups, and that the 
combinations of these descriptive characteristics of each group, may have influenced their 
balance performance differently, resulting in similar TUG scores. For instance, EXP had 
poorer disease severity scores yet better EF, whereas the PBO had experienced higher 
depressive scores but lower EF. This may have contributed to similar mobility capabilities in 
both groups, though they were influenced differently. 
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The participants of the EXP group maintained a high session attendance rate throughout 
the intervention. All 25 participants maintained an attendance rate of 70% and above for the 
duration of the intervention which is similar to the study of Tanaka et al. (2009). Only one 
participant had an attendance rate less than 75%. Eleven participants had attendance rates 
above 90%. Three participants were excluded from the study for an attendance rate less 
than 70%. Although they were allowed to continue with the intervention their results were 
not included in the study. This is considered a good attendance rate compared to studies 
such as Shubert et al. (2010) who reported an attendance rate ranging from 40 to 100%. 
 
The attrition rate (study drop-outs) of the current study was low. In the EXP, of the 30 
participants who started the eight-week balance training programme, only two dropped out. 
Three were not included in the data analysis as they did not meet the required 70% 
attendance criteria. In the PBO, four participants dropped out of the original 21. This leaves 
a 6.7% attrition rate in the EXP, 19% in the PBO and 11.8% if EXP and PBO are combined. 
Compared to studies such as Shubert et al. (2010) who reported an attrition rate of 33%, 
this is much lower. Although participants attended these classes over a 12-week period, 
they attended only twice a week whereas the current study had classes three times a week 
over an eight-week period. 
 
3.  Secondary Outcome Variables 
3.1 Global Cognition: Montreal Cognitive Assessment (MoCA) 
The scores between EXP and PBO were similar for the pre- and mid-interventions. The 
scores for PBO at pre-, mid- and post-intervention all fell below the cut-off of 26, as did the 
scores for EXP at pre- and mid-intervention. Although not significant, the post-intervention 
score (26.5 ± 2.4) for EXP was above the cut-off score, which is classified as normal 
cognition. To date no minimal detectable change (MDC) has been reported for the MoCA, 
however considering that the individuals in the EXP improved from MCI to no cognitive 
impairment classification after the treatment phase, this may be considered as clinically 
significant instead, albeit not statistically significant. The only significant change over time 
was observed in the EXP group over the baseline phase as well as from pre- to post-
intervention. Considering that there was no significant change over the treatment phase, this 
overall change may be attributed to a learning or demand effect and not necessarily to the 
intervention. In other words, participants may have become accustomed to the assessment 
questions. Similarly, MacKee and Hackney (2013) found a main effect of time for the MoCA, 
in their study on adapted tango in PD, but no treatment effect. 
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3.2  Parkinson’s Disease Severity 
3.2.1 Hoehn and Yahr Scale (HY)  
In the current study, the EXP group maintained their HY stage rating and thus did not show 
any further disease progression. In contrast, the PBO group did show some deterioration in 
their disease severity over time: this change was not significant, however, nor can it be 
considered a clinically significant change as some clinicians have suggested that only a 
change from one stage to another is clinically significant (Goetz et al., 2004). Furthermore, 
for disease severity it is best to refer to the MDS-UPDRS II and III data, since the wide 
difference between stages in the original HY is not sensitive enough to determine treatment-
related changes especially in the lower PD stages (< 3). Therefore, the HY is mostly 
recommended for inclusion and exclusion criteria and for descriptive purposes in research 
(Goetz et al., 2004). 
 
3.2.2 Movement Disorder Society – Unified Parkinson’s Disease Rating Scale (MDS – 
UPDRS):  
The MDS-UPDRS was designed to detect both disease progression and changes 
associated with therapeutic interventions such as this study’s exercise intervention (Horváth 
et al., 2015). Previous researchers have found that subscale II of the UPDRS is a better 
indicator of disease progression compared to other subscales (Harrison et al., 2011). These 
researchers suggested that subscale II is more sensitive to functional change and is less 
affected by motor fluctuations like part III (the motor examination subscale). In addition, 
subscale III was found to be influenced by placebo-related improvements, whereas subscale 
II was not. Other researchers, however, have suggested that both subscales II and III should 
be considered when assessing disease progression, especially in early PD (Parashos et al., 
2014; Tomlinson et al., 2013). These are observations made concerning the original UPDRS 
whereas the newer MDS-UPDRS is considered to be more comprehensive and consistent 
than the original (Goetz et al., 2008). Moreover, Lang et al. (2013) report subscale II to be 
even more sensitive to change over time than the original UPDRS subscale II in individuals 
with early- to mild-stage PD. Subscales I and IV of the original and new versions differ quite 
considerably while parts II and III remain similar and have been calibrated (Goetz et al., 
2012). Subscale II assesses motor features of experiences of daily living (M-EDL) and is 
able to identify problems with daily activities. Higher subscale II scores are linked with 
increasing severity of disease and its duration (Rodriguez-Blazquez et al., 2013). In the 
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current study, the EXP improved their MDS-UPDRS subscale II over the treatment phase, 
while there was no improvement in the score of the PBO.  
 
Subscale III is able to evaluate the severity of motor symptoms reliably. The recent study of 
Horváth et al. (2015) estimated minimal clinically important differences (MCID) in part III of 
the MDS-UPDRS as -3.25 points for improvement and +4.63 points for deterioration. In the 
current study, there was a treatment effect for part III, and the PBO showed deterioration 
from pre- to post-intervention as well as a tendency to deteriorate from mid- to post-
intervention, which indicates an increase in PD severity. However, although this 
deterioration over the whole 16 weeks is considered significant, it falls slightly below the cut-
off for MCID (change of 4.1). Although there was no improvement in the EXP, neither was 
there any deterioration. Thus, it is possible that the exercise may have acted to prevent 
possible progression of the disease. 
 
There was also a treatment effect seen for Total MDS-UPDRS. The study of Pierobon et al. 
(2014) saw a similar improvement in MDS-UPDRS III and MDS-UPDRS Total following an 
intensive rehabilitation programme. Although they did not include a control group in their 
study, they distinguished between “impaired” and “not impaired” and “depressed” vs “non-
depressed” individuals with PD. Regardless of the grouping, they saw the same trend and 
significant improvement (p < 0.0001) in MDS-UPDRS III and MDS-UPDRS Total as was 
seen in the current study. 
 
3.3  Quality of Life: 39-Item Parkinson’s Disease Questionnaire (PDQ-39) 
Schrag et al. (2000) did a stepwise multiple regression analysis on 92 individuals with PD 
and found that depression, disability, postural instability, and cognitive impairment have the 
greatest influence on QOL in PD. Due to the nature of the intervention, the current study 
wanted to determine the impact of the SMT programme on specific aspects of functioning 
and wellbeing in PD. Therefore, the PDQ-39 profile form was assessed instead of the 
summary index, which determines the impact of the illness on functioning and well-being 
(Jenkinson et al., 1997). The tendency in the PDQ-39 variable MOB (mobility) complements 
and compares to the treatment effect observed for the TUG. Both of these assessments 
evaluate functional mobility and balance. The EXP and PBO differed significantly at mid-
intervention for COM (communication) and at post-intervention for BOD (bodily discomfort). 
Although the two groups were significantly different at these time points, there was no 
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significant improvement or deterioration in either group during the lead up to these points 
and thus they would not appear to be of great relevance. 
 
There was a significant reduction in STI (stigma) in the EXP, perhaps as a result of the SMT 
or from being around other individuals with PD. An informal observation of the EXP was that 
hardly any of the participants had met each other before and apart from a few who attended 
a once-monthly PD support group, they did not interact with other PD individuals. It is not 
known what accounted for the improvement over the baseline phase in MOB (mobility) in 
the PBO.  
 
Both the EXP and PBO showed improvements in EMO (emotional wellbeing). The PBO had 
an initial decrease over the baseline phase and the EXP decreased from pre- to post-
intervention; however, closer inspection shows that the EXP improvement took place 
primarily over the treatment phase. This predominantly mid- to post-intervention 
improvement in the EXP may have been as a result of the SMT or increased social 
interaction of the SMT or a combination of the two. 
 
3.4  Depression: Hamilton Rating Scale for Depression (HAM-D) 
The two groups differed significantly from each other throughout the baseline and treatment 
phases. The EXP were classified as being without depression and they stayed this way 
throughout the study (pre: 5; mid: 4; post: 4). The PBO were classified as having mild 
depression and they, too, stayed in this classification for the duration of the study (pre: 8; 
mid: 9; post: 9). Although the differences between the two groups remained significant 
throughout (pre: p ˂ 0.001; mid: p ˂ 0.001; post: p ˂ 0.001) and the two groups were in 
different categories throughout, there is only a small difference between the two categories 
of no depression (0-6) and mild depression (7-17). A possible reason for the discrepancy 
between the two groups could be the timing of their interventions. The EXP ran from late 
July to early December, while the PBO ran from late October to early March. As mentioned 
earlier, the PBO group ran over the year-end holiday time which is considered to be a 
stressful and often depressing time of the year, particularly for those who have lost loved 
ones or whose family do not live close by. Furthermore, three participants in the PBO lost a 
close family member or friend in the duration of the study. The 2005 study by Prado and 
Barbosa investigated the presence of depression in 60 individuals with PD and reported a 
frequency of depression of 38.33%. Of those found to be depressed, 82.60% had mild 
depression, 8.69% had moderate depression and 8.69% had severe depression. Thus, the 
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finding of the control group falling into the mild depression category is not out of the ordinary. 
Uekermann et al. (2003) suggest that depressed mood in PD has the potential to aggravate 
cognitive impairments, including EF. Thus depression could potentially have influenced the 
EF of the PBO group in this study. 
 
4.  Primary Outcome Variables 
4.1 Executive Function (Updating, Set shifting and Inhibition) 
4.1.1 Updating: Trail Making Test (TMT) part A (TMT A) and part B (TMT B) 
The Trail Making Test (TMT) was included in this study to assess Updating (also known as 
working memory). Trail Making Test part A was the only TMT variable to demonstrate a 
treatment effect or any significant changes over time. The PBO’s time to complete the TMT 
A deteriorated over the 16-week period of the study, while the EXP maintained their times. 
At the end of the treatment phase the PBO and EXP were significantly different. The TMT A 
requires the use of visual scanning and visuomotor speed and is not generally considered 
to assess pure EF, while the more challenging TMT B reflects Updating. The difference 
(TMT B – TMT A) and ratio (TMT B / TMT A) scores were developed to provide a more 
distinct measure of the executive components that distinguish the two parts of the test 
(Drane et al., 2002). However, no differences were observed in these variables, indicating 
that the SMT programme did not benefit working memory/updating.  
 
This is similar to the PD study of Duchesne et al. (2015) and non-Parkinson’s disease 
studies of Shubert et al. (2010) and Liu-Ambrose et al. (2008) who also found no significant 
improvements in these variables. The exercise interventions used in these three studies 
were an aerobic exercise training programme, an exercise-based balance programme and 
a strength and balance training programme, respectively. Liu-Ambrose et al. (2008) used 
TMT B as a measure of Set shifting. Although there was no statistically significant 
improvement in Set shifting (TMT B), the EXP group improved by 8.7% compared to the 
control group who deteriorated by 3.6%. The current study also showed no statistically 
significant improvement in TMT B of EXP yet they also improved by 9% (over the 16 weeks) 
compared to the 30% deterioration of PBO (30% deterioration over baseline phase, 
plateauing over treatment phase). Although Shubert et al. (2010) found a tendency to 
improve in TMT A time (p = 0.03), there was no improvement in TMT B. Their study reported 
great variation in the results of this test, particularly in TMT B (> 218 seconds variation), 
which is comparable to the current study. The EXP variation in the TMT B ranged from 281 
to 330 seconds over the 16 weeks, while the PBO variation ranged from 625 to 863 seconds. 
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One must bear in mind that the studies of Shubert et al. (2010) and Liu-Ambrose et al. (2008) 
were not conducted in a PD population. Duchesne et al. (2015) suggest that the motor 
element of the TMT could increase the difficulty of completing this task in those with PD. 
 
Interestingly, in an unrelated study, Engel-Yeger et al. (2012) reported that deterioration in 
sensory-processing abilities can lead to inefficiencies in visuomotor performance. This may 
indirectly suggest that the SMT programme improved sensory-processing abilities in 
individuals with PD. Individuals with PD typically have deficits in sensory processing and 
integration, which is not improved, and may be aggravated, by dopaminergic medication 
(Mongeon et al., 2009). The basal ganglia (which are defective in PD) play a critical role in 
proprioceptive integration with visual information which is provided simultaneously during 
the action or recalled from memory. This interaction between the visual and proprioceptive 
information assists individuals with PD by guiding their movements. This is also one of the 
reasons why individuals with PD are predominantly visually dependent for accuracy in 
targeted movements (Adamovich et al., 2001).  
 
4.1.2 Set shifting: Wisconsin Card Sorting Test (WCST) 
The WCST test was used to assess Set shifting in the PD participants of the current study. 
In the variable Perseverative Responses (PR), significant differences were observed 
between EXP and PBO at all three time points. This variable refers to the number of times 
an individual continues (or persists) in responding to an incorrect card characteristic (Strauss 
et al., 2006), as well as an inability to use feedback to modify response patterns (Moore et 
al., 2000). It may indicate an inability to surrender the old sorting category in favour of a 
different one. It is unclear why the two groups should have differed from the start and 
maintained the difference throughout. The PBO did tend to improve at the mid-intervention 
point but deteriorated again to post-intervention. The EXP improved in WCST: PR and 
WCST: TE over the baseline phase, which may suggest that a learning effect took place for 
this test. This is likely confirmed by the tendency of the PBO to improve in the WCST: PR 
for this same period. Global WCST Score did not differ between the two groups at any time 
point but the PBO scored lower on average than the EXP. One might assume that this 
conflicts with the PR scores where EXP did better. However, this score does not just depend 
on right and wrong answers, but also the number of attempts. Over time there was no 
difference in Global WCST Score, thus there was no difference in Set shifting. Miyake et al. 
(2000) discussed the strength of involvement of EF when a task or test is novel or new. 
Repeated attempts at the task may reduce its efficacy in assessing the target EF, resulting 
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in low correlations between EF performance at the task when it was novel and later when it 
becomes familiar. David et al. (2015) also touched on the known practice effects of repeated 
cognitive or EF testing. Lemay et al. (2010) looked at practice effect and test-retest reliability 
of EF tests in middle-aged to elderly subjects and Burke et al. (2015) looked at practice 
effects on repeated neuropsychological measures of executive functioning. Lemay et al. 
(2010) did three assessments with each assessment 14 days apart and they found practice 
effects for all tests except those that utilized a different format for subsequent tests. On the 
other hand, Burke et al. (2015) also did three assessments with each assessment six 
months apart and found no practice effects. However, these studies were conducted in a 
normal population. My assessments were conducted between eight and nine weeks apart. 
I believe that the baseline phase would have helped with this as the practice effect would 
have been evident over the baseline phase. Reinforcing this, none of the EF variables in 
this study showed a statistically significant practice effect. 
 
Alevriadou et al. (1999) reported a significant correlation between the WCST variables PR, 
percent PR (not used in this study) and FTMS and UPDRS part III (motor score). In addition 
to this, a significant correlation was observed between PR and percent PR and the PD 
symptom rigidity. 
 
Tanaka et al. (2009) used the WCST test in their study which examined the impact of a 
multi-modal exercise programme on executive function in older people with PD. They chose 
to only use the WCST to assess EF in terms of mental flexibility (also known as Set shifting), 
attention and abstraction. Their results showed a significant improvement in the treatment 
group in the CC and “Perseverative errors” variables compared to the control group; 
however, they did not note any significant improvement in the variable FTMS. This is similar 
to the current study which also demonstrated no improvement in this variable. The current 
study, did not see the same significant improvements regarding CC and PR (very similar to 
“Perseverative errors”) that Tanaka et al. (2009) observed. 
 
4.1.3  Inhibition: Adapted Stroop Task 
Treatment effects were observed for CRT 1: accuracy, CRT 2: time and Interference score: 
accuracy, as well as a tendency for a treatment effect for CRT 1: time. The CRT 1 and CRT 
2 are considered the easiest two conditions of the adapted Stroop task and measure 
response to identify the colour name of a word in a neutral text colour (CRT 1: Reading) and 
block colour without colour-word information (CRT 2: Naming), respectively. They do not 
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assess Inhibition but reaction time to a stimulus. CRT 1 is considered the easier of the two. 
The treatment effect observed in CRT 2: time and tendency in CRT 1: time may be due to 
an improvement in response time as a result of the SMT programme and the two groups 
differed significantly at post-intervention. The improvement in CRT 1: accuracy reveals that 
the participants were able to perform the test more accuracy. 
 
Incongruent 1 and Incongruent 2 are the more difficult components of the adapted Stroop 
task and specifically assess the ability to respond on the basis of text colour while inhibiting 
the prepotent reaction to the word name. At all three time points, the EXP and PBO differed 
with regards to Inhibition 2: time. Although this was the only response time of the four that 
showed significance, closer inspection of the other three revealed consistent (although not 
significant) differences between EXP and PBO at all three time points (pre-, mid- and post-
intervention). It is possible that the age difference and the depressive moods of the PBO 
could have played a role as both age (Allain et al., 2005) and depressed moods (Uekermann 
et al., 2003) are known to be linked with EF. At post-intervention, the two groups also differed 
significantly regarding Incongruent 1: time and Incongruent 2: accuracy. 
 
Both Interference: time and Interference: accuracy demonstrated differences between the 
EXP and PBO over the duration of the study. Interference: time was significantly different at 
all three time points and Interference: accuracy at mid- and post-intervention. The treatment 
effect and difference between the two groups suggest that the EXP were better able to inhibit 
their prepotent responses, which manifested as an improvement in their accuracy. The 
significant differences between the two groups over the study duration with regards to 
Interference Score: time suggest that the PBO battled with regards to the aspect of time. 
Interestingly, if one refers back to Figure 5.8, one can clearly observe the progressive 
deterioration of the time to complete TMT A (the easier of the two parts). 
 
Changes over time in EXP were seen in several variables. Improvement in Incongruent 1: 
time is unlikely to be too meaningful as changes took place over the baseline phase, 
treatment phase as well as the duration of the study (baseline and treatment phases). CRT 
1: time and Incongruent 1: time were significant over the duration of the study but not for the 
treatment phase, and thus the improvement is unlikely to have occurred as a result of the 
SMT. Improvement in CRT 2: time was significant over the treatment phase as well as the 
duration of the study. This could be indicative of a learning effect for the test. However, both 
groups underwent a baseline or control phase first, thus the practice effect would have been 
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added to the experimental and placebo groups' treatment phase. Consequently, when the 
different scores are averaged over the treatment phase, the practice effect disappears 
leaving the treatment effect (provided the two groups have the same number of subjects). 
The only variable to show a significant practice effect over baseline was the TUG and none 
of the other dependent variables. Hence, when the treatment phase improved significantly 
the treatment effect was greater than the practice effect. 
 
Poor performance on the Incongruent component of the Stroop task is considered a strong 
predictor of executive dysfunction. Individuals are required to ignore insignificant stimuli or 
inhibit their natural response. Impaired Stroop task performance in non-demented PD 
patients predicted future dementia development (David et al., 2015; Janvin et al., 2005). 
Impaired Inhibition is associated with poorer gait performance and balance in the elderly (Xu 
et al., 2014). 
 
In contrast to the current study, David et al. (2015), Duchesne et al. (2015), Baker et al. 
(2010) and Liu-Ambrose et al. (2008) all reported improvements in Inhibition as a result of 
their exercise interventions. In the current study only Interference 1: accuracy (measure of 
Inhibition) demonstrated a treatment effect. An observation regarding these studies is that 
they were conducted over three months to one year. Perhaps significant changes might 
have been observed if the SMT was conducted over a longer period. 
 
4.2  Functional Balance 
4.2.1 Perceived Stability of Balance: Activities-specific Balance Confidence Scale (ABC) 
The Activities-specific Balance Confidence Scale (ABC) was designed to measure the 
confidence of individuals in their ability to perform activities of daily living without falling. Both 
groups tended to show a learning effect over the baseline phase. Only the EXP improved, 
however, over the treatment phase and overall from pre- to post-intervention. It would 
appear that as their functional mobility and balance improved so, too, did their confidence in 
their balance. This is also reflected in the TUG results. At post-intervention, the two groups 
differed significantly, suggesting that even without seeing a treatment effect for this variable, 
ABC probably improved as a result of the improved functional mobility via the SMT. A similar 
improvement in ABC was seen in the balance training study of Smania et al. (2010) in 
individuals with PD. In contrast, the Wii Fit balance training programme of Esculier et al. 
(2012) saw no improvement in ABC. Neither group attained the minimal detectable change 
MDC of 11.12 (Dal Bello-Haas et al., 2011). 
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Mak et al. (2009) showed that over a 12-month period balance confidence can predict fear 
of falling in individuals with PD: a score lower than 69% was associated with an increased 
risk for recurrent falls and a cut-off score has been determined as ≤ 46% (Almeida et al., 
2014). The EXP was above the 69% cut-off for the duration of the study, while the PBO was 
below this at both the pre- and mid-intervention time points. At post-intervention, the PBO 
improved to move above the cut-off to 71.9%. 
 
4.2.2  Mobility: Timed Up and Go Test (TUG) 
The Timed Up and Go (TUG) Test is considered a simple test requiring an individual to stand 
up from a chair, walk 3 metres, turn around, walk back to the chair and sit down. It is 
considered a good test of functional mobility and balance. Although this appears easy, the 
TUG actually assesses multiple balance and mobility components (Herman et al., 2010). 
The TUG is considered to be associated with cognitive function, including EF, as well as 
motor performance. This is seen in the planning and organization needed to perform this 
movement (Stegemöller et al., 2014; McGough et al., 2011; Herman et al., 2010). 
 
A treatment effect was demonstrated for the TUG and the two groups differed significantly 
at post-intervention. The EXP improved over the baseline phase, treatment phase, as well 
as over the 16-week duration of the study. In contrast, the PBO plateaued and no 
improvement was seen. Thus, although the EXP’s improved ABC score mirrored their 
improved TUG score, this was not the case for the PBO. Thus, it would appear that the PBO 
perceived an improvement in their balance due to the feedback-wristband but this did not 
translate into an actual improvement in functional mobility and balance (TUG). No MCD or 
MCID have been determined for the TUG. 
 
The improvement in TUG seen in the current study, in contrast to the study of Shubert et al. 
(2010) who saw no improvement in TUG in their EXP as a result of an exercise-based 
balance intervention, is similar to other studies which also saw a significant improvement in 
TUG times in response to exercise interventions (Sage & Almeida, 2010; Sage & Almeida, 
2009; Hackney & Earhart 2008). 
 
5. Study Limitations and Future Studies 
Some limitations were noted during the course of this study and will now be briefly 
discussed. The participants were selected using a sample of convenience. Unfortunately, it 
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was not practical to randomize participants for this study. This would have meant having 
more, smaller groups spread over the Western Cape, making holding and travelling to and 
from the exercise groups impossible. Insufficient resources (manpower and financial) made 
it impossible to implement this study further afield during the study period. Thus, participants 
had to reside within a 70km radius of Stellenbosch in the Western Cape and be responsible 
for their own transport to the SMT programme. Future studies would be enhanced by 
targeting a wider area and having more groups available. Consequently, one 
understandable limitation of convenience sampling is that it may not be representative of 
the population. The sample size was also small and, thus, it may not be appropriate to 
extrapolate these finding to the greater PD population. Research in the future would be 
improved by having a larger sample size. This may also explain the observed differences 
between the two groups at baseline. 
 
Participants were tested on their medication for this study. Future research should also 
attempt to assess participants off their medication (after a wash-out period). Unfortunately, 
it was not possible to do this in the current study due to limited man-power and resources. 
However, participants were tested at the same time (plus or minus one hour) at each testing 
session in order to maintain consistency during the study.  
 
The current study was conducted over an eight-week period and it is possible that this was 
not long enough to see changes in EF. Other studies investigated the effect of their exercise 
intervention on EF over a minimum 12-week period (Duchesne et al., 2015; David et al., 
2015; McKee & Hackney, 2013; Cruise et al., 2010; Tanaka et al., 2009).  
 
This study only made use of one version of the MoCA in English and Afrikaans, and therefore 
did not randomize the use of the MoCa. This was because there was only one Afrikaans 
version available at the time of the study. In future studies it may be beneficial to use one or 
more of the other MoCA versions as well.  
 
Another limitation to this study was the increase in social and cognitive interaction as a result 
of participating in this study. Participants attended sessions three times a week for eight 
weeks where they met and engaged with other PD participants going through similar 
experiences and difficulties and interacted with the biokineticists and research assistants. 
The placebo group did not receive this same social or group interaction. This was also 
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mentioned in the study of David et al. (2015). A potential way to improve on this in future 
studies would be to organize PD-relevant talks or educational classes for participants. 
 
As noted earlier in the chapter, some of the older participants were not completely confident 
using a computer and/or a computer mouse. It may be worthwhile developing a system that 
requires participants to press only two individual buttons rather than specific keys on a 
keyboard. An alternative option may be to focus only on non-computerized tests. 
 
The beginning stages of the programme were highly repetitive which was positive in terms 
of emphasizing posture and practicing balance but at times it was a little too drawn out and 
perhaps boring. Most of the participants enjoyed the latter parts of the study with the 
increasing challenges and this should perhaps have begun earlier. The research of 
Abbruzzese et al. (2016) emphasize the importance of intensive challenging rehabilitation 
for those with PD to induce neuroplasticity. In addition, Allen et al. (2011) also recommend 
that highly challenging balance exercises be incorporated into PD rehabilitation 
programmes. Future studies should consider increasing the intensity and challenge of the 
balance exercises as this could have a different outcome on the EF variables. 
 
The three tests which were used in this study – the WCST, the adapted Stroop task and the 
TMT – are standardized and commonly used neuropsychological tests for the assessment 
of EF in PD (Dirnberger & Jahanshahi, 2013). They are objective tests and can be easily 
compared. The WCST and adapted Stroop task were computer based and the TMT 
conducted with pen and paper. During the study it became apparent that they were possibly 
not functional enough. In other words, the tests differed in comparison to activities or tasks 
encountered in daily living. 
 
Every attempt was made to make this study enjoyable and convenient for the participants, 
such as assessing them in their homes where possible and phoning the PBO group every 
two weeks to follow up with them. This study also appears to be the first to investigate the 
impact of an SMT programme on the EF of individuals with PD. As can be seen in the 
available literature, studies addressing the effects of exercise on EF in PD are scarce.  
 
Reflecting back on the study, I believe the sensory-motor training programme was 
successful. The participants really seemed to enjoy it and the attendance for classes was 
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mostly very high. Informal feedback from the participants, as well as their caregivers, was 
very positive. 
 
6. Conclusion 
In conclusion, the SMT programme conducted three times per week over eight weeks, in a 
sample of participants with mild to moderate PD, had an influence on selected aspects of 
EF. The neuroplasticity mechanisms pertaining to the results of this study are likely to 
include an increase in BDNF and in cerebral blood flow, as well as the cognitive reserve 
theory. The SMT programme did not have a significant effect on the ability to shift back and 
forth between different choices (Set shifting) nor on the ability to hold and work with 
information in one’s mind (Updating). However, an improvement relating to the ability to 
inhibit prepotent responses (Inhibition) was noted but further research is needed to confirm 
this. Impaired Inhibition has been associated with poorer balance and gait so an intervention 
that can maintain or improve Inhibition will be of significant benefit. An interesting finding 
from the study was the improvement in visuomotor abilities. There is a link between 
visuomotor ability and sensory integration, which people with PD battle with and a SMT 
programme is able to assist this. General cognition, perception of depressive moods, and 
quality of life in general, remained unchanged as a result of the eight-week SMT. However, 
significant improvements in balance confidence and functional mobility were observed. 
These can have a direct impact on the life of individuals with PD in terms of improved 
balance and a reduction in fall risk. In addition to this, significant improvements were noted 
in MDS-UPDRS II, III and Total which relate to a reduction in PD severity. 
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Appendix B 
Informed Consent Form 
 
 
 
 
STELLENBOSCH UNIVERSITY 
INFORMED CONSENT TO PARTICIPATE IN RESEARCH 
The Influence of an Eight-week Sensory-motor Training Intervention on the Executive 
Function of Independent-living Individuals with Parkinson’s Disease. 
 
You are invited to participate in a research study conducted by Michelle Puren (Main researcher, 
biokineticist and MSc Student) and Dr Karen Welman (Study Leader and biokineticist), through the 
Department of Sport Science at Stellenbosch University. The data generated from the study will be 
utilized in an MSc thesis and in research articles which will assist in increasing the existing 
knowledge in the field of Parkinson’s Disease and exercise. 
1. PURPOSE OF THE STUDY 
 
The main objectives of the study are: 
1. To investigate whether eight weeks of a specific sensory-motor intervention will have a 
significant effect on brain function (executive function). 
2. To determine whether eight weeks of a specific sensory-motor intervention will have a 
significant effect on quality of life, depression and perceived stability or balance 
 
2. PROCEDURES 
We will begin with a telephone call (the first contact session) and then six testing sessions conducted 
at Stellenbosch University’s Sport Science Department or at your home (for your convenience). The 
telephone call should take approximately 15-30 minutes to complete. Each appointment for testing 
should take approximately 60-90 minutes. Testing sessions 1 and 2 will take place within a few days 
of each other and will then be followed by an eight-week baseline period. After this eight-week period, 
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you will be re-tested with testing sessions 3 and 4 again taking place within a few days of each other. 
You will be asked to complete the same tests and questionnaires that you completed the first time 
around. After this, you will be participating in one of two sensory-motor interventions over an eight 
week period. After this eight-week period, you will again be re-tested with testing sessions 5 and 6 
again taking place within a few days of each other. These will be the last testing sessions and you 
will be asked to complete the same tests and questionnaires that you completed previously. 
 
Phone call Session: at the beginning of the telephone call, you will be introduced to the researcher. 
This informed consent form will be explained to you and you will be given the opportunity to ask 
questions. Once you have given your consent (permission to participate) and provided you meet all 
the inclusion requirements, you will be included in the study.  
 
First Testing Session: during this session, your completed informed consent form will be collected. 
You will have additional opportunity to ask questions. Your body measurements will be recorded and 
a short functional test will be conducted. Three questionnaires concerning quality of life, balance 
confidence and a Parkinson’s Disease rating scale will be completed with you 
 
Second Testing Session: during this second testing session, two additional questionnaires will be 
completed with you to assess cognitive status and your mood. Following this, tests of brain function 
(executive function) will be conducted, using pen and paper as well as a computer, and you will be 
given clear instruction regarding what you need to do for each test. 
 
Resting Phase: We will then have an eight-week baseline period (also known as a control phase) 
where you will continue with your normal activities of daily living. There should be no changes to 
your activity levels during this time period. 
 
Third and Fourth Testing Sessions: during these testing sessions, all the questionnaires and tests 
that were conducted at the first and second testing sessions will be repeated. 
 
Sensory-motor Intervention: We will then have an eight week sensory-motor intervention period 
and you will be in one of two sensory-motor groups: 
Feedback-wristband: if you are in this group, you will be required to wear a feedback-wristband for 
the eight-week duration. The feedback-wristband needs to be worn at all times. The feedback-
wristband will give you sensory feedback through the sensation of touch (tactile stimulation). There 
should be no changes to your activity levels during this time period.  
Sensory-motor training programme: if you are in this group, you will be required to participate in 
a structured sensory-motor training programme. You will need to attend three sessions per week 
over the eight-week period. Each session will be led by a qualified biokineticist and one or two 
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research assistants. A biokineticist is a clinical exercise specialist who is registered with the Health 
Professions Council of South Africa (HPCSA). The research assistants will be there to help you if 
you feel a bit unstable or if you are anxious about attempting an activity on your own. Each week of 
the balance training programme will have a different aim and each session will focus on a different 
objective. The programme will become increasingly more challenging as the weeks progress. Each 
session will begin with a 10-minute warm-up, followed by 15-40 minutes of balance training and 
ended with a 10-minute cool-down and relaxation technique session. Other than the sensory-motor 
training programme, there should be no changes to your activity levels during this time period. 
 
Fifth and Sixth Testing Sessions: during these testing sessions, all the questionnaires and tests 
that were conducted at the previous testing sessions will be repeated. 
 
3. DOCTOR / SPECIALIST COMMUNICATION 
We would like to have your doctor / specialist’s contact details so that we can contact them 
telephonically or via email to inform them of your intent to participate in the research. They will also 
get a summary of the proposed research protocol. If you have not seen your doctor / specialist in 
the six months prior to the start of the research study, the department of Sport Science will pay for 
this appointment.  
 
4. PARTICIPATION 
You will need to have a minimum attendance of 70% for the balance training sessions. You will not 
be able to continue if you miss more than 30% of the sessions (in total) or if you miss two consecutive 
sessions. 
You will also be responsible for your own transport to the venue for the balance training sessions. 
 
5. POTENTIAL RISKS 
The sensory-motor training programme and the testing used during this intervention are scientific 
and evidence-based and should not pose any serious risk. The potential for balance loss and / or 
falling is a possibility but we will do our best to minimise these risks. We will have chairs and mats 
available during the sensory-motor training programme in an attempt to avoid this. You will be 
permitted to stop at any stage if you do not feel you are able to continue with a particular exercise. 
We will also be on hand to assist you. Safety procedures will be in place in case of any emergencies 
that may arise during testing or the balance training programme. The biokineticists are qualified in 
basic life support and emergency contact numbers will be on hand (Netcare 082 911, Constantiaberg 
MediClinic 021 799 2196, Cape Medical Response 082 782 444). The University of Stellenbosch is 
insured for emergencies during research interventions. The Sport Science department will cover 
costs if Netcare (private ambulance service) is required and the person does not have their own 
medical aid. 
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6. POTENTIAL BENEFITS 
As a participant, you will not directly benefit from your involvement in the study (you will not receive 
payment for participating in the study), however, your balance might improve as a result of your 
involvement in one of the sensory-motor interventions. 
Upon completion of the study, you will also receive a DVD of the exercises which will be used in the 
sensory-motor training programme. There is also the potential benefit of improved brain function 
(executive function) as a result of your participation in the study (this is not guaranteed as this is 
what is being investigated). 
 
7. PARTICIPATION COSTS 
Participation in this study is strictly voluntary. There will be no financial remuneration for participation 
in the study nor will there be any cost to you to participate in the study.  
 
8. CONFIDENTIALITY 
Your information will be protected and remain anonymous in this study. All participants’ names will 
be coded in order to ensure anonymity. Your data will be stored on a password protected computer 
accessible by the researchers alone. Questionnaires, informed consent forms and any other hard 
copy information will be stored in a locked filing system in the Motor Learning Laboratory at 
Stellenbosch University’s Department of Sport Science. No participant names will be given in the 
MSc thesis or in any research articles. 
 
9. PARTICIPATION, WITHDRAWAL & RIGHTS OF RESEARCH SUBJECTS 
Your participation in this study is voluntary and you are free to withdraw at any time without reason. 
You also have the right to decline to answer any questions which you do not wish to answer. The 
researcher reserves the right to withdraw your participation from this study should a situation arise 
where this is warranted. If you have questions concerning research subject rights, please contact 
Ms Maléne Fouché (mfouche@sun.ac.za; 021 808 4622) at Stellenbosch University’s Division for 
Research Development. 
All efforts are made to ensure your safety during the balance exercises and testing. However, if you 
obtain a research-related injury the researcher is trained in first aid and able to assist you. You can 
contact Mr van Kerwel (wvankerwel@sun.ac.za) at the University of Stellenbosch for information on 
the issue of compensation and coverage of medical expenses in the event of a research-related 
injury. 
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10. RESEARCHERS 
The two main researchers for this study are Dr Karen Welman (Study leader; welman@sun.ac.za; 
021 808 4733 or 082 098 5387) and Michelle Puren (MSc Student; 13874322@sun.ac.za; 084 246 
7870). Please direct any queries or concerns regarding this study to them.  
 
SIGNATURE OF RESEARCH SUBJECT OR LEGAL REPRESENTATIVE 
 
The information above was explained to        (me/the subject/the participant) by   
     (name of relevant person) in      (English /Afrikaans /Xhosa /other) and   
  (I am/the subject is/the participant is) in command of this language or it was satisfactorily 
translated to     (me/him/her).        (I/the participant/the subject) was given the 
opportunity to ask questions and these questions were answered to     (my/his/her) 
satisfaction.  
(I hereby consent to voluntarily participate in this study/I hereby consent that the subject/participant 
may participate in this study.) I have been given a copy of this form. 
________________________________________ 
Name of Subject/Participant 
________________________________________ 
Name of Legal Representative (if applicable) 
_____________________________________________    ______________ 
Signature of Subject/Participant or Legal Representative    Date 
SIGNATURE OF INVESTIGATOR  
 
I declare that I explained the information given in this document to __________________ (name of 
the subject/participant) and/or (his/her) representative ____________________ (name of the 
representative). (He/she) was encouraged and given sufficient time to ask additional questions. This 
conversation was conducted in (Afrikaans/*English/*Xhosa/*Other) and (no translator was used/this 
conversation was translated into ___________ by _______________________). 
________________________________________   ______________ 
Signature of Investigator            Date 
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Appendix C 
Newspaper Articles 
 
 
 
Article 1: False Bay Echo. Article 2: Constantiaberg Bulletin. 
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Appendix D 
The Hoehn and Yahr Scale 
 
 
The Hoehn and Yahr scale (HY) is a clinical rating scale that describes broad categories of motor 
function in PD. This scale is widely used because it is simple and easily applied. Since it captures 
typical patterns of progressive motor impairment, which is apparent in PD subjects, it can be applied 
whether they are receiving dopaminergic therapy or not. It has been found that progression in HY 
stages correlate with motor decline, decline in quality of life, and neuroimaging and studies of 
dopaminergic loss (Hoehn & Yahr, 1967). 
 
Table 1. The Hoehn and Yahr Scale which is used to categorize motor function in PD (Hoehn 
& Yahr, 1967). 
 
Stage Description 
Stage 1 Only unilateral involvement, usually with minimal or no 
functional disability 
Stage 2 Bilateral or midline involvement without impairment of 
balance 
Stage 3 Bilateral disease: mild to moderate disability with impaired 
postural reflexes; physically independent 
Stage 4 Severely disabling disease; still able to walk or stand 
unassisted 
Stage 5 Confinement to bed or wheelchair unless aided 
 
Stellenbosch University  https://scholar.sun.ac.za
131 
 
Appendix E 
PD-related Medication and Affected Side 
 
 
Table .1: List of Medication and Affected Side of Sample 
      
EXP Medication AS PBO Medication AS 
1 Carbilev Right 1 Sinemet Left 
2 Carbilev Left 2 Requip; Carbilev Both 
3 Carbilev; Serdep Right 3 Carbilev Right 
4 Carbilev Left 4 Madopar Right 
5 Carbilev Right 5 Carbilev Both 
6 Azilect Left 6 Carbilev Both 
7 Carbilev; Dissipal Right 7 Pexola; Carbilev; Azilect; 
Sinemet 
Both 
8 Carbilev; Parkilyne Right 8 Medopar; Pexola Right 
9 Pexola; Akineton Right 9 Medopar Left 
10 Carbilev; Trepline Right 10 Medopar Both 
11 Stalevo; Requip; Parkilyne Both 11 Carbilev Both 
12 Carbilev Left 12 Carbilev; Pexola; Sinmet Left 
13 None Right 13 Carbilev; Migroben; Zuvamor Both 
14 Parkilyne; Carbilev  Right 14 Carbilev Left 
15 Cyprolex; Carbilev Left 15 Carbilev Left 
16 Carbilev Right 16 Pexola; Azilect Both 
17 Carbilev; Pexola Right 17 Pexola; Carbilev; Sinmet Both 
18 Carbilev; Trepiline Right    
19 Carbilev; Azilect Both    
20 Carbilev; Azilect Both    
21 Dissipal Both    
22 Carbilev Left    
23 None Left    
24 Carbilev; Topiramat; Solain; 
Dissipal; Pexola 
Left    
25 Madopar; Requip Both    
Abbreviations: EXP Experimental group; PBO Placebo group; AS Affected side 
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Appendix F 
Personal Information Form 
 
 
 
Personal Information Form: 
Name: 
Surname: 
Age: 
Gender: 
Contact number (please indicate your preferred contact method): 
 
Level of Parkinson’s (Hoehn &Yahr Scale), if known 
When were you diagnosed with PD? 
Most affected side: (Left, right, both) 
 
Occupation (if retired, state previous): 
Current medication; and duration of use: 
 
 
Any adverse effects of medication: 
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Who is your caregiver: 
Relationship of caregiver: 
Time spent without caregiver: 
Would your caregiver like to attend the exercises as well?  
Household chores: 
 
 
 
 
Leisure time activities: 
 
 
 
 
Has your doctor given you approval to participate in this study?  
 
Who is your doctor? 
Would you mind if we contact him/her? 
If not please provide us with his/her contact no. 
 
 
Are you going away anytime between August and November 2014? If yes, please state dates. 
 
 
 
* Afrikaanse vorms is ook beskikbaar. 
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Appendix G 
Session Information Sheet 
 
 
Session Information Sheet 
Please tick which dates, time and area would suit you best to come for exercises: 
Days: Please select a minimum of 3 possible days 
 
 
Times: 
 
 
Area:  
 
 
 
 
Mondays Tuesdays Wednesday
s 
Thursdays Fridays 
Fishhoek Kenilworth/ 
Kirstenhof 
Stellenbosc
h 
Paarl Strand 
9:00 – 10:00 10:00 – 11:00 11:00 – 12:00 
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Appendix H 
General Information and Health Form 
 
General Information and Health Form 
 
Patient Name: ______________________ Patient Surname: ______________________ 
 
Assessment date: _____________________ Date of Birth:  ______________________ 
 
Level of Parkinson’s disease (if known): _____________________ 
 
Complete the following questions as accurately as possible. Tick the appropriate block ( ). 
1. Has your doctor given you permission to participate in this study?       Yes      No 
Doctor’s name and contact details __________________________________________________ 
 
2. Are you on regular medication?       Yes      No 
If yes, please indicate name, dosage and purpose _____________________________________ 
_____________________________________________________________________________ 
 
3. Most affected side:  Left   Right    Both 
 
4. Occupation (if you are retired, please indicate this and what you did before you retired:  
_____________________________________________________________________________ 
 
5. Do you do housework and / or gardening?       Yes      No 
If yes, please indicate what chores you do____________________________________________ 
 
6. How often do you participate in physical activity or exercise? 
Times per week: ____________ Duration: _____________ Type: _________________________ 
 
7. Do you have a history of any of the following? 
 Heart attack      Coronary thrombosis     Narrowing arteries 
 High cholesterol    High blood pressure    Leaking valve 
 Stroke        Angina /Chest pains    Other heart condition or disease 
 Rheumatic fever    Known heart murmur     Palpitations 
 Recent operation     Aedema / swelling of ankles  Breathing problems / difficulties 
 Low blood pressure   Seizures        Lung disease 
 Fainting or dizziness   Cancer        Diabetes 
 Intermittent claudication  Unusual fatigue /      Pain/ discomfort in chest, neck,    
            shortness of breath       jaw, arms 
 Other (please indicate): ________________________________________________________ 
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8. Do you have a recent history of, or currently have, any joint / muscle injuries or pain? 
        Neck   Upper back   Lower back    Hip 
        Thigh   Knee     Lower leg     Ankle 
        Foot    Shoulder    Elbow      Wrist or hand 
        Other (please specify: ______________________________________________________ 
 
9. Has your doctor previously indicated any other conditions that we should know of? 
_____________________________________________________________________________ 
 
10. Are you colour blind?       Yes      No 
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Appendix I 
39-Item Parkinson’s Disease Questionnaire (PDQ-39) 
 
Please complete the following: 
Please tick one box for each question 
Due to having Parkinson’s Disease, how often during the last month have you…  
 Never Occasion-
ally 
Sometimes Often Always 
(Or cannot 
do at all) 
1. Had difficulty doing the leisure 
activities which you would like to do? 
     
2. Had difficulty looking after your 
home, e.g. DIY, housework, 
cooking? 
     
3. Had difficulty carrying bags of 
shopping? 
     
4. Had problems walking half a mile?      
5. Had problems walking 100 yards?      
6. Had problems getting around the 
house as easily as you would like? 
     
7. Had difficulty getting around in 
public? 
     
8. Needed someone else to 
accompany you when you went out? 
     
9. Felt frightened or worried about 
falling over in public? 
     
10. Been confined to the house more 
than you would like? 
     
11. Had difficulty washing yourself?      
12. Had difficulty dressing yourself?      
13. Had problems doing up your 
shoe laces? 
     
14. Had problems writing clearly?      
15. Had difficulty cutting up your 
food? 
     
16. Had difficulty holding a drink 
without spilling it? 
     
17. Felt depressed?      
18. Felt isolated and lonely?      
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19. Felt weepy or tearful?      
20. Felt angry or bitter?      
21. Felt anxious?      
22. Felt worried about your future?      
23. Felt you had to conceal your 
Parkinson's from people? 
     
24. Avoided situations which involve 
eating or drinking in public? 
     
25. Felt embarrassed in public due to 
having Parkinson’s Disease? 
     
26. Felt worried by other people's 
reaction to you? 
     
27. Had problems with your close 
personal relationships? 
     
28. Lacked support in the ways you 
need from your spouse or partner? 
(If you do not have a spouse or 
partner tick here) 
     
29. Lacked support in the ways you 
need from your family or close 
friends? 
     
30. Unexpectedly fallen asleep 
during the day? 
     
31. Had problems with your 
concentration, e.g. when reading or 
watching TV? 
     
32. Felt your memory was bad?      
33. Had distressing dreams or 
hallucinations? 
     
34. Had difficulty with your speech?      
35. Felt unable to communicate with 
people properly? 
     
36. Felt ignored by people?      
37. Had painful muscle cramps or 
spasms? 
     
38. Had aches and pains in your 
joints or body? 
     
39. Felt unpleasantly hot or cold?      
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Appendix J 
Activities-specific Balance Confidence Scale (ABC) 
 
0%  10  20  30  40  50  60  70  80  90  100%  
                 
 
 
 
 
How confident are you that you will not lose your balance or become unsteady when you…  
1. Walk around the house? 
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
2. Walk up or down stairs?  
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
3. Bend over and pick up a slipper from the front of a closet floor  
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
4. Reach for a small can off a shelf at eye level? 
0%  10  20  30  40  50  60  70  80  90  100%  
 
  
5. Stand on your tiptoes and reach for something above your head? 
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
6. Stand on a chair and reach for something? 
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
7. Sweep the floor?  
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
8. Walk outside the house to a car parked in the driveway?  
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
9. Get into or out of a car?  
0%  10  20  30  40  50  60  70  80  90  100%  
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10. Walk across a parking lot to the mall?  
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
11. Walk up or down a ramp? 
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
12. Walk in a crowded mall where people rapidly walk past you?  
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
13. Are bumped into by people as you walk through the mall? 
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
14. Step onto or off an escalator while you are holding onto a railing? 
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
15. Step onto or off an escalator while holding onto parcels such that you cannot hold onto the 
railing?  
0%  10  20  30  40  50  60  70  80  90  100%  
 
 
16. Walk outside on icy sidewalks?  
0%  10  20  30  40  50  60  70  80  90  100%  
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Appendix K 
The Hamilton Rating Scale for Depression (HAM-D) 
 
Patient Name: _____________________ 
Assessment date: _____________________ 
Instructions: 
Complete the scale based on a structured interview. For each item, select the one “cue” which best 
characterizes the patient. Be sure to record the answers in the appropriate spaces (positions 0 through 4). 
 
1) Depressed mood (sadness, hopeless, helpless, worthless) 
 
        Absent; 
 
        These feeling states indicated only on questioning; 
 
        These feeling states spontaneously reported verbally; 
 
        Communicates feeling states non-verbally, i.e. through facial expression, posture, voice and tendency 
to weep;  
 
        Patient reports virtually only these feeling states in his/her spontaneous verbal and non-verbal 
communication 
 
2) Feelings of guilt 
 
 Absent;  
 
 Self-reproach, feels he/she has let people down; 
 
 Ideas of guilt or rumination over past errors or sinful deeds; 
 
 Present illness is a punishment. Delusions of guilt; 
 
 Hears accusatory or denunciatory voices and/or experiences threatening visual hallucinations      
 
3) Suicide 
 
 Absent;  
 
 Feels life is not worth living; 
 
 Wishes he/she were dead or any thoughts of possible death to self; 
 
 Ideas or gestures of suicide; 
 
 Attempts at suicide (any serious attempt rate 4) 
 
4) Insomnia: Early in the night 
 
 No difficulty falling asleep; 
 
 Complains of occasional difficulty falling asleep, i.e. more than 1/2 hour; 
 
 Complains of nightly difficulty falling asleep 
 
5) Insomnia: Middle of the night 
 
 No difficulty; 
 
 Complains of being restless and disturbed during the night; 
 
 Waking during the night - any getting out of bed rates 2 (except for purposes of voiding)    
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6) Insomnia: Early hours of the morning 
 
 No difficulty; 
 
 Waking in early hours of the morning but goes back to sleep; 
 
 Unable to fall asleep again if he/she gets out of bed   
 
7) Work and Activities 
 
  No difficulty; 
 
 Thoughts and feelings of incapacity, fatigue or weakness related to activities, work or hobbies; 
 
 Loss of interest in activity, hobbies, or work - either directly reported by the patient or indirect in 
listlessness, indecision and vacillation (feels he/she has to push self to work or activities); 
 
 Decrease in actual time spent in activities or decrease in productivity. Rate 3 if the patient does not 
spend at least three hours a day in activities (job or hobbies) excluding routine chores; 
 
 Stopped working because of present illness. Rate 4 if patient engages in no activities except routine 
chores, or if patient fails to perform routine chores unassisted. 
 
8) Retardation   
 
 Normal speech and thought; 
 
 Slight retardation during interview; 
 
 Obvious retardation during interview; 
 
 Interview difficult; 
 
 Complete stupor 
 
9) Agitation 
 
 None; 
 
 Fidgetiness; 
 
 Playing with hands, hair, etc; 
 
 Moving about, can't sit still; 
 
 Hand wringing, nail biting, hair-pulling, biting of lips 
 
10) Anxiety Psychic 
 
 No difficulty; 
 
 Subjective tension and irritability; 
 
 Worrying about minor matters; 
 
 Apprehensive attitude apparent in face or speech; 
 
 Fears expressed without questioning 
 
 
11) Anxiety Somatic (physiological concomitants of anxiety) such as: 
Gastro-intestinal - dry mouth, wind, indigestion, diarrhoea, cramps, belching; Cardiovascular - palpitations, 
headaches; Respiratory - hyperventilation, sighing; Urinary frequency; Sweating 
 
 Absent;  
 Mild;          
 Moderate; 
 Severe; 
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 Incapacitating 
 
12) Somatic symptoms gastro-intestinal 
 
 None; 
 
 Loss of appetite but eating without staff encouragement. Heavy feelings in abdomen; 
 
 Difficulty eating without staff urging. Requests or requires laxatives or medication for bowels or 
medication for  
      gastro-intestinal symptoms 
 
13)  General somatic symptoms 
 
 None; 
 
 Heaviness in limbs, back, or head. Backaches, headaches, muscle aches. Loss of energy and 
fatigability; 
 
 Any clear-cut symptom rates 2 
 
14) Genital symptoms (symptoms such as loss of libido, menstrual disturbances) 
 
 Absent; 
 
 Mild; 
 
 Severe 
 
15) Hypochondriasis 
 Not present; 
 
 Self-absorption (bodily); 
 
 Preoccupation with health; 
 
 Frequent complaints, requests for help, etc;  
 
 Hypochondriacal delusions 
 
16) Loss of weight (Rate either A or B) 
 
A) According to the patient: 
 
 No weight loss; 
 
 Probable weight loss associated with  
      present illness; 
 
 Definite (according to patient) weight loss; 
 
 Not assessed 
B) According to weekly measurements: 
 
 Less than 1lb weight loss in week; 
 
 Greater than 1lb weight loss in week; 
 
 Greater than 2lb weight loss in week; 
 
     Not assessed 
 
17) Insight 
 
 Acknowledges being depressed and ill; 
 
 Acknowledges illness but attributes cause to bad food, climate, overwork, virus, need for rest, etc;  
 
        Denies being ill at all 
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Appendix L 
Montreal Cognitive Assessment (MoCA) 
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Appendix M 
Trail Making Tests (TMT) parts A and B 
 
Trails A: Sample 
 
 
Trails B: Sample 
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Trails A: 
 
 
Trails B: 
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Appendix N 
Sensory-motor Training Programme with Aims and Objectives 
Week 1 
Aim: Familiarization and alignment 
1. To increase proprioceptive input to foot, sacro-iliac joint (SIJ) and cervical spine to ensure proper positioning during exercise sessions. 
Session 1 
Objective: Foot proprioception 
Session 2 
Objective: SIJ proprioception 
Session 3 
Objective: Cervical spine proprioception 
 Cue Posture 
 Short foot training 
 Sitting: Passive modelling or hand positioning 
 Standing: 
- try to maintain short foot (SF) 
- modified tandem stance with SF  
- one leg balance with SF 
- pick foot up in air and maintain SF 
 Curl toes up and increase arch (pull towards heel) 
 Toe abduction (spreading) 
 Towel dragging 
 Inversion 
 Eversion 
 Plantar flexion 
 Marble pick ups 
 Weight shifts 
 Cue posture - close zip for TA activation 
 Short foot training (recap) – 10min 
 SIJ training 
 Seated:  
- Pelvic tilt  
 Standing:  
- Pelvic tilt 
- try to maintain short foot (SF) 
- one leg balance with SF 
- modified tandem stance with SF 
 Weight shifts with TA activation 
 Cue posture 
 Short foot training (recap) 
 Cervical spine training with SIJ training 
 Repeat SIJ training with nodding movement of head 
(Roll shoulders, arms down, someone is pulling on your 
ears, chin in) 
 
Week 2 
Aim: Static balance  
1. To maintain postural control on unstable surfaces and progress to weight shifting, eliminating vision or adding head movements. 
2. Focus on using the ankle strategy during exercise sessions. 
Session 1 
Objective: Posture 
Session 2 
Objective: Base of support 
Session 3 
Objective: Centre of gravity 
 Cue Posture  Cue posture  Cue posture 
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 Balance exercises 
 Sitting with feet on firm surface: 
- trunk leans in different directions 
- Reaching for objects 
- Catching and throwing objects (group) 
 Standing with feet on firm surface: 
- Eyes open 
- Trunk leans in different directions 
- Reaching for objects 
- Catching and throwing objects (group) 
 Modified Tandem stance: 
- Eyes open 
 Somatosensory activity 
 The ball game 
 Over the moon 
 Over the moon – rock forward, step up 
 Balance exercises 
 Standing with feet on firm surface: 
- Eyes open 
- Trunk leans in different directions 
- Reaching for objects 
- Catching and throwing objects (group) 
 Modified Tandem stance: 
- Eyes open 
- Trunk leans in different directions 
- Reaching for objects 
- Catching and throwing objects (group) 
 Single leg stance: 
- Eyes open 
 Somatosensory activity 
 Belly button training 
 Standing weight shifts 
 Balance exercises 
 Standing with feet on firm surface: 
- Eyes open 
- Trunk leans in different directions 
- Reaching for objects 
- Catching and throwing objects (group) 
 Modified Tandem stance: 
- Eyes open 
- Dim room lights 
- Dark glasses 
 Single leg stance: 
- Eyes open 
- Dim room lights 
- Dark glasses 
 Somatosensory activity 
 Standing weight shifts 
 Making waves 
Week 3 
Aim: Static balance  
1. To maintain postural control on unstable surfaces and progress to weight shifting, eliminating vision or adding head movements. 
2. Focus on using the ankle strategy during exercise sessions and introduce hip strategy. 
Session 1 
Objective: Posture 
Session 2 
Objective: Base of support 
Session 3 
Objective: Centre of gravity 
 Cue Posture 
 Balance exercises 
 Sitting with feet on firm surface: 
- trunk leans in different directions 
- Reaching for objects 
- Catching and throwing objects (group) 
 Standing with feet on firm surface: 
- trunk leans in different directions 
 Cue posture 
 Balance exercises 
 Standing with feet on firm surface: 
- trunk leans in different directions 
- Reaching for objects 
- Catching and throwing objects (group) 
 Modified Tandem stance on firm surface: 
- Eyes open 
 Cue posture 
 Balance exercises 
 Standing with feet on  firm  surface: 
- trunk leans in different directions 
- Reaching for objects 
- Catching and throwing objects (group) 
 Modified Tandem stance on  firm surface: 
- Eyes open 
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- Reaching for objects 
- Catching and throwing objects (group) 
 Modified Tandem stance on firm surface: 
- Eyes open 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Somatosensory activity 
 Standing weight shifts 
 Making waves 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Single leg stance on firm surface: 
- Eyes open 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Somatosensory activity 
 Keeping you on your toes 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Single leg stance on firm surface: 
- Eyes open 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Somatosensory activity 
 Rock and walk 
Week 4 
Aim: Dynamic balance  
1. To maintain postural control on progressively unstable surfaces while adding upper- and lower extremity movement. 
2. Maintain ankle strategy during exercise sessions and focus hip strategy. 
Session 1 
Objective: Posture 
Session 2 
Objective: Base of support 
Session 3 
Objective: Centre of gravity 
 Cue Posture 
 Balance exercises 
 Modified Tandem stance on firm surface: 
- Eyes open 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Single leg stance on firm surface: 
- Eyes open 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Walking (15m) 
- normal walking  
- high knees walking 
 Cue posture 
 Balance exercises 
 Modified Tandem stance on firm surface: 
- Eyes open 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Single leg stance on firm surface: 
- Eyes open 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Walking (15m) 
- normal walking  
- high knees walking 
 Cue posture 
 Balance exercises 
 Single leg stance on firm surface: 
- Eyes open 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Walking (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Walking with reduced vision (15m) 
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- butt kicks walking 
- sideways walking 
 Somatosensory activity 
 Opposing circles and high fives 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Somatosensory activity 
 Follow the light 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Somatosensory activity 
 Agility ladders 
Week 5 
Aim: Dynamic balance  
1. To maintain postural control on progressively unstable surfaces while adding upper- and lower extremity movement. 
2. Maintain ankle strategy, focus on hip strategy and start introducing stepping strategy in exercise sessions 
Session 1 
Objective: Posture 
Session 2 
Objective: Base of support 
Session 3 
Objective: Centre of gravity 
 Cue Posture 
 Balance exercises 
 Single leg stance on compliant surface: 
- Eyes open 
- Dark glasses 
- One eye closed 
- Both eyes closed 
 Walking (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Walking with reduced vision (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Cue posture 
 Balance exercises 
 Walking (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Walking with reduced vision (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking with reduced vision 
 Weight shifts with stepping strategy with 
reduced vision 
 Somatosensory activity 
 Follow the light 
 Cue posture 
 Balance exercises 
 Walking (15m)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Walking with reduced vision (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking with reduced vision 
 Weight shifts with stepping strategy with 
reduced vision 
 Somatosensory activity 
 Agility ladders 
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 Somatosensory activity 
 Opposing circles and high fives 
Week 6 
Aim: Functional balance  
1. To perform functional movements of everyday life on progressively unstable surfaces. 
2. Maintain ankle and hip strategy and focus on stepping strategy in exercise sessions 
Session 1 
Objective: Posture 
Session 2 
Objective: Base of support 
Session 3 
Objective: Centre of gravity 
 Cue posture 
 Balance exercises 
 Recap Modified Tandem stance on  firm  
 Recap Single leg stance on firm surface: 
 Walking (15m)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Walking with reduced vision (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking with reduced vision 
 Weight shifts with stepping strategy with reduced 
vision 
 Walking with reduced vision & head 
movements (15m) 
- normal walking  
- high knees walking 
 Cue posture 
 Balance exercises 
 Walking (15m)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Walking with reduced vision (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking with reduced vision 
 Weight shifts with stepping strategy with 
reduced vision 
 Walking with reduced vision & head 
movements (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Cue posture 
 Balance exercises 
 Walking (15m) with added obstacles 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Walking with reduced vision (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking with reduced vision 
 Weight shifts with stepping strategy with reduced 
vision 
 Walking with reduced vision & head movements 
(15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
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- butt kicks walking 
- sideways walking 
 Somatosensory activity 
 Agility ladders 
 Somatosensory activity 
 Agility ladders 
 Somatosensory activity 
 Agility ladders 
Week 7 
Aim: Functional balance  
1. To perform functional movements of everyday life on progressively unstable surfaces. 
2. Maintain ankle and hip strategy and focus on stepping strategy in exercise sessions 
Session 1 
Objective: Posture 
Session 2 
Objective: Base of support 
Session 3 
Objective: Centre of gravity 
 Cue posture 
 Balance exercises 
 Recap Modified Tandem stance on firm  
 Recap Single leg stance on firm surface: 
 Walking (15m) with added obstacles 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Reaching exercises 
- Reaching high on shelf  
- Reaching shoulder height 
- Reaching down to ground 
 Weight shifts with stepping strategy 
 Walking with direction change (t-test)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking with reduced vision 
 Cue posture 
 Balance exercises 
 Recap Modified Tandem stance on firm  
 Recap Single leg stance on firm surface: 
 Walking (15m) with added obstacles 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Reaching exercises 
- Reaching high on shelf  
- Reaching shoulder height 
- Reaching down to ground 
 Weight shifts with stepping strategy 
 Walking with direction change (t-test)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking with reduced vision 
 Cue posture 
 Balance exercises 
 Recap Modified Tandem stance on firm  
 Recap Single leg stance on firm surface: 
 Walking (15m) with added obstacles 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Reaching exercises 
- Reaching high on shelf  
- Reaching shoulder height 
- Reaching down to ground 
 Weight shifts with stepping strategy 
 Walking with direction change (t-test)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking with reduced vision 
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 Weight shifts with stepping strategy with reduced 
vision 
 Walking and counting (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
- backwards walking 
 Group Sit-to-stands in circle (move from chair 1 to 
chair 2) 
 Weight shifts with stepping strategy with 
reduced vision 
 Walking and counting (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
- backwards walking 
 Group Sit-to-stands in circle (move from chair 1 
to chair 2) 
 Weight shifts with stepping strategy with reduced 
vision 
 Walking and counting (15m) 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
- backwards walking 
 Group Sit-to-stands in circle (move from chair 1 to 
chair 2) 
Week 8 
Aim: Functional balance  
1. To perform functional movements of everyday life on progressively unstable surfaces. 
2. Maintain ankle and hip strategy and focus on stepping strategy in exercise sessions 
 
Session 1 
Objective: Posture 
Session 2 
Objective: Base of support 
Session 3 
Objective: Centre of gravity 
 Cue posture 
 Balance exercises 
 Recap Modified Tandem stance on  firm  
 Recap Single leg stance on firm surface: 
 Walking with added obstacles and music 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Reaching exercises with reduced vision 
- Reaching high on shelf  
- Reaching shoulder height 
- Reaching down to ground 
 Cue posture 
 Balance exercises 
 Walking with added obstacles and music 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Walking with direction change and obstacles (t-
test)  
- normal walking  
- high knees walking 
- butt kicks walking 
 Cue posture 
 Balance exercises 
 Walking with added obstacles and music 
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking 
 Weight shifts with stepping strategy 
 Walking with direction change and obstacles (t-test)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
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 Weight shifts with stepping strategy 
 Walking with direction change and obstacles (t-
test)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
 Tandem Walking with reduced vision 
 Walking and counting backwards (15m)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
- backwards walking 
 Group Sit-to-stands in circle 
(move from chair 1 to chair 2) 
 360° turns 
- sideways walking 
 Tandem Walking with reduced vision 
 Walking and counting backwards (15m)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
- backwards walking 
 Group Sit-to-stands in circle 
 (move from chair 1 to chair 2) 
 360° turns  
 Sitting on Swiss Ball 
 Sitting on Swiss Ball + Reaching exercises  
- Reaching high on shelf  
- Reaching shoulder height 
- Reaching down to ground 
 Tandem Walking with reduced vision 
 Walking and counting backwards (15m)  
- normal walking  
- high knees walking 
- butt kicks walking 
- sideways walking 
- backwards walking 
 Group Sit-to-stands in circle 
 (move from chair 1 to chair 2) 
 360° turns  
 Sitting on Swiss Ball 
 Sitting on Swiss Ball + Reaching exercises  
- Reaching high on shelf  
- Reaching shoulder height 
- Reaching down to ground 
 
Warm-up and Cool-Down at the beginning and end of every session. 
Aim: To provide an opportunity to warm up and prepare for the session ahead, at the beginning, and to cool down and relax, at the end.  
Warm Up 
Objective: Preparation for session (10 minutes) 
Cool Down 
Objective: Relaxation at end of session (10 minutes) 
 Warm-up game: Balloon Volleyball / Circle Soccer / Shift Around The Clock / Line 
passing 
 Whole body stretches 
 Shoulder circles 
 Neck stretch 
 Arm stretch 
 Arm pushes and circles 
 Back squeezes 
 Hugs 
 Deep breathing 
 Muscular relaxation 
 Hands  
 Arms 
 Neck  
 Face 
 Chest  
 Stomach 
 Buttocks 
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 Wrist circles 
 Thumb to finger 
 Quadriceps stretch 
 Hamstrings stretch 
 Calf stretch 
 Deep breathing 
 Legs 
 Deep breathing 
 Chin-to-chest 
 Chin-to-shoulder 
 Trunk rotation 
 Close eyes  
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Appendix O  
Safety guidelines 
 
The following booklet contains tips to keep in mind while doing balance training. Please make 
yourself familiar with its contents before you start the 8-week intervention program. 
 Nothing should hurt. This is a simple rule, if it hurts inform the instructor. You should 
never get the idea that you should grin and just bear it. Nothing should hurt, cause physical 
problems or should make you feel uncomfortable or anxious. 
 Arm’s-length rule. Whenever you are not sitting, you should be no farther than an arm’s 
length away from a balance support. This support will usually be a sturdy chair, but it could 
also be a walker or cane, handrail or counter, partner or assistant or even the instructor’s 
hand. 
 Ninety percent rule. This rule says that you should attempt only what you are ninety 
percent confident you can do safely – that is, what you are pretty sure you can do. 
 Choose or refuse rule. Participation is always your own choice. If any activity makes you 
uncomfortable, stop and wait until you have the confidence to proceed. 
 Signs to stop an activity immediately. Please inform the instructor if you experience any 
of the symptoms below 
o Dizziness and/or nausea 
o Shortness of breath 
o Unusual fatigue 
o Heart racing or pounding 
o Uneasiness or anxiety 
o Blurred vision or slurred speech 
o Pain or tightness in chest, jaw or arm 
o Sudden paleness or clammy skin 
 Medication, medication, medication. Please ensure that you take your medication as per 
your prescription. The exercise sessions should not serve as a substitution for your 
medication. 
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 Make sure you understand. Please inform the instructor if any of the exercises or 
movements are not completely understood. This will increase your chance of benefiting 
from the program. 
  Good posture. The following points on posture should be maintained throughout the 
session: 
o Stand/sit up straight 
o Keep shoulders back 
o Keep abdomen tucked in 
o Keep feet flat on the floor 
 In case of EMERGENCY. The following steps should be followed in case any participant 
becomes severely ill, disorientated, falls and/or gets injured: 
o Stop exercising immediately 
o Inform the instructor if necessary 
o Any participants standing should sit down 
o Clear the area around the injured participant 
o Make the participant as comfortable as possible 
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Appendix P 
Excessive depressive moods (http://www.nhs.uk) 
 
If the participant experiences some of these signs listed below for most of the day, every day for 
more than two weeks, you should advise them to seek help from their general physician. 
 
Psychological signs include: 
• continuous low mood or sadness 
• feeling hopeless and helpless 
• having low self-esteem  
• feeling tearful 
• feeling guilt-ridden 
• feeling irritable and intolerant of others  
• having no motivation or interest in things 
• finding it difficult to make decisions 
• not getting any enjoyment out of life 
• feeling anxious or worried  
• having suicidal thoughts or thoughts of harming yourself 
 
Physical signs include: 
• moving or speaking more slowly than usual  
• change in appetite or weight (usually decreased, but sometimes increased)  
• constipation  
• unexplained aches and pains 
• lack of energy or lack of interest in sex (loss of libido) 
• changes to your menstrual cycle 
• disturbed sleep (for example, finding it hard to fall asleep at night or waking up very early in 
the morning) 
 
Social signs include: 
• not doing well at work 
• taking part in fewer social activities and avoiding contact with friends 
• neglecting your hobbies and interests 
• having difficulties in your home and family life 
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